The space-time continuum of ras signal transduction pathway by Chandra, Anchal
 Anchal Chandra - Dissertation   1 
 
THE SPACE-TIME CONTINUUM OF 
RAS SIGNAL TRANSDUCTION 
PATHWAY 
 
 
 
 
Dissertation 
Zur Erlangung des Grades eines 
Doktors der Naturwissenschaften 
der Fakultät für Chemie der 
Technischen Universität Dortmund 
 
 
vorgelegt von 
Anchal Chandra 
Aus Hardwar, Indien 
 
  Dortmund 2011  
 
 
 
 
 Anchal Chandra - Dissertation   2 
The work described in this thesis was performed under the supervision of Prof. Dr. 
Philippe Bastiaens from January 2007 to June 2011 at the Max Planck Institute for 
Molecular Physiology, Dortmund and funding of International Max Planck research 
school-Chemical Biology. 
 
 
 
1st Examiner: 
Prof. Dr. Philippe Bastiaens               Department of Systemic Cell Biology  
Max-Planck Institute for Molecular 
Physiology 
Department of Chemistry 
Technical University, Dortmund 
 
 
 
2nd Examiner:  
Prof. Dr. Alfred Wittinghofer            Department of Structural Biology 
Max-Planck Institute for Molecular 
Physiology 
Professor of Biochemistry  
Ruhr-University, Bochum 
 
 
Tag der Abgabe: 02.11.2011 
Tag der Disputation: 29.07.2011 
 
 Anchal Chandra - Dissertation   3 
Zusammenfassung 
Die räumliche Aufteilung periphärer Membran-Proteine, wie GNBP (Ras) moduliert 
deren Spezifität der Signalverarbeitung innerhalb der Zelle. Reversible 
Palmitoylierung durch Palmitoylacyltransferasen (PATs der DHHC der DHHC 
Familie) erzeugt die Verteilung von Ras hin zu der Plasma-Membran (PM) über den 
sekretorischen Weg, indem der entropie-getriebenen Gleichverteilung palmitoylierter 
Proteine auf alle Zellmembrane entgegenwirkt wird (Rocks et al., 2010). In dieser 
Arbeit wird beschrieben, dass DHHC-PATs sich nicht durch Substratspezifität 
auszeichnen und es wird postuliert, dass DHHC Proteine die Palmitoylierungsreaktion 
nicht katalysieren. Stattdessen verstärken sie die Konzentration des Palmitat-
Thioester-Zwischenproduktes und erzeugen auf diese Weise ein zytosolisches 
Reservoir um Palmitoylierung zu vereinfachen. 
 
In dieser Arbeit soll ebenfalls beschrieben werden, wie GSF PDEδ den zügigen 
Transfer von Ras Protein zwischen PM, Golgi Apparat, endoplasmatischem 
Retikulum (ER) und Zytoplama unterstützt. Weiterhin wird aufgezeigt werden, dass 
dies allein solche farnesylierten Ras Proteine betrifft, welche depalmitoyliert oder, im 
Fall von Ras mit polykationischem Motiv, PM-desorbiert sind. In Verbindung mit 
dem Palmitoylierungskreislauf wirkt PDEδ, indem es die Diffusion von 
depalmitoyliertem Ras vereinfacht und erlaubt so dessen kinetisches 
Eingefangenwerden am Golgi Apparat ermöglicht. Andererseits erhöht die 
Solubilisierung von Kras, welches ein polybasisches Segment auszeichnet, weg von 
Endomembranen die Geschwindigkeit, mit der Kras von der PM wieder eingefangen 
werden kann, wodurch dessen Equilibriumsverteilung aufrecht erhalten wird. Dies ist 
wichtig, da PDEδ auf diese Art die durch Ras vermittelte Signaltransduktion 
verstärkt, indem es die Ras-Konzentration an der PM erhöht, und im Gegenzug 
bewirkt das Herunterregeln von PDEδ ein Unterdrücken von regulierten und 
onkogenischen Ras Signalen. Zusätzlich wird die Regulierung von farnesyliertem 
Ras*PDEδ Einheiten via G-Protein Arl2/Arl3 auf eine GTP-abhängige Art 
beschrieben. Diese Erkenntnis deckt einen von PDEδ-abhängigen Mechanismus auf, 
der für die räumliche Organisation von Ras Proteinen in Zellmembranen 
verantwortlich ist und dessen Einfluss auf das Signalverhalten von Ras Wildtyp- bzw. 
mutierter Form. 
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Abstract 
Spatial partioning of peripheral membrane proteins such as GNBP (Ras) modulates its 
intracellular signaling specificity. Reversible palmitoylation by Palmitoylacyl-
transferases (DHHC family PATs) creates cellular partioning of Ras to the plasma 
membrane (PM) via the secretory pathway by counteracting entropy-driven 
equipartitioning of palmitoylated proteins to all cellular membranes (Rocks et al., 
2010). This work describes that DHHC-PATs lack substrate specificity and postulates 
that DHHC proteins do not catalyze the palmitoylation reaction. Rather, they enhance 
the concentration of palmitate-thioester intermediate to generate a cytosolic reservoir 
in order to facilitate palmitoylation. 
This study also describes how the GSF PDEδ mediates rapid shuttling of Ras protein 
pools between PM, Golgi apparatus, endoplasmatic reticulum (ER), cytoplasm and 
demonstrate that this is specific only to farnesylated Ras proteins that are either 
depalmitoylated or PM-desorbed in case of polycationic Ras. PDEδ functions in 
conjunction with the palmitoylation cycle by facilitating depalmitoylated Ras 
diffusion thus permitting its kinetic trapping at the Golgi apparatus. On the other 
hand, solubilization of polybasic stretch-containing Kras from endomembranes by 
PDEδ enhances the speed of re-trapping at the PM and thereby reinstates equilibrium. 
Importantly, PDEδ activity augments Ras mediated signal transduction by 
maintaining Ras at the PM and that down-modulation of PDEδ suppresses both 
regulated and oncogenic Ras signaling. In addition to this, allosteric regulation of 
farnesylated Ras*PDEδ cargo via G-proteins Arl2/Arl3 in a GTP-dependent manner 
is described. These findings reveal PDEδ-dependent mechanisms responsible for the 
spatial organization of Ras proteins in cellular membranes, and their importance in 
signaling via wild type and mutant Ras. 
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I 
1 Introduction 
1.1 Guanine nucleotide binding proteins 
The Guanine nucleotide-binding proteins (GNBPs), together with their associated 
regulators and effectors, participate as central control elements in signal transduction 
pathways.  Many fundamental cellular processes such as cell growth, differentiation, 
vesicular and nuclear transport, are regulated by GNBPs. Ras serves as a prototype for 
the super-family of GNBPs: which cycles between the active GTP-bound state (the 
“on” state) and the inactive GDP-bound state (the “off” state). The exchange of GDP 
to GTP turns the switch on and the hydrolysis of GTP turns it off. In the GTP bound 
form, the GNBPs display a binding surface with high affinity for downstream effector 
proteins [for instance, Hras-GTP has a Kd (dissociation constant) of 18nM for a 
protein kinase Raf1 (Herrmann et al., 1996)]. The structural changes are confined to 
two loop regions called switch I and II (Milburn et al., 1990). However, the intrinsic 
GTPase activity of Ras-related proteins is typically low [4.2x10-4 s-1 for Hras (Neal et 
al., 1988)], which would tend to prolong signal transduction. Thus the high affinity 
effector-binding conformation of Ras proteins is transient; GTP hydrolysis and 
release of γ-phosphate leads to reorientation of effector binding residues, the release 
of effector proteins (due to reduced affinity), and attenuation of downstream 
signaling. The hydrolysis of GTP to GDP is greatly enhanced by the action of GTPase 
activating proteins (GAPs) (Figure 1.1). There are often multiple GAPs that function 
on a given Ras protein, allowing for a variety of input sources at this stage of 
regulation. 
The rate-limiting step in Ras protein activation is the exchange of bound GDP for 
GTP [3.4 x10-4 s-1 for Hras (Neal et al., 1988)]. This favors an inactive steady-state 
conformation of Ras even in the presence of a high cellular GTP/GDP ratio [~10 fold 
(Van Dyke et al., 1977)]. This kinetic limitation is the basis for stimulus-induced 
mechanisms of Ras protein regulation. Activation of GNBPs thus requires guanine 
nucleotide exchange factors (GEFs) that catalyze the release of GDP (Figure 1.1), 
thus promoting GTP loading and activation of Ras [~ 6 fold stimulation of Hras by 
exchange factor SOS1 (Chardin et al., 1993)]. Several GEFs may act on a particular 
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Ras protein, with each GEF responding to distinct upstream stimuli thus generating 
different biological outputs. 
 
Figure 1.1 Schematic representation of GTPase cycle     Reproduced from Dissertation Sirajuddin M. 2007. 
1.2 Structural outlines of the G domain 
The G domain is highly conserved in all GNBPs. The conserved G domain has an 
approximate molecular mass of 21 kDa and has a typical fold consisting of a mixed 
six-stranded β sheet and five α helices (Figure 1.2). Crystal structures of all available 
GNBPs show that Ras shares a common structural core – the G domain fold (Vetter 
and Wittinghofer, 2001). Therefore, Ras is considered a paradigm for most of the 
GNBPs of the TRAFAC class.  
The G domain contains five conserved sequence elements around the guanine 
nucleotide binding site, called G1 to G5 (Bourne et al., 1991; Saraste et al., 1990). 
The G1 motif (GxxxxGKS), also known as P-loop (phosphate binding loop) interacts 
with the α- and β-phosphates of the nucleotide. The G2 motif contains an invariant 
threonine (Thr35 in Ras), which is involved in Mg2+ coordination and direct binding 
to the γ-phosphate. The conserved aspartate (Asp57 in Ras) of G3motif (DxxG) binds 
to the magnesium ion via a water molecule and the glycine (Gly60 in Ras) makes a 
main chain contact to the γ-phosphate. Together these two motifs G2 and G3 trigger 
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conformational changes when the γ-phosphate is hydrolyzed. Therefore the regions 
that include these motifs are termed switch regions. Switch I includes the G2 motif 
and switch II includes the G3 motif. The switches are the main determinants for 
binding of effector molecules. The G4 motif (NKxD) is important for guanine 
nucleotide specificity. The aspartate (Asp119 in Ras) makes a bi-furcated contact to 
the guanine base ensuring the specificity. The alanine (Ala146 in Ras) of G5 motif 
(SAL/K) makes a main chain interaction with the guanine base (Vetter and 
Wittinghofer, 2001) . 
 
Figure 1.2  Structure of Ras G domains  
Ribbon plot of the minimal G domain, with the conserved sequence elements 
and the switch regions in different colors as indicated. The nucleotide and 
Mg2+ ion are shown in ball-and-stick representation. Reproduced from Vetter 
and Wittinghofer, 2001. 
 
1.3 Ras/mitogen-activated protein (MAP or ERK) 
kinase cascade  
The signal transduction via the Ras-MAPK cascade is mediated by sequential 
phosphorylation and activation of protein kinases along the different tiers of the 
cascade. Although the main core phosphorylation chain of the cascade includes Raf 
kinases, MEK1/2, ERK1/2 (ERKs) and RSKs, other alternatively spliced forms and 
distinct components exist in the different tiers, and participate in Ras signaling under 
specific conditions. These components enhance the complexity of the Ras cascade 
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and thereby, enable the wide variety of functions that are regulated by the pathway 
itself. Another factor that is important for the dissemination of Ras signals is the 
multiplicity of the cascade's substrates, which include transcription factors, protein 
kinases and phosphatases, cytoskeletal elements, regulators of apoptosis, and a variety 
of other signaling-related molecules. Growth factor context determines the topology 
of the MAPK signaling network and that the resulting dynamics govern cell fate. 
Ras can be activated when a growth factor binds to a receptor tyrosine kinase such as 
the epidermal growth factor receptor (EGFR) resulting in dimerization and 
autophosphorylation of the receptor. This autophosphorylated receptor then binds to 
the SH2 domain of the adaptor protein GRB2. Through its SH3 domains, GRB2 is 
bound to SOS (Son of Sevenless), which is thus recruited to the plasma membrane. 
SOS proteins (SOS1 and SOS2) are important RAS-GEFs (guanosine nucleotide 
exchange factors), which catalyze exchange of GDP to GTP in Ras. The increased 
proximity of SOS to membrane bound RAS results in increased nucleotide exchange 
on Ras. Many other receptor types, including the G protein-coupled receptors, can 
activate Ras through stimulation of the exchange factors. Ras-GTP has wide range 
effector molecules of which the serine-threonine kinase RAF (MAPKKK = MAP 
kinase kinase kinase) is the most important effector. Activated RAF-kinases 
phosphorylate the MEK (MAPKK =  MAP kinase kinase), which in turn 
phosphorylates and activates ERK (MAP Kinase) (Figure 1.3). ERK/MAPK has 
many nuclear as well as cytosolic substrates, such as transcription factors and 
signaling proteins. This mitogen stimulated Ras signaling results in a change in the 
pattern of gene expression, which may stimulate cell proliferation, promote cell 
survival or control cell differentiation.  
Over the past few years, a number of Ras related genetic disorder known as 
RASopathies have been described (Shaw et al., 2007; Roberts et al., 2007; Schubbert 
et al., 2006; Tartaglia et al., 2007; Pandit et al., 2007; Razzaque et al., 2007; Digilio et 
al., 2002; Hart et al., 2002; Wallace et al., 1990; Aoki et al., 2005; Niihori et al., 
2006). These disorders are mainly caused by germline mutations in genes encoding 
components of Ras/MAPK/pathway. All the mutations result in dysregulation of the 
RAS/MAPK pathway, share a predisposition to develop malignancies and with 
functional studies confirming a constitutively active Ras pathway. This underscores 
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the essential role the Ras pathway in normal embryonic and postnatal development. 
 
Figure 1.3 Overview of the Ras-MAPK pathway and the associated disorders     Reproduced from Denayer et al., 2008. 
1.4 Ras lipidation 
Cellular proteins undergo a vast array of dynamic and static modifications in their 
amino acid backbone, which can dramatically extend and regulate their functional 
output. After protein synthesis, post-translational modifications (PTMs) impart 
proteins with additional function and regulatory control beyond genomic information. 
This allows cells to maintain homeostasis of proteins and respond to extracellular 
signals. Proteins are often subjected to the different co- and post-translational 
modifications, such as phosphorylation, glycosylation and lipidation (lipid 
modifications). The covalent attachment of the lipid moieties represents an essential 
modification found in many Ras family proteins. Three types of lipid modifications 
are known so far: GPI-anchoring, prenylation and acylation (Figure 1.4). Prenylation 
includes attaching farnesyl and geranylgernayl groups and acylation includes N-
myristoylation, N-palmitoylation and S-palmitoylation (Bhatnagar and Gordon, 1997; 
Casey and Seabra, 1996; Resh, 1999).  
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Figure 1.4 Major Lipid Modifications of Proteins 
Prenylation is an irreversible post-translational modification of the protein by 
unsaturated fatty acids via the stable thioester bond. Myristoylation is a stable 
co-translational modification of the N-terminal glycine by the saturated 
myristic acid. Reversible S-palmitoylation occurs at the cysteine residues via 
the thioester-type bond. Gly-glycine, Cys-cysteine, Eth-ethanolamine, P-
phosphate, Man-mannose, GlcN-glucosamine, I-inositol. Reproduced from 
Yeung Tony., 2008).  
Prenylation is an irreversible lipid modification involving covalent attachment to the 
cysteine residues located near to the C terminus of the target proteins. Two types of 
prenyl groups are known to form thioester linkage with the cysteines, farnesyl (15-
carbon) and geranylgernayl (20-carbon) isoprenoids. Specific prenyltransferases 
catalyze the prenylation reaction: the CAAX prenyltransferases and the protein 
geranylgeranyltransferase type I. The prenylation is often required for the proper 
functioning of the modified proteins, either as a mediator of the membrane 
association, as a transport signal, or as a determinant for the specific protein-protein 
interactions (Casey and Seabra, 1996).  
N-myristoylation occurs co-translationally by addition of the 14-carbon saturated 
myristic fatty acid to the N-terminal glycine residue localized within the consensus 
sequence. The myristoylation occurs via the amide bound catalyzed by the specific 
enzyme N-myristoyl-transferase (Raju and Sharma, 1999). Functionally, 
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myristoylation is involved in the membrane anchoring of the target proteins (Resh, 
1999).  
Palmitoylation occurs either through labile thioester linkage (S-palmitoylation) at 
cysteine residue or stable amide linkage (N-palmitoylation) at glycine/cysteine 
residue (Figure 1.5). In contrast to other static lipid modifications, the versatility of 
palmitoylation as a membrane interaction and the protein-sorting module is greatly 
enhanced by its reversibility. S-palmitoylation is unique in that it allows reversible 
attachment of palmitate or other saturated long chain fatty acids to the target proteins 
and is dynamically regulated by extracellular cues. The reversible nature of protein 
palmitoylation enables proteins to shuttle between intracellular compartments. 
Irreversible N-palmitoylation is observed with limited proteins, such as secreted 
morphogen Sonic hedgehog (Pepinsky et al., 1998). Among the cellular palmitoylated 
proteins, polypeptides involved in the signal transduction (e.g. GPCRs, α-subunits of 
G-proteins, Ras-protein, endothelial nitric oxide synthase, adenylate cyclase, 
phospholipase C and non-receptor tyrosine kinases) are often targets for this dynamic 
modification (Bijlmakers and Marsh, 2003; Dunphy and Linder, 1998). When 
discussing the possible functions of palmitoylation, a distinction must be made 
between “constitutive” and “dynamic” palmitoylation. “Constitutive” palmitoylation 
will refer to the original palmitoylation that takes place before the substrate protein 
reaches its final destination, in this case plasma membrane while “Dynamic” 
palmitoylation will refer to the regulation of the acylated state of the substrate protein 
once its began functioning within the signaling network. 
 
Figure 1.5 S-palmitoylation versus N-palmitoylation 
Chemical structures of thioester-linked S-palmitoylation (Left) and amide-
linked N-palmitoylation (right) palmitate attached to a protein. Reproduced 
from Resh, 2006.      
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1.5 Cellular palmitoylation machinery 
1.5.1 Significance of Palmitoylation 
Palmitoylation is versatile in modifying a protein function beyond membrane binding 
and targeting. The visual transduction cycle relies on signaling via a G-protein 
coupled receptor  (GPCR)- Rhodopsin and G-proteins. Palmitoylation of G-protein 
coupled receptor Rhodopsin slows the shutoff of photoexcited rhodopsin, thereby 
extending the activity of this G-protein coupled receptor in vitro (Wang et al., 2005). 
Light absorption triggers isomerization of the rhodopsin- bound chromophore 11-cis-
retinal to all-trans-retinal and thereby initiates visual signaling. Resynthesis of 11-cis-
retinal begins with the conversion of all-trans-retinal to all-trans-retinol (vitamin A). 
The next step is esterification of all-trans-retinol with palmitate to generate an all-
trans-retinyl ester. In this reaction, the retinal protein LRAT (lecithin retinol 
acyltransferase) functions as a palmitoyl acyl transferase. In addition, the reaction 
requires RPE65 (retinal pigment epithelium 65), a protein that exists in a membrane-
bound, palmitoylated form (mRPE65) and a soluble form. mRPE65 functions as the 
palmitate donor (Xue et al., 2004). Moreover, palmitoylation generates a switch that 
alters ligand-binding specificity. The membrane-bound, palmitoylated RPE65 binds 
all-trans-retinyl esters, whereas the soluble form binds all-trans-retinol. Thus, ligand-
binding selectivity is regulated during cycles of light and dark by protein 
palmitoylation. Protein palmitoylation also plays an important role in BMP-induced 
MAPK activation, osterix expression, and osteoblast differentiation (Leong et al., 
2009). A study of Huntington protein, Htt illustrates altering dynamics of protein-
protein interaction by palmitoylation (Yanai et al., 2006; Huang et al., 2004). 
Myristoylated, palmitoylated protein Vac8 mediates vacuole fusion, vacuolar 
inheritance in yeast and cytosol to vacuole transport. Specificity of palmitoylation at 
the three-cysteine residues determines the functional relevance of Vac8. 
Palmitoylation of either Cys4 or Cys5 confers membrane binding and vacuole fusion 
whereas; palmitoylation at of Cys7 does not (Subramanian et al., 2006). 
Furthermore, as palmitoylation is reversible, it allows dynamic regulation of 
membrane localization and trafficking. This has been best demonstrated in case of 
Ras proteins where the acylation state of Ras proteins regulates its dynamic 
localization (Rocks et al., 2005) and in case of synapses where palmitoylation 
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regulate membrane localization and activity of AMPA (Hayashi et al., 2005) and 
GABAA receptor (Keller et al., 2004). Palmitoylation of the post-synaptic density 
protein PSD95 permits clustering of the protein at synapses and regulates synaptic 
strength (El-Husseini et al., 2002). A recent global study of the neural palmitoyl-
proteome highlights the breadth of targets that are rapidly modulated by 
palmitoylation (Kang et al., 2008), further emphasizing the importance of this 
modification in dynamic biological processes. 
1.5.2 Function of Palmitoylation 
Palmitoylation regulate diverse functions of the modified proteins to bind to lipid 
bilayers (membrane binding), to cycle around in the cell (membrane trafficking), and 
to associate with specific membranes (membrane targeting) (Plowman and Hancock, 
2005; Wright and Philips, 2006). Membrane binding of a protein is enhanced by 
hydrophobic insertion of the acyl chain into the lipid bilayer thus altering its 
localisation and function. Although in the case of Ras proteins, a single lipid 
modification such as prenylation is usually enough to  transiently associate soluble 
protein with endomembranes (Choy et al., 1999; Shahinian and Silvius, 1995), kinetic 
trapping owing to its palmitoylation aids is stable anchoring of Ras proteins to the PM 
(Shahinian and Silvius, 1995). Membrane targeting may occur by kinetic trapping. 
Addition of a palmitate by a Palmitoyl acyltransferase (PAT) yields a dually lipidated 
protein that has a long lived association with the membranes. The subcellular 
localisation of a PAT then determines topological distribution of a dually lipidated 
Ras protein. Upon encountering the membrane harboring its cognate PAT, the 
farnesylated Ras protein is palmitoylated and is stably associated with that 
compartment. Targeting of palmitoylated proteins into membrane rafts can be 
accounted for by the saturated nature of the fatty acyl chain. Saturated fatty acids 
prefer to insert into liquid ordered raft domains rather than the bulk plasma membrane 
(Webb et al., 2000; Liang et al., 2001, 2004). 
Interestingly, regulation of palmitate exposure has been suggested, similar to several 
N-terminal myristoylated proteins that undergo a “myristoyl switch”. Myristate is 
sequestered within a hydrophobic pocket of the protein in one state and then flipped 
out when the stimulus is applied such as ligand binding (Resh, 2004). Such a function 
has also been suggested for BET3, a protein involved in tethering transport vesicles to 
the Golgi. The crystal structure reveals a molecule of palmitate completely buried 
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within a hydrophobic channel of the protein (Turnbull et al., 2005). 
A newly defined role of palmitoylation is as a checkpoint of protein quality control as 
described in case of yeast chitin synthase Chs3 (Lam et al., 2006) and yeast SNARE 
protein Tlg1 (Valdez-Taubas and Pelham, 2005). Palmitoylation of Chs3 serves as an 
indicator of proper protein folding and loss of palmitoyation leads to protein 
aggregration and retention in ER thus regulating ER export of this multi membrane 
spanning protein (Lam K.K et al., 2006). 
1.5.3 Ras Acylation cycle 
Cycles of de-/reacylation (Figure 1.6) contribute to the specific localization and rapid 
inter-compartmental exchange of peripheral, palmitoylated proteins like Ras. 
Typically all Ras proteins undergo three steps of post-translational modifications, 
which include prenylation at the cysteine of C-terminal CaaX region, proteolysis of 
terminal AAX and carboxymethylation at the ER. H and Nras undergo an irreversible 
farnesylation as well as secondary modification- palmitoylation imparting 
reversibility and dynamic behavior. These modifications render Ras molecules 
extremely hydrophobic hence increasing their affinity towards cellular membranes. 
Ras acylation cycle is mainly regulated by two sets of enzymes- Palmitoyl acyl 
transferases (PATs) and thioesterases. Subcellular specificity of PATs and ubiquitous 
expression of thioesterases regulates the Ras acylation status. Thus ensuring Ras 
enrichment in cellular compartments essential for it’s functioning.  H/Nras is trapped 
at Golgi apparatus since Golgi serves as primary site of palmitoylation (Rocks et al., 
2010), catalyzed by Golgi resident palmitoylating enzymes (PATs) (Hancock et al., 
1989, 1990). After palmitoylation at the Golgi, palmitoylated Ras is enriched at the 
PM via vesicular transport (Choy et al., 1999). On the other hand, a depalmitoylation 
step catalyzed by an Acyl-Protein Thioesterase (APT) releases the protein by cleaving 
the palmitoyl anchor hence reducing Ras affinity for PM. This results in retrograde 
trafficking back to Golgi membranes by a non-vesicular pathway (Goodwin et al., 
2005). However, the mechanism detailing transport of depalmitoylated Hras and Nras 
(together with several other palmitoylated Ras proteins) to Golgi apparatus for 
another round of palmitoylation has not been described so far and is a matter of 
further investigation. Chapter 4 of this thesis provides details regarding the PDEδ 
mediated regulatory mechanism for depalmitoylated Ras proteins and how it shields 
the lipid moiety of depalmitoylated, farnesylated Ras and prevents its binding to other 
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subcellular membranes such as ER in the viscinity and aqueous cytosolic 
environment. PDEδ thus enhances the encounter rate of depalmitoylated Ras for 
Golgi. Ras acylation cycle thus maintains the PM and Golgi localization of Ras by 
countering entropic homogenization of Ras and hence ensuring its compartment 
related activity.  
 
Figure 1.6 Schematic representation of Ras acylation cycle 
Reproduced from Conibear and Davis, 2010.  
1.5.4 Enzymology of palmitoylation 
New insights into mechanism of protein palmitoylation have been provided with the 
identification of palmitoyl acyl transferases (PATs). PATs catalyze the attachment of 
palmitate to protein substrates. Much of the difficulty in working with these proteins 
arose from the fact that many PATs are integral membrane proteins, and thus largely 
insoluble in water. Palmitoylation has been shown to occur spontaneously in vitro in 
number of cases. The presence of palmitoyl-CoA alone can be enough to induce 
transfer of the palmitate moiety to an exposed cysteine residue. A basic environment 
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is required to de-protonate the cysteine residue to create a thiolate ion. This thiolate 
ion can then undergo nucleophilic attack of the partially positive carbonyl on the 
palmitoyl moiety. After resolution of the tetrahedral intermediate formed between the 
target protein and the palmitoyl-CoA, the palmitate is transferred to the target protein. 
Since the cytoplasm of a cell is a reducing environment, the prospect that this occurs 
in vivo has credibility. Most of the cytosolic acyl-CoA in the cell is bound to acyl-
CoA binding proteins (ACBPs). This sequesters acyl-CoAs and provides a 
mechanism for minimizing otherwise uncontrolled effects of acyl-CoAs on cellular 
processes. Since it is highly dubious that in vivo palmitoylation reflects acyl-transfer 
under physiologically relevant conditions, a protein/enzyme mediated transfer 
mechanism has been proposed. 
1.5.5 DHHC family of Palmitoyl acyl transferases 
The enzymes that mediate palmitoylation- thiol directed Palmitoyl acyltransferases 
(PATs) are polytypic membrane proteins implying that cellular palmitoylation 
reaction occur at cytosol-membrane interface. There are 23 putative S-palmitoyl 
transferases in mammals and 7 in yeast characterized by presence of DHHC 
(aspartate-histidine-histidine-cysteine) motif within a 50 amino acid cysteine- rich 
domain denoted as CX2CX9HCX2CX2CX4DHHCX5CX4NX3FX4 (Mesilaty-Gross et 
al., 1999; Putilina et al., 1999). In addition to the central DHHC domain three further 
sequence motifs have been identified in members of the DHHC family (Figure 1.7). A 
DPG (aspartate-proline-glycine) motif has been identified just to the C-terminus of 
the second transmembrane region. A TTxE (threonine-threonine-any-glutamate) motif 
has also been identified after the fourth transmembrane helix (Mitchell et al., 2006). A 
third motif towards the C-terminus of many proteins has been identified that contains 
a conserved glycine and asparagine (González Montoro et al., 2009). The large 
numbers of these DHHC proteins are coupled with their localization to distinct 
membrane compartments (Ohno et al., 2006) implying that the cellular palmitoylation 
machinery is a highly regulated and coordinated system. 
 
Figure 1.7  Domain organization and topology of DHHC family PATs 
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1.5.6 Sequence conservation and phylogeny of DHHC domain 
Searching translated genomic databases with a 51 amino acid region that encompasses 
the DHHC-CRD region revealed a large number of eukaryotic DHHC proteins, but no 
examples of prokaryotes or archea sequences have been found. This appears to 
coincide with the widespread occurrence of protein palmitoylation in eukaryotes and 
its apparent absence in prokaryotes. The sequence and predicted domain organization 
of a large number of eukaryotic DHHC proteins were compared (Figure 1.8). The 
sequences include 8 DHHC proteins from S. cerevisiae, 9 in Trypanosoma brucei, 23 
in D. melanogaster, 16 in C. elegans, 18 in Takifugo rubripes, 31 in Arabidopsis 
thaliana, and 23 in Homo sapiens (GenBank). All DHHC proteins, with the exception 
of yeast Ynl155W, are polytopic integral membrane proteins with four or more 
transmembrane domains (Figure 1.8). The DHHC-CRD is generally located between 
TM2 and TM3, which is predicted to put it on the cytosolic face of the membrane 
along with the N terminus that precedes TM1 and the C terminus that lies after TM4.  
 
Figure 1.8 Homology and phylogeny of DHHC (aspartate-histidine-histidine-
cysteine) proteins 
(A) Schematic diagram of a DHHC domain protein. The N-terminal region, 
transmembrane domains (gray boxes; TM), DPG (aspartate-proline-glycine) 
motif, DHHC, TTxE (threonine-threonine-asparagine-glutamate) motif, and 
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C-terminal regions are indicated. (B) The 51 amino acid core sequence 
derived from the DHHC of human and yeast Erf2 homologs was aligned 
using ClustalX. Two classes of conserved residues are highlighted. The 
cysteine, histidine, and aspartate residues that make up the DHHC domain 
are shaded black. Additional conserved residues found in the DPG, DHHC, 
and TTxE motifs are shaded red. The letters nf represent the sequence NEDF 
(asparagine-glutamate-aspartate-phenylalanine), and the letters he represent 
the sequence HRLKE (histidine-arginine-leucine-lysine-glutamate). 
Reproduced from Mitchell D.A et al., 2006. 
1.5.7 Yeast, mammalian PATs and their substrate specificity 
Yeast DHHC Family of Proteins 
DHHC-CRD domain has been identified in various known as well as putative PATs 
in both yeast and higher eukaryotes. In addition to Akr1 and Erf2, there are 5 yeast 
DHHC proteins identified (Mitchell et al., 2006) so far. Protein palmitoylation can 
clearly contribute to membrane binding, membrane targeting, and membrane 
trafficking. These effects can be explained by multiple molecular mechanisms (Figure 
1.9). Membrane binding is enhanced by hydrophobic insertion of the acyl chain into 
the lipid bilayer. Membrane targeting may occur by kinetic trapping: For some 
proteins, once the protein is modified by a membrane-bound PAT, the palmitoylated 
protein remains trapped in that particular membrane because of the strength of the 
hydrophobic interaction between the palmitate moiety and the bilayer (Shahinian and 
Silvius, 1995; Schroeder et al., 1996). Thus, in some cases, the localization of the 
PAT determines the initial site of localization of the modified protein (Figure 1.9). 
 
Figure 1.9 Schematic representation of the intracellular sites of protein 
palmitoylation 
Ras proteins (red) are palmitoylated at the cytoplasmic surface of the ER and 
then traffic through the secretory pathway to the inner leaflet of the plasma 
membrane, where they can be depalmitoylated. Depalmitoylated Ras 
becomes repalmitoylated at the Golgi surface. Hh (Hedgehog) also traffics 
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through the secretory pathway. N-palmitoylation of Hh may occur within the 
lumen of the ER, the Golgi, or both. The dually lipidated (cholesterol + 
palmitate) Hh protein is then secreted from the cell. SFKs are 
cotranslationally N-myristoylated on soluble polysomes in the cytosol. SFKs 
such as Fyn appear to traffic directly to the plasma membrane, where 
palmitoylation occurs. Other SFKs such as Lck traffic through the secretory 
pathway. Palmitoylation could occur during biosynthetic transit or at the 
plasma membrane. Reproduced from Marilyn D. Resh, 2006. 
 
 Consistent with this model, the yeast DHHC proteins are widely distributed on 
cellular membranes. Erf2 (Bartels et al., 1999), Swfl (Valdez-Taubas and Pelham, 
2005) and Pfa4 (Ohno et al., 2006) reside on the ER. Akrl and Akr2 are localized at 
the Golgi (Roth et al., 2002; Ohno et al., 2006), Pfa5 is found at the plasma membrane 
(Ohno et al., 2006) and Pfa3 is localized on the vacuole (Smotrys et al., 2005). Recent 
evidence also suggests that Swfl localizes to actin patches, however the majority of 
Swfl's function here appears to be independent of its PAT activity (Dighe and 
Kozminski, 2008). Over the years various DHHC proteins: substrate pairs have been 
identified using yeast genetics and /or biochemical analysis (Figure 1.10).  
A global analysis of protein palmitoylation performed in yeast has considerably 
expanded the palmitoyl-proteome (Roth et al., 2006). The analysis identified thirty-
five new palmitoyl-proteins, increasing the yeast palmitoylproteome to fifty-four 
proteins. Among the proteins identified was a family of amino acid permeases, which 
fall into the subclass of palmitoylated proteins with multiple transmembrane domains. 
The site of palmitoylation in these permeases is a cysteine located at the extreme C-
terminus within a ‘FWC’ sequence (Roth et al., 2006). Whether this palmitoylation 
consensus sequence extends outside of this family of proteins has yet to be 
determined. Similar studies involving deletion of genes encoding DHHC proteins 
either singly or in combination in yeast strains revealed putative enzyme: substrate 
pairs and demonstrated that DHHC proteins account for most cellular palmitoylation 
events (Roth et al., 2006). Of note, the family of amino acid permeases was 
discovered to be palmitoylated by Pfa4 (Roth et al., 2006), the same DHHC protein 
that palmitoylates another multiple transmembrane domain protein Chs3 (Lam et al., 
2006). Also, Pfa3 for instance, was reported to be a general palmitoyltransferase with 
minimal specificity towards the protein substrate (Nadolski and Linder, 2009). 
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Figure 1.10 DHHC-CRD palmitoyl acyl transferases (PATs) and their 
substrates 
                       (Adapted from Marilyn D. Resh, 2006) 
Mammalian DHHC Family of Proteins 
The mammalian family of DHHC proteins is significantly larger than the yeast family 
however very little sequence similarity has been described apart from DHHC domain. 
There are 23 human DHHC genes denoted DHHC1-DHHC24 (DHHC10 is not 
annotated as a gene). Significant progress has been made in characterizing this large 
family of enzymes with respect to substrate identification, localization, and 
expression patterns (Mitchell DA et al., 2006). Like in yeast, the mammalian DHHC 
proteins have a diverse distribution and a majority localize to the ER/Golgi (Ohno et 
al., 2006). One of the most fruitful approaches to identify enzyme: substrate pairs was 
pioneered by (Fukata et al., 2004). Unfortunately, numerous studies on DHHC 
proteins have led to only partial agreement regarding the substrate specificity of 
DHHC proteins (Hou et al., 2009). 
1.6 Targeting of peripheral membrane proteins 
1.6.1 Lipid composition of plasma membrane: 
The plasma membrane is rich in anionic phospholipids (15-20%), the majority of 
which are prefentially distributed to the inner leaflet (Quinn, 2002; Leventis and 
Silvius, 1998). This distinctive composition confers a uniquely negative surface 
charge to the cytosolic aspect of the cell membrane. The lipid composition of the 
plasma membrane largely comprises of the zwitterionic, electrically neutral lipids of 
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) constituting ~ 60%, 
Introduction 
 Anchal Chandra - Dissertation   26 
with the charged monovalent acidic lipid phosphatidylserine (PS) constituting ~ 25% 
of the inner leaflet of the plasma membrane (Figure 1.11). Compared to other 
phospholipids, phosphoinositides are present in very low levels (1-2%) and have a 
strong negative valency of 4 (McLaughlin et al., 2002).  Yet, the polyvalent anionic 
phosphoinositides, PI(4)P, PI(4,5)P2 and PI(3,4,5)P3, play an important role in nearly 
all aspects of cell physiology, as much as they may be laterally sequestered into 
microdomains by polycationic peptides (McLaughlin and Murray, 2005; Di Paolo and 
De Camilli, 2006; Lemmon, 2003; Heo et al., 2006; Golebiewska et al., 2006). 
                                     
Figure 1.11 Lipid composition of membranes in different cell compartments 
The lipid compositional data (shown in graphs) are expressed as a percentage 
of the total phospholipid (PL) in mammals (blue) and yeast (light blue). As a 
measure of sterol content, the molar ratio of cholesterol (CHOL; in 
mammals) and ergosterol (ERG; in yeast) to phospholipid is also included. 
The figure shows the site of synthesis of the major phospholipids (blue) and 
lipids that are involved in signaling and organelle recognition pathways (red). 
It should be appreciated that the levels of signaling and recognition lipids are 
significantly below 1% of the total phospholipid, except for ceramide (Cer). 
The major glycerophospholipids assembled in the endoplasmic reticulum 
(ER) are phosphatidylcholine (PtdCho; PC), phosphatidylethanolamine 
(PtdEtn; PE), phosphatidylinositol (PtdIns; PI), phosphatidylserine (PtdSer; 
PS) and phosphatidic acid (PA). In addition, the ER synthesizes Cer, 
galactosylceramide (GalCer), cholesterol and ergosterol. Both the ER and 
lipid droplets participate in steryl ester and triacylglycerol (TG) synthesis. 
The Golgi lumen is the site of synthesis of sphingomyelin (SM), complex 
glycosphingolipids (GSLs) and yeast inositol sphingolipid (ISL) synthesis. 
PtdCho is also synthesized in the Golgi, and may be coupled to protein 
secretion at the level of its diacylglycerol (DAG) precursor. Approximately 
45% of the phospholipid in mitochondria (mostly PtdEtn, PA and cardiolipin 
(CL)) is autonomously synthesized by the organelle. BMP (bis 
(monoacylglycerol) phosphate) is a major phospholipid in the inner 
membrane of late endosomes (not shown). PG, phosphatidylglycerol; 
PI(3,5)P2, phosphatidylinositol-(3,5)-bisphosphate; PI(4,5)P2, 
phosphatidylinositol-(4,5)-bisphosphate; PI(3,4,5)P3, phosphatidylinositol-
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(3,4,5)-trisphosphate; PI4P, phosphatidylinositol-4-phosphate; R, remaining 
lipids; S1P, sphingosine-1-phosphate; Sph, sphingosine. Adapted from Won 
Do Heo et al., 2006. 
 
1.6.2 Surface charge of the plasma membrane: 
The accumulation of negative charges on the inner leaflet creates an electric field 
equivalent to 105 V/cm that strongly attracts cationic molecules, including inorganic 
ions and peptides or proteins with clusters of cationic residues (Figure 1.12) 
(McLaughlin, 1989; Olivotto et al., 1996). This electrostatic attraction is effective 
within the Debye length (estimated to approximate 1 nm) and, as described by the 
Gouy-Chapman theory, is directly proportional to the surface charge density and 
inversely proportional to the ionic strength (McLaughlin S. 1989). It is important to 
note that the surface potential is different from the transmembrane potential, which is 
largely an electrodiffusional (Nernst) voltage generated by the differential 
permeability of the membrane to inorganic ions. Transmembrane proteins, such as ion 
channels, are sensitive to the combined surface and Nernst potentials, while peripheral 
proteins are only subjected to the surface potential on their side of the bilayer. 
The negative surface charge on the inner leaflet of the plasma membrane is crucial for 
the targeting of many intracellular signaling proteins. Most of the peripheral proteins 
including the myristoylated alanine-rich C-kinase substrate (MARCKS), c-Src, K-
Ras4B and Rac1 contain a cationic motif that is necessary for their electrostatic 
attachment to the inner leaflet of the plasmalemma (McLaughlin and Aderem, 1995; 
Hancock et al., 1990; Choy et al., 1999; Michaelson et al., 2001; Murray et al., 1998). 
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Figure 1.12 Surface potential attracts cationic molecules to the inner leaflet of 
the plasma membrane 
Accumulation of anionic phospholipids on the inner leaflet of the plasma 
membrane leads to generation of a negative surface potential (φsurface) 
within the Debye layer (~1 nm). The surface potential is directly proportional 
to the surface charge density and inversely proportional to the ionic strength 
of the cytosol. This potential attracts cations and macromolecules with 
polybasic motifs. A smaller surface potential is also thought to exist on the 
outer surface, due to the accumulation of negatively charged glycolipids and 
proteins. Superimposed on these surface potentials is an electrodiffusional 
(Nernst) potential caused by an imbalance in the transmembrane ionic 
composition and the differential ionic conductance of the membrane. While 
peripheral proteins are affected by the surface potential on the inner leaflet, 
they are not affected by the transmembrane (Nernst) potential. 
Transmembrane proteins are sensitive to the combined effects of surface and 
transmembrane potential. Reproduced from Yeung Tony, 2008. 
 
It has become apparent that the electrostatic affinity of these polycationic proteins 
with the plasmalemma is not depended on the structure of the cationic motif but is 
regulated by equilibrium binding of positively charged amino acid clusters to 
negatively charged PI(4,5)P2 and PI(3,4,5)P3 lipids in the PM (Heo et al., 2006). 
Thus, mutations that alter the original sequence yet preserve the net cationic charge of 
the region have no effect on the localization of the protein (Hancock et al., 1990; 
Choy et al., 1999; Michaelson et al., 2001; Roy et al., 2000; Okeley and Gelb, 2004). 
Another important feature of such kind of equilibrium binding is proximity to an 
acylated or prenylated moiety (eg. a myristoyl or a farnesyl tail) that is important in 
membrane targeting.  
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1.6.3 Polycationic Ras subfamily proteins 
Most of the polybasic cluster containing Ras superfamily proteins are distributed into 
3 categories (Figure 1.13A): Polybasic proteins with N-terminal myristoylation sites, 
polybasic-myristoyl (such as Arl), with C-terminal prenylation sequence, polybasic-
prenyl (Kras4B, Diras1/2, Rheb, RhebL1 etc) or without primary lipid modifications 
(Rit), polybasic nonlipid PM targeting motifs. Unstructured clusters of basic residues 
consisting of four or more Lys or Arg residues at positions 5 to 20 from the C-
terminus (Heo et al., 2006), target a wide variety of peripheral Ras proteins to the 
plasma membrane (Figure 1.13B). In case of Ras subfamily proteins, polybasic 
proteins are basically categorized as polybasic-prenylated, polybasic-nonprenylated or 
polybasic-palmitoylated (Figure 1.13). A keen observation of these PM targeting 
proteins indicates presence of more lysine or arginine residues in proximity to the C-
terminus thus ensuring strong affinity towards more anionic PM as compared to other 
endomembranes. 
A          B  
Figure 1.13 Polybasic C-terminal containing Ras superfamily proteins 
(A) Phylogenetic tree of 48 small GTPases that were identified to be partially 
or fully localized to the PM. Individual membrane targeting elements are 
color coded: red for polybasic clusters and blue, green, and orange for 
palmitoyl, prenyl, and myristoyl consensus sequences, respectively. (B) 
Correlation between PM localization and the presence of lysine residues in 
region 5 to 20 amino acids from the C terminus. Reproduced from Heo et al., 
2006. 
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1.6.4 Regulation of polybasic Ras proteins at the PM 
To ensure that proteins that are intended to bind the inner aspect of the plasma 
membrane are not mistargeted to other (non-membranous) polyanionic structures, two 
independent components are required: an electrostatic interaction and partioning of a 
hydrophobic tail into the lipid bilayer. Hence, altering the electrostatic interaction can 
affect membrane specific localization of these peripheral proteins. As originally 
proposed by (McLaughlin and Aderem, 1995), modulating net charges of either 
protein or surface charges of the membrane could release bound polypeptides, thereby 
operating as binary electrostatic switches. In this manner, electrostatics could provide 
a new dimension to the regulation of a large number of GTPases and of 
transmembrane proteins with juxtamembrane cationic domains (Strickfaden et al., 
2007; Bivona et al., 2006; Kim et al., 1994). There are several ways to toggle the 
electrostatic switch (Figure 1.14). One is to alter the net charge of the bound protein 
through phosphorylation of residues in the immediate vicinity of the cationic motif. It 
has been demonstrated that phosphorylation of serine and/or threonine residues within 
the cationic domain of K-Ras, MARCKs, and the MAPK cascade scaffold protein 
Ste5 cause their dissociation from the membrane (Bivona et al., 2006; Allen and 
Aderem, 1995; McLaughlin and Aderem, 1995). Phosphorylation of amino acids in a 
positively charged protein domain decreases its net charge thereby dissociating it 
from the membrane.  
 
Figure 1.14 Changes in the net charge of the protein modulate the effect of 
surface charge on protein localization 
(I) Basic residues can be electrostatically shielded by binding anionic 
proteins. (II) Similarly protein phosphorylation (red P) dissociates cationic 
residues from the membrane. (III) Lipid metabolism alters the membrane 
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charge leading to dissociation of cationic clusters from the plasma 
membrane. The membrane surface charge of the endocytic and secretory 
pathways may equally affect protein localization to intracellular signaling 
platforms. Anionic, neutral, and cationic clusters or species are respectively 
shown in red, green, and blue as indicated by the electric charge gradient 
scale.  (Reproduced from Goldenberg and Steinberg, 2010). 
Alternatively, instead of modifying the protein charges, changes in the electric field at 
the inner surface of the PM may take place. Treatment of intact cells with calcium 
ionophore leads to activation of phospholipase C (PLC) thus elevating cytosolic 
calcium levels which shields the anionic surface charges of the PM (Figure 1.15). On 
the other hand, PLC activation induces hydrolysis of +4 valency anionic 
phospholipids such as PI(4,5)P2 thus reducing the anionic charges on the PM. Thirdly, 
calcium released from ER as a results of DAG production via PI(4,5)P2 hydrolysis 
also aids in activating lipid scramblase, resulting in translocation of PS to the outer 
leaflet thus further altering the charges on the inner leaflet of the PM (Yeung et al., 
2006). This ultimately leads to reduce affinity of polycationic proteins and hence 
causes their dissociation from the PM.   
 
Figure 1.15 PIP2 cleavage to IP3 and DAG initiates intracellular calcium 
release and PKC activation 
Diacylglycerol functions as a second messenger signaling lipid, and is a 
product of the hydrolysis of the phospholipid PIP2 (phosphatidyl inositol-
bisphosphate) by the enzyme phospholipase C (PLC) (a membrane-bound 
enzyme) that, through the same reaction, produces inositol triphosphate (IP3). 
Although inositol trisphosphate (IP3) diffuses into the cytosol, diacylglycerol 
(DAG) remains within the plasma membrane, due to its hydrophobic 
properties. IP3 stimulates the release of calcium ions from the smooth 
endoplasmic reticulum, whereas DAG is a physiological activator of protein 
kinase C  (PKC). The production of DAG in the membrane facilitates 
translocation of PKC from the cytosol to plasma membrane. (Modified from 
Wikipedia, Erik Korte "PIP2 cleavage by PLC to release IP3 and DAG"). 
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1.7 Cyclic nucleotide Phosphodiesterases 
Cyclic nucleotide second messengers (cAMP and cGMP) play a central role in signal 
transduction and regulation of physiologic responses. Cyclic nucleotide 
phosphodiesterases (PDEs) form a large superfamily of enzymes that regulate the 
cellular levels of second messengers, cAMP and cGMP, by controlling their rates of 
degradation. They regulate the compartmentalization, duration and amplitude of 
cyclic nucleotide signaling which is attributed to their unique tissue, cellular, and 
sometimes-subcellular distribution. 21 genes, 11 families encoding PDE with varying 
selectivities for cGMP and cAMP have been identified in human genome, and the 
corresponding proteins have been characterized in terms of their physiological and 
regulatory properties (Conti and Jin, 1999; Francis et al., 2001; Soderling and Beavo, 
2000). 
Of the 11 PDE families, 3 families specifically hydrolyze cGMP (PDE5, PDE6 and 
PDE9), 3 families hydrolyze cAMP (PDE4, PDE7 and PDE8) and 5 families 
hydrolyze both cyclic nucleotides with varying efficiency (PDE1, PDE2, PDE3, 
PDE10 and PDE11). The substrate specificity of the PDE enzymes is defined by the 
intricate network of hydrogen bonds formed by the conserved glutamine with the 
purine ring.  
1.7.1 cGMP PDEs 
cGMP controls a diverse array of physiological processes, including platelet function, 
neutrophile adhesion, sperm motility, neuronal signaling, and vascular, smooth 
muscle relaxation. cGMP PDEs are categorized in three major subgroups: cGMP-
stimulated cyclic nucleotide PDEs, photoreceptor cGMP-specific PDEs, and cGMP-
binding cGMP-specific PDEs. 
cGMP PDEs play a key role in controlling epithelial cell functions such as ciliary 
motility and cytokine production. Moreover, cGMP specific PDE6 thermodynamics is 
of great importance for the photo-transduction responses in mammalian eye. 
1.7.2 cGMP specific phosphodiesterase-6 (PDE6) 
PDE6 is a key component exclusively expressed in photoreceptors, where it exists in 
a rod and cone specific form. Retinal rod cGMP phosphodiesterase (PDE6 family) is 
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an effector enzyme in the vertebrate visual transduction cascade. Unlike other known 
PDEs that form homodimers, the rod PDE6 catalytic core is a heterodimer composed 
of two catalytic subunits PDE6α and PDE6β, encoded by PDE6A and PDE6B genes 
respectively, two identical inhibitory subunits PDE6γ, encoded by PDE6G (Baehr et 
al., 1979; Deterre et al., 1988) and one regulatory subunit PDE6δ, encoded by the 
PDE6D gene (Norton, 2004). The cone PDE6 enzyme represents two identical 
catalytic subunits PDE6α’, encoded by PDE6C gene and two identical cone-specific 
inhibitory subunits PDE6γ’, encoded by PDE6H gene (Gillespie and Beavo, 1988) 
(Figure 1.16).  
The catalytic subunits of PDE6, α and β, undergo posttranslational prenylation that is 
farnesyl- and geranylgeranyl side chains respectively at the C-terminus CAAX 
(C=cysteine, A=aliphatic, X=any amino acid) motif. The prenylated, 
carboxymethylated C-termini are responsible for anchoring PDE6 to the outer 
segment of disk membrane and thereby facilitating two-dimensional collisions with 
transducin during visual excitation (Anant et al., 1992; Qin et al., 1992). The 
inhibitory γ-subunits binding, is regulated allosterically by cGMP binding to a protein 
domain of the catalytic subunits, the so-called GAF domain (Norton et al., 2000). A 
putative fourth 17kDa subunit was co-purified with bovine retinal phosphodiesterase 
(Hurwitz et al., 1985) and was later referred to as delta subunit-PDEδ. The structure 
of the membrane bound rod PDE6 holoenzyme is αβγ2, whereas it is α’2γ2 for cone 
PDE6 (Artemyev et al., 1996).  
 
Figure 1.16 Schematic subunit composition and structure of rod and cone 
The catalytic core of rod PDE6 enzyme is represented by PDE6A and 
PDE6B subunits. The catalytic core of cone PDE6 is represented by two 
identical PDE6C subunits. The regulatory domains of both rod and cone 
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PDE6 are represented by tandem GAF domains (GAFa and GAFb). Both 
enzymes contain regions at their catalytic and GAF domains that interact 
with the respective inhibitory subunit PDE6G and PDE6H. The PDE6D 
subunit, which is unique to the rod PDE6 enzyme, is also shown in the 
picture. PDE6D interacts with the catalytic core (PDE6A and PDE6B) of the 
rod PDE6 enzyme and defines enzyme solubilization from the plasma 
membrane. Reproduced from Ridge et al., 2003. 
1.7.3 PDE6 enzymes 
A number of hereditary eye diseases are caused by mutation in PDE6 genes. A form 
of dysplasia (RDC, rod-cone dysplasia) in Irish Setter Terrier is caused by a point 
mutation in codon 807 of PDE6β, leading to C-terminal truncation of PDEβ and to a 
total loss of catalytic activity in rods (Suber et al., 1993). The homozygous nonsense-
mutation in PDEα and PDEβ leads in humans to a form of autosomal-recessive 
retinitis pigmentosa and a missense mutation in PDEβ causes an autosomal-dominant 
form of inheriditary congenital stationary night blindness (Lorenz et al., 1998).  
1.7.4 PDE6 regulatory binding protein (PDEδ)  
17kDa delta subunit (PDEδ) of Phosphodiesterase6 (PDE6) was originally reported to 
act in a negative feedback mechanism during light activation to impair transducin-
mediated activation of PDE6. In photoreceptor rod cells binding of the PDE6 catalytic 
subunits results in the release of the complex from disk membranes and hence the 
termination of transducin-induced activation of PDE6 (Zhang et al., 2007). However, 
the role of PDEδ extends beyond retinal tissue and the photo-transduction cascade. 
This highly conserved protein sequence has been detected in a variety of non-retinal 
tissues, including, heart, placenta, lung, brain, skeletal muscles and liver (Ahumada et 
al., 2002; Ma and Wang, 2007). PDEδ has also been proposed to play a role in 
recycling and internalization of human prostacyclin receptor (Wilson and Smyth, 
2006) and vesicular transport as an effector for, or via forming a complex with Arl2 
and Arl3 (Hanzal-Bayer et al., 2002) and Rab13 (Marzesco et al., 1998).  
Cytoplasmic prenyl binding factor PDEδ have been proposed to assist in H/N/Kras 
signaling in a similar way to Rho- and Rab-GDIs (Guanine-nucleotide Dissociation 
Inhibitors) that bind to prenylated GDP-bound small G-proteins and thus constitute a 
cytoplasmic pool of inactive G-proteins (Hanzal-Bayer et al., 2002). PDEδ has been 
reported as a binding partner for various prenylated small G proteins like K/Hras and 
non-prenylated small G proteins like Arl2 an d Arl3 (Hanzal-Bayer et al., 2002; 
Nancy et al., 2002; Bhagatji et al., 2010; Chen et al., 2010). However, details about 
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function of PDEδ subunit in modulating Ras signaling and its consequences on Ras 
function are still elusive.  
1.7.5 PDEδ homologues 
The sequence of PDEδ is highly conserved among mammals, since the bovine, 
canine, and murine proteins only differ from the human protein by one non-
conservative (T68A) and 0-3 conservative changes. In Drosophila melanogaster and 
the eyeless nematode Caenorhabditis elegans, orthologues exist sharing 61% and 
69% identity with human PDEδ, respectively. Subsequent research for proteins 
closely related to PDEδ revealed significant similarities with the UNC-119/RG4 
group of proteins from mammals, zebrafish, C. elegans, and D. melanogaster. These 
proteins were identified on the basis of their high expression in the C. elegans nervous 
system as well as in mammalian photoreceptor cells (Ershova et al., 1997). But to 
date, still very little is known about their function. The ubiquitous expression of PDEδ 
in tissues other than retina and expression of PDEδ orthologs in eyeless C. elegans, 
which do not express other prenylated PDE6 subunits (Li et al., 1998), supports 
additional functions, distinct from its role in photoreceptor physiology and stability in 
rod and cone cells (Florio et al., 1996; Marzesco et al., 1998; Zhang et al., 2007). 
1.7.6  Similarities between PDEδ and RhoGDI 
Besides an unrelated N-terminal region of 50-90 residues, the alignment of human 
PDEδ with human RG4 and RhoGDI proteins demonstrated that they exhibit 47% 
similarity and 22% identity for the human proteins, extending through to their C-
termini. Alignment of UNC119/RG4, PDEδ and RhoGDI of human origin also 
revealed that the structural features, conserved between PDEδ and RhoGDI, are also 
conserved in UNC119/RG4 (Figure 1.17). These structural features contain the 
elements responsible for their immunoglobulin-like fold as well as hydrophobic 
residues at conserved positions, which could line the surface of a prenyl-binding 
pocket. The prenyl-binding domain of RhoGDI is similar in size to, PDEδ, and there 
is 18% amino acid identity between the PDEδ and the prenyl-binding domain of 
RhoGDI (Cook et al., 2000). The structure-based sequence alignment shows that the 
residues lining the inner surface of this hydrophobic pocket are in identical or very 
similar positions in both proteins, suggesting that not only the fold but also the lipid-
binding pockets are common features of both PDEδ and RhoGDI. After 
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superimposition of the protein backbones of RhoGDI and PDEδ, the geranylgeranyl 
moiety of Cdc42 fits surprisingly well over almost its complete length into the 
hydrophobic pocket of PDEδ (Figure 1.17) (Linari et al., 1999). 
 
Figure 1.17 Alignments of PDEδ, RhoGDI and UNC119/RG4 proteins 
(A) Alignment of PDEδ (upper part) and UNC119/RG4 proteins (lower part) 
from various species. Identities are shown as white on a black background; 
similarities are shaded gray (white and black letters for hydrophobic and non 
hydrophobic amino acids, respectively). Sequences that could not be aligned 
are indicated by number of residues; Total length of each sequence is 
indicated within brackets. BRARE, Danio rerio (zebrafish); CAEEL, 
Caenorhabditis elegans; CAEBR, Caenorhabditis briggsae; CANFA, Canis 
familiaris; DROME, Drosophila melanogster. (B) Alignment of human RG4, 
PDEδ and RhoGDI proteins. Annotations are the same as in A. Reproduced 
from Nancy et al., 2002. 
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Figure 1.18 Structural homology of PrBP/PDEδ, unc119, and RhoGDI 
Multiple sequence alignment of PrBP (PDEδ) (8 vertebrate, 5 invertebrate 
sequences), unc119 (7 vertebrate, 5 invertebrate sequences), and RhoGDI (15 
vertebrate, 4 invertebrate sequences) identified amino acids that are invariant 
within each protein family (vertical lines within boxes). Sites that are 
identical in all sequences of PrBP (PDEδ) and unc119 are shown as lines 
connecting PrBP (PDEδ) and unc119 boxes. Structural homology of the 
prenyl-binding pocket shown at the top as α -helix and β -sheet is based on 
comparison of the three-dimensional structures for PrBP (PDEδ) (PDB 
1KSH; (Hanzal-Bayer et al., 2002) and RhoGDI (PDB 1DOA; Hoffman et 
al., 2000).  Reproduced from Zhang H. et al., 2006. 
 
Hanzal-Bayer et al., 2002 and Nancy V et al., 2002 therefore proposed that 
UNC119/RG4, PDEδ and RhoGDI define a new family of proteins, conserved 
through evolution, that interact with prenylated proteins (Figure 1.18). Such a high 
evolutionary conservation suggests that the function of PDEδ has been conserved as 
well. In addition, the C-terminus of PDEδ contains putative SRV and FYV sequence 
motifs described as necessary and sufficient for the interaction with PDZ domains 
present in many proteins of synaptic, septate and tight junctions (PSD95, Dlg, ZO-1) 
(Marzesco et al., 1998). PDZ domains are involved in sub membranous protein 
networks and in the recruitment of proteins to specific plasma membrane 
microdomains (Fanning and Anderson, 1998; Kornau et al., 1995). 
1.7.7 PDEδ interaction with Arl2 and Arl3: Structural insight 
Other than the isoprenylated proteins identified from yeast-two-hybrid, PDEδ also 
interacts with certain proteins in a prenylation independent manner, such as Arl2 and 
Arl3 (Linari et al., 1999). Arl2/3 are small GTPases belonging to Arf family of Ras 
superfamily. Arf family members play important roles in intracellular vesicular 
trafficking processes. Crystal structure of PDEδ co-crystallized with Arl2/GTP 
verified the presence of a hydrophobic domain packed by two opposite β –sheets 
(Figure 1.19). A similar, anti-parallel, β -strand interaction has been observed in the 
complexes of Ras proteins with the Ras-binding domain of Raf (Nassar et al., 1995) 
or RalGDS (Huang et al., 1998; Vetter et al., 1999) and PI3-Kinase (Pacold et al., 
2000).   
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 A                                                       B 
 
Figure 1.19 Crystal structure 
Ribbon diagram: Arl2-GTP: PDEδ (A) & Rap1A-GppNHp: RafRBD (B).  
Reproduced from Hanzal-Bayer et al., 2002. 
The binding of Arl2 to PDEδ was found independent of lipids, suggesting that PDEδ 
can interact with proteins in two ways: (1) through a lipid binding pocket (Figure 
1.20) and, (2) b-sheet/b-sheet interactions (Hanzal-Bayer et al., 2002). The interaction 
between PDEδ and Arl2 or Arl3 is GTP-specific, indicating that PDEδ is a bona fide 
effector protein of these two GNBP. In addition to this, PDEδ exhibits a strong 
inhibitory effect on dissociation of GTP from Arl2 and Arl3 (Linari et al., 1999), 
which is not unusual for an effector (Herrmann et al., 1995). 
                                     A                                 B 
 
 
Figure 1.20 The hydrophobic pocket in PDEδ  
(A) Cut through a surface representation of RhoGDI showing the deep 
hydrophobic pocket with the geranylgeranyl moiety (red) from Cdc42-GDP 
(violet ribbon). (B) PDEδ has a similar but less deep hydrophobic pocket. 
The geranylgeranyl moiety of Cdc42 has been positioned by superimposition 
of the protein backbone of RhoGDI to PDEδ, followed by a small manual 
adjustment within the pocket. (Hanzal-Bayer et al, 2002). 
1.7.8 PDEδ and Arl2 role in maintaining photoreceptor physiology 
In photoreceptor cells biochemically identified binding partners of PDEδ include 
rhodopsin kinase (GRK1), cone pigment kinase (GRK7) and the PDE catalytic 
subunits (PDEα, β ), all of which are prenylated at their C-termini. It has been 
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demonstrated that absence of PDEδ in retina impairs transport of prenylated proteins, 
particularly GRK1 and cone PDE, to rod and cone outer segments, resulting in altered 
photoreceptor physiology and a phenotype of a slowly progressing rod/cone 
dystrophy (Zhang et al., 2007) (Figure 1.21). 
 
Figure 1.21 Localization of rod and cone PDE6 in WT and Pde6d−/− retina 
Confocal immunolocalizations of GRK1, rod PDE6, and Tγ in WT (A, C, 
and E) and PDEδ −/− (B, D, and F) retina cryosections. (A and B) 
Immunoreactivity for GRK1 is prominent over rod and cone outer segments 
(OS) in WT retina although nearly undetectable in PDEδ −/− rod and cone 
OS. (C and D) Localizations of rod PDE6 in WT and PDEδ −/− retinas, 
respectively (MOE antibody; Cytosignal). Rod PDE6 labeling is typically 
restricted to rod OS in WT retina. Aberrant distribution of rod PDE6 was 
observed in inner segments and synaptic terminals of PDEδ −/− rods. (E and 
F) Distributions of rod Tγ in WT and PDEδ −/− retinas, respectively. Tγ 
mislocalizes, in part, to the inner segment, perinuclear, and synaptic regions 
(white arrows) of PDEδ −/− photoreceptors. In each image, propidium iodide 
(red) demonstrates the extent of the ONL by binding nucleic acids (both 
DNA and RNA). IS, inner segments; OPL, outer plexiform layer. 
Reproduced from Zhang et al., 2007. 
1.7.8.1 Hypothetical model for PDEδ function in photoreceptors 
Based on observations from Zhang et al., 2007, it has been hypothesized that PDEδ 
may be involved in the intracellular trafficking of isoprenylated phototransduction 
proteins (GRK1, PDE6 <α, β>) from the inner segment to the outer segment. It is 
presumed that in WT photoreceptors, prenylated cone PDE6α′, farnesylated GRK1 
and farnesylated rod and cone Tγ depend on a prenyl binding protein (PrBP) such as 
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PDEδ for extraction from the ER and delivery to a transport carrier. Subsequently, 
prenylated proteins may co-transport to the outer segments using vesicles with a 
transmembrane protein as guide, either rhodopsin or GC1/GC2, or another integral 
membrane protein ( Figure 1.22A). In the absence of PDEδ, selected prenylated 
proteins fail to be delivered to a carrier and do not transport (Zhang et al., 2007). In 
rods, GRK1 is largely absent in PDEδ−/− ROS. In cones ( Figure 1.22B), PDEδ 
deletion affects both GRK1 and cone PDE6 equally although the former is 
farnesylated and the latter geranylgeranylated. Hence in the absence of PDEδ, 
solubilization of these proteins is inhibited and transport to the COS impeded.  
However details regarding several of these claims are still elusive, such as whether 
PDEδ prefers farnesylated or geranylgeranylated substrates. Geranylgeranylated 
PDEβ is expressed as a dimer with its farnesylated partner PDEα and hence it is not 
clear if PDEδ binds to only its farnesylated subunit and not directly to 
geranylgeranylated subunit. Also, mechanisms of delivery of prenylated proteins as 
cargo to a vesicular transport carrier in photoreceptors are also unknown. Since PDEδ 
co-crystallized with Arl2 (Hanzal-Bayer et al., 2002), an Arf-like small GTPase, it is 
conceivable that Arl2 or its close cousin Arl3 may play a role in either docking to 
vesicles or in mediating release of prenylated cargos from PDEδ. In this work, we 
have answered these queries and have demonstrated how PDEδ regulate prenylated 
substrates such as Ras family proteins spatial distribution, signaling and its function 
in tumor models. Also the mechanism and putative role of Arl2/3 in regulating PDEδ 
function has been described. 
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B  
 
 Figure 1.22 Putative model of post-biosynthesis transport of membrane 
proteins   in rods and cones  
Reproduced from Zhang et al., 2007. 
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II 
2 Experimental Procedures 
2.1 Materials 
2.1.1 Antibodies and Dyes 
Primary antibodies: 
Anti GFP (JL-8)   Mouse  Clonetech (632381) 
Anti GST   Goat  Genescript (A01379) 
Anti Rheb   Rabbit  Cell signaling (4935) 
Anti Nras (F-155)  Mouse  SCBT (sc-31) 
Anti Hras (C-20)  Rabbit  SCBT (sc-520) 
Anti Kras-2B (C-19)  Rabbit  SCBT (sc-521) 
Anti PDEδ (N-15)  Goat  SCBT (sc-50260) 
pErk1/2   Mouse  Cell signaling (CS-9106) 
Total Erk1/2   Mouse  Cell signaling (CS-4696) 
pRaf    Rabbit  Cell signaling (CS-9427)                       
Total Raf   Mouse  BD-biosciences (610152) 
Cyclophilin-B   Rabbit  Alexis (ALX-210-237) 
Anti GAPDH (C65)  Mouse  Calbiochem (CB-1001) 
 
Secondary antibodies: 
Donkey anti Mouse IR-Dye 800CW                             Licor 
Donkey anti Mouse IR-Dye 680CW                             Licor 
Donkey anti Rabbit IR-Dye 680CW                             Licor 
Donkey anti Goat IR-Dye 800CW                                Licor 
Donkey anti Goat IR-Dye 680CW                                Licor 
IRDye 800CW Streptavidin                                          Licor 
 
Dyes: 
Cy3 and Cy5 mono-reactive dye                                  Amersham 
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2.1.2 Buffers and solutions 
TBS (Tris buffered saline)                              100 mM Tris·Cl pH 7.50  
                                                                         0.9% NaCl (w/v) 
Sample loading buffer (5X)                             250 mM Tris pH 6.8 
                                                                         10% SDS 
                                                                         50% glycerol  
                                                                         10% BME  
SDS PAGE electrophoresis buffer (10X)        250 mM Tris 
                                                                         1.92 M glycine 
                                                                         1% SDS 
Transfer buffer                                                 25 mM Tris 
                                                                         192 mM glycine 
                                                                         20% Methanol 
Imaging medium                                             1X Hanks with Ca2+ and Mg2+         
                                                                         0.6% Glucose 
                                                                         10mM HEPES 
Cell lysis buffer (1X)                                      20 mM Tris-HCl (pH 7.5) 
 150 mM NaCl 
 1 mM Na2EDTA 
 1 mM EGTA 
 1% Triton 
 2.5 mM sodium pyrophosphate 
 1 mM beta-glycerophosphate 
 1 mM Na3VO4 
   1 µg/ml leupeptin 
2.1.3  Consumables and kits 
QIAprep Spin Miniprep Kit                                  Qiagen 
HiSpeed Maxi Plasmid Kit                                   Qiagen 
QIAquick Gel Extraction kit                                 Qiagen 
QIAquick PCR purification kit                             Qiagen 
RNAeasy Spin Kit                                                 Qiagen 
OneStep RT-qPCR SYBR Green Kit                    Qiagen 
35 mm glass bottom culture dishes                       MatTekCorp.  
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2.1.4 Reagents 
Bryostatin                                                               Enzo lifesciences 
2-Bromopalmitate                                                   Sigma 
Cycloheximide                                                       Sigma 
Palmostatin-B 
Protease inhibitor cocktail                                     Roche’s 
Phosphatase inhibitor cocktail                               Roche’s 
N-Ethylmaleimide (NEM)                                     Sigma 
Hydroxylamine                                                      Fluka 
Biotin-BMCC                                                        Pierce 
Protein G-sepharose®                                            Sigma 
Odyssey blocking buffer                                        Licor 
Glutathione sepharose-4B                                      GE lifesciences  
Effectene                                                                Qiagen 
GenJet™                                                                Signagen 
Lipofectamine 2000                                               Invitrogen 
 
2.1.5 Plasmids 
A) Dictyostelium constructs:  
Human Hras wt, Hras C181S/C184S and Hras C181S/C184S CLLL were cloned C-
terminal of GFP tag into an extra chromosomal expression vector pDm317 [act15] || 
GFP:gene || neoR || Extrachr (Ddp1-based) bearing neomycin resistance gene, using 
Bgl-II and Spe-I restriction sites. The open reading frame of the GFP gene is under 
the control of an endogenous actin-15 promoter and succeeded by an actin-8 
terminator. Same inserts were cloned into pDM134, which contains a hygromycin-
resistance cassette and the entire monomeric red fluorescent protein mRFP-mars. 
B) Mammalian expression constructs: 
Plasmid constructs for mCit-Nras wt, mCit-NrasG12D, GalT-ECFP, paGFP-Hras 
C181S/C184S have been described elsewhere (Rocks et al., 2010; Rocks et al., 2005). 
mCitrine fusion constructs for different Ras proteins including Rap1a, Rap1b, Rheb, 
Rheb-L1, Rap2c, Rap2b, Rap2a, Kras4B were generated by insertion of full length 
respective cDNAs into mCitrine-C1 or EYFP-C1 vector (Clontech). mCh-Hras 
C181S/C184S, paGFP-Hras C181S/C184S CLLL, paGFP-NrasG12D ΔCaaX, 
paGFP-Nras ΔCaaX, mCit-NrasG12D ΔCaaX, mCit-HrasC181S/C184S CLLL, mCit-
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Kras Δ(2E), Δ(4E), Δ(6E) were generated by site directed mutagenesis. mCh-/dCh-
PDEδ, mTFP-PDEδ were generated by inserting BspEI/EcoRI PCR amplified PDEδ 
fragment. GST fused 3X-RBD (52-132 amino acids) tandem fragments were cloned 
into pGEX-2T vector spaced with a 9 amino acids linker (-NLSSDSSNS). GST-
PDEδ, GST-RafRBD recombinant proteins for pull down assays were kindly 
provided by Dr Lothar Gremer and Doro Vogt. 
2.1.6 Cell culture medium & antibiotics  
Dulbecco’s Modified Eagle’s medium (DMEM)                    Sigma 
Roswell Park Memorial Institute medium (RPMI-1640)  Invitrogen 
HLC5 medium                                                                  Formedium 
trypsin/EDTA                                                                             PAN 
Fetal bovine serum (FBS)                                                           PAN 
Penicillin/streptomycin                                                             Gibco 
Amphotericin-B                                                                         PAN 
Hygromycin-B                                                                         Sigma 
G-418                                                                                        Sigma 
OptiMEM I + GlutaMax                                                   Invitrogen 
PBS (1X)                                                                                   PAN  
L-Glutamine                                                                              PAN 
Imaging medium                                                               Invitrogen 
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2.1.7 siRNA  
Table 2.1: PDEδ  specific siRNA sequences 
Canine PDEδ  specific siRNA sequences 
siRNA-1 Sense:  
r(GAA GGG CUU CAA ACU AAA U) dTdT 
Anti Sense: 
r(AUU UAG UUU GAA GCC CUU C) dAdG 
siRNA-2 Sense: 
r(AAC UGG GAA UGU UAU CAU A)dTdT 
Anti Sense: 
r(UAU GAU AAC AUU CCC AGU U)dAdG 
siRNA-3 Sense: 
r(CGC UUA CCA CGA GAG CCA A)dTdT 
Anti Sense: 
r(UUG GCU CUC GUG GUA AGC G)dTdT 
Human PDEδ  specific shRNA sequences 
sh- 1 FI363813  
TACTCTGGCAAGGAACAGAAGACCTGTCT 
sh- 3 FI363815 
GGCTTCAAACTAAATTGGATGAACCTTCG 
Murine PDEδ  specific shRNA sequences 
sh-1 FI567650  
ATATCCTGAGAGGCTTCAAACTAAATTGG 
sh- 2 FI567652 
TCCACAAACACCTGGCAGTCCTTGATAGA 
sh- 3 FI567651 
AATCCTCAAGTGCAAGGCAGTGTCTCGAG 
sh- 4 FI567653 
CTTCTTGTCAGCACATCCAAAGTGAGGCT  
2.1.8 Cell lines 
MDCK (ATCC No. CCL-34) 
Madin-darby canine kidney cells- MDCK cells are immortalized, epithelial cells 
derived from a kidney of an adult female cocker spaniel. They grow in a monolayer, 
attached to each other by regular cell-to-cell contacts 
MDCK-f3 
Virally Hras oncogene transformed derivative of MDCK cell line. They display long, 
spindlelike morphology and grow in multiple layers without regular cell-to-cell 
contacts. 
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HepG2 (ATCC No. HB-8065) 
Human hepatocellular carcinoma cells- Derived from the liver tissue of a 15-year-old 
Caucasian American male with a well differentiated hepatocellular carcinoma. These 
cells are epithelial in morphology. 
mPDAC  
Murine Pancreatic ductal adenocarcinomas cells lines from explanted murine tumors 
were established using previously published methods (Olive et al., 2009; Schreiber et 
al., 2004; Skoulidis et al., 2010). 
mPDAC (79990) - Tissue-specific conditional KrasG12D allele (Hingorani et al., 
2003; Hingorani et al., 2005; Skoulidis et al., 2010) has been ‘knocked in’ to a single 
endogenous locus, and is expressed under native regulatory control just as in the 
corresponding human cancers. KrasG12D activation is triggered via tissue-specific 
expression of Cre recombinase, driven by the regulatory elements of the pancreatic 
and duodenal homeobox 1 (Pdx1) promoter, without concurrent expression of the 
Trp53R270H trans-dominant mutant. 
mPDAC (79751, 79217, 80000, 87038) - tissue-specific conditional KrasG12D allele  
has been ‘knocked in’ to a single endogenous locus, and is expressed under native 
regulatory control. KrasG12D activation is triggered via tissue-specific expression of 
Cre recombinase, driven by the regulatory elements of the pancreatic and duodenal 
homeobox 1 (Pdx1) promoter, with concurrent expression of the Trp53R270H trans-
dominant mutant. 
BJ cells (ATCC No. CRL-252)  
Primary human foreskin fibroblasts derived cell lines 
a) BJ/hTERT/SV40-Hraswt: derived from BJ cells by ectopic expression of 
telomerase catalytic subunit (hTERT), the simian virus 40 large-T oncoprotein & 
Hras wt allele. 
b) BJ/hTERT/SV40-HRasG12V: derived by ectopic expression of telomerase 
catalytic subunit (hTERT) in combination with two oncogenes (the SV-40 virus large-
T oncoprotein and an oncogenic allele of Hras. 
These cell lines werekindly provided by Dr. Christian Schmees. 
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2.2 Molecular biology techniques 
2.2.1 Transformation of E. coli 
DNA (0.5 µg plasmid DNA) was mixed with 100 µl of thawed competent bacteria 
and incubated on ice for 15 min. After heat shock at 42ºC for 90 sec and incubation 
on ice for 1 min, 1 ml of LB medium was added and the mixture was incubated for 45 
min in a shaker at 37ºC. The bacteria were carefully pelleted by short centrifugation 
and the supernatant was decanted. The resuspended bacteria were plated on antibiotic 
containing agar plates that were incubated over night at 37 ºC. 
2.2.2 Transformation in Dictyostelium cells 
3 x 107 log phase cells were washed and suspended in electroporation buffer. 2ug 
DNA was added to the cuvette containing cells and incubated on ice for 5 min. The 
used field strength was 1.2 kV/cm; capacitance was 3 µF and a 600-Ω resistance. 
Hygromycin (1:1000 final; stock = 20mg/ml) and G418 (1:1000 final; stock = 
50mg/ml) was added 20 h after the electroporation. Positive clones were picked and 
cultured in fresh medium containing selection markers after 2 days. 
 
2.2.3 RNA preparation and RT-PCR 
For quantification of PDEδ mRNA content in MDCK cells, RNA was extracted using 
RNA-easy mini kit (Qiagen). RNA concentrations were measured and purity was 
verified spectroscopically. RT-PCR was performed using Quantifast-1 step RT-PCR 
kit (Qiagen) in an iQ5 thermocycler (Biorad). Gene specific amplification primers 
were ordered from Qiagen. Downregulation efficiency was estimated from samples 
treated with anti-PDEδ siRNA, non-targeting controls, mock controls and GAPDH 
siRNA as reference by applying Pfaffl’s method (Livak and Schmittgen, 2001; Pfaffl, 
2001). 
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2.3 Cell biology techniques 
2.3.1  Mammalian cell culture  
MDCK cells (Madine-Darby Canine Kidney, ATCC number: CCL-34) were routinely 
maintained in MEM Eagle’s supplemented with 10 % fetal bovine serum, penicillin 
(1000U/ml) and streptomycin (1g/ml) at 37ºC and 5% CO2. For life cell microscopy, 
cells were cultured on 35-mm glass bottom MatTek dishes (Nalgene Nunc 
International, Naperville, IL) and transferred to low bicarbonate DMEM without 
phenol red supplemented with 25 mM HEPES pH 7.4 (imaging medium). 
Transfections were performed with Effectene transfection reagent (Qiagen) for 
plasmids and RNAifect transfection reagent (Qiagen). Pancreatic cancer cell lines 
from explanted murine tumors were established using previously published methods 
(Olive et al., 2009; Schreiber et al., 2004; Skoulidis et al., 2010). All experiments 
using mPDAC lines reported in this study were conducted in early passage cell lines 
(≤P10) grown in complete medium (DMEM+10%FBS+1% Penicillin/Streptomycin). 
Stimulation with pharmacological reagents: 
The cells were stimulated with 200 ng/mL recombinant human EGF, 100nM 
Bryostatin-1, 50 µM Palmostatin-B, 50 µM 2-bromopalmitate.  
2.3.2 Dictyostelium cell culture 
Wild type D.discoideum strain Ax2 cells were grown axenically in HL5 medium at 
22°C. Transformation of D.discoideum amoebae was accomplished by electroporation 
using supercoiled DNA of pDm317 EGFP Hraswt, Hras C181S/C184S mutant. All 
transformants were maintained in G418 (20 µg/ml). 
Sample Preparation. For vegetative D.discoideum cells, 50-200ul of cell suspension 
from a confluent petridish was taken and added to 35mm dishes (MatTek Corp.). 
Cells were allowed to settle down and attach for 15-20 min and washed twice with 
17mM phosphate buffer (pH 6.5). Measurements were performed on cells incubated 
in buffer. 
For polarized cells and cell immobilization for FRAP experiments, cells from a 
confluent dish were washed in phosphate buffer and redissolved in 4.8ml phosphate 
Experimental procedures 
 Anchal Chandra - Dissertation   50 
buffer and applied on top of 6 well non nutrient agar plate (800ul/well). Then allowed 
to dry for 20 min and incubated for 6 hours in an incubator at 22°C. For observation 
at higher magnification polarized cells growing on top of non-nutrient agar was 
carefully taken, inverted and placed in a 35mm dish (Mattek Corp.) with cells facing 
down and imaged. 
2.3.3 Preparation of mammalian cell lysates 
MDCK, HepG2 cells were grown in 35 mm cell culture dishes in DMEM with 10% 
FBS. Cells were starved for 20 hours in starving medium without serum. The starved 
cells were treated with EGF (200 ng/ml) and/or Palmostatin-B (50 µM). After 
washing cells twice with PBS, 200 ml of lysis buffer (containing protease inhibitors 
and phosphatase inhibitor cocktail I & II) was added to the cells and incubated for 10 
min. Then the cells were scraped off the dish, transferred to a reaction tube and 
homogenized by passing several times through a 26-inch gauge needle. The resulting 
lysate was centrifuged for 30 minutes at 15.000 x g, 4°C and the pellet was discarded. 
The protein concentration of the supernatant was determined using the Bradford 
protein assay. 
2.3.4 GST Pulldown Assay  
50 ml GST, GST-RafRBD or GST-PDEδ fusion proteins were captured on 30 µl of 
pre-equilibrated GSH-sepharose beads for 30 min at 4 °C. Then 3 wash steps with an 
excess of assay buffer (30 mM Tris pH 7.5, 100 mM NaCl, 5 mM MgCl2, 3 mM DTE 
and 0.1% Triton X-100) were performed. Whole cell lysates were isolated from 
mammalian MDCK cells expressing wild type Ras and their respective mutants. 
These lysates were incubated with GST/GST-RafRBD/GST-PDEδ loaded GSH-
sepharose beads (as described above) for 30 min at 4 °C in a final volume of 500 µl 
assay buffer. After 4X washes, supernatant was removed and 25ml of 2X Laemmli 
buffer was added to the beads. Samples were then heated at 95°C for 5 min and SDS–
PAGE was performed. For western blot analysis mouse anti-GFP (Clontech-632375) 
1:5000, rabbit cyclophilin-B (Axxora-210237) 1:2000 and mouse anti-GST (Abcam-
55129) 1:1000 were used. The primary antibody staining was visualized by using IR 
680 Donkey anti-rabbit and IR 800 Donkey anti-mouse IgG (LICOR) on the Odyssey 
Infrared Imaging System. 
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2.3.5 RNA Interference  
Alexa Fluor-647 labeled negative control siRNA and 4 canine-PDEδ specific siRNAs 
(Qiagen) (table 2.1) were designed from the transcript sequence retrieved from NCBI. 
siRNA transfections were performed using RNAifect (Qiagen) as prescribed by the 
company. Out of four sequences screened, three showed highest knockdown in 
MDCK cells with similar efficiency as deduced from both RT-PCR and western 
blotting whereas two sequences (si-1 and si-3) showed good knockdown efficiency 
against human and murine-PDEδ in BJ-(hTERT/SV40/HrasG12V) and mPDAC cells 
respectively. Dharmacon’s ON-TARGET plus SMARTpool siRNA were also 
obtained to specifically target murine-PDEδ in different mPDAC clonal cell-lines. 
siRNA transfection: 2x105 cells were seeded and cultured in full growth medium for 
16h. After 16h, cells were transferred to Optimem + GlutaMax I (Invitrogen) and 
transfected with 200 nM siRNA-1, 100 nM siRNA-2, 100 nM siRNA-3 specific for 
PDEδ or non targeting control siRNA. After 10h of incubation, the transfection mix 
was aspirated and replaced with fresh Optimem + GlutaMax I. Cells were transfected 
the next day with paGFP HRasC181S/C184S (0.5 mg) or paGFP HRASC181S/184S 
CLLL (0.5 mg) or paGFP Nras-CaaX (0.5 mg) using Effectene transfection reagent. 
Approximately, 48h after siRNA transfections, live cell microscopy was performed. 
2.3.6 Western blots 
MDCK cells were plated at a density of 2 x 105 cells/ml in 35-mm MatTek dishes for 
16h, then transfected with PDEδ specific siRNA and incubated for 48-72h. Cells were 
washed with ice cold PBS and 0.2 ml ice-cold lysis buffer containing protease 
inhibitors (Roche), phosphatase inhibitor I and II (Sigma) was added in each dish. 
After 10 min of incubation on ice, cells were scraped off the dish and centrifuged at 
14,000 g for 20 min at 4°C. Supernatants were recovered and stored at -80 °C. 50 µg 
of whole cell lysate from each sample was mixed with sample buffer and resolved 
onto 10% bis-tris SDS-PAGE gels by electrophoresis in MOPS buffer. The gel was 
blotted onto a 0.2 mm Nitrocellulose membrane and blocked in Licor blocking buffer 
for 1h at room temperature (RT). The blot was incubated with PDEδ, GAPDH, total 
Erk1/2, pErk1/2, pRaf, total Raf, cyclophilin-B, pAkt, total Akt, Hras, Nras, Kras 
antibodies overnight at 4 °C and then with IR secondary antibodies (Licor). The blots 
were scanned on a Licor odyssey imaging system. Antibodies used for western 
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blotting were PDEδ (N-15): (Santa Cruz Biotechnology-50260) 1:750, Nras (F-155): 
(Santa Cruz Biotechnology-31) 1:1000, Rheb: (Cell signaling-4935) 1:1000, total Raf: 
(BD biosciences-610152) 1:2000, pRaf: (Cell signaling-9427) 1:1000, total Erk: (Cell 
signaling-4696) 1:2000, pErk: (Cell signaling-9106) 1:2000, Cyclophilin-B: (Axxora-
210237) 1:2000. 
2.3.7  Biotin acyl exchange assay  
BAE assay was performed as described (Drisdel and Green, 2004; Politis et al., 2005). 
MDCK cells were seeded in 35-mm dishes at a density of 2x105 cells/dish and 
incubated for 24h. The cells were then transfected with expression plasmids encoding 
for mCit-Hras wt, mCit-Hras C181S, mCit-Hras C184S, mCit-Nras, mCit-
Rap2a/2b/2c (1 µg) using the Effectene transfection reagent (Qiagen) and incubated 
for 20h. Separately, cells were treated with either Palmostatin-B or DMSO for 2h 
wherever required. Cells were then lysed with cell lysis buffer containing 5 mM 
EDTA, 1% Triton X-100, 50 mM N-ethylmaleimide, protease inhibitor cocktail 
(Roche) in PBS pH 7.4. After 5 min of incubation on ice the cells were scraped and 
the lysates were homogenized. The homogenized lysates were rotated for 1h at 4 °C 
and then centrifuged at 12,000 g for 20 min at 4°C. To prevent unspecific binding of 
protein to sepharose, the lysates were pre-incubated with Sepharose-G (Sigma). 
Samples were then centrifuged and the supernatants were rotated with Living 
Colors® Full-Length A.v. anti-GFP polyclonal antibody (Clontech) for 60 min at 4 
°C. The protein-antibody complex was precipitated with Sepharose-G by rotation for 
1 h at 4 °C. The purified protein was then additionally treated with 50 mM N-
ethylmaleimide for 1 h at RT. After treatment and centrifugation, the pellets were 
washed twice with PBS and each sample was divided into two fractions. One fraction 
was treated with 1 M Hydroxylamine (pH = 7.4) by rotation for 1 h at RT to remove 
palmitate groups, and the other fraction was treated with PBS and served as control 
sample. All samples were then treated with 320 µM (Btn)-BMCC™ and rotated for 2 
h at RT or overnight at 4 °C. Samples were washed twice and resolved on SDS-PAGE 
and western blotting was performed with the mouse monoclonal anti-GFP N-terminal 
antibody (Clontech-632380) to detect total mCit-Ras. The primary antibody staining 
was visualized by using IR 800 Goat Anti-Mouse IgG Antibody (LICOR), while 
biotinylated protein (representing palmitoylated protein) was visualized with IR 
680CW Streptavidin (LICOR) on the Odyssey® Infrared Imaging System (LICOR). 
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Figure 2.1 Schematic of the proteomic acyl-biotinyl exchange methodology 
  Reproduced from Wan et al., 2007. 
 
2.3.8 Triple (3X)-RBD staining 
(3X)-RBD, a construct containing three subsequent repeats of the Ras binding domain 
of Raf1, was labeled with Amersham Cy3.5 mono-reactive dye (GE healthcare) as per 
manufacturer’s instruction. mPDAC cells were transfected with PDEδ-siRNA (50nM) 
and then incubated for 72h. Both, untreated as well as siRNA treated cells were fixed 
with 4% paraformaldehyde and permeabilized with 0.1% tween-20. Cy3.5 labeled 
(3X)-RBD was then added to these fixed cells on the microscope. Images were 
acquired immediately within 30-60 sec in order to avoid unspecific labeling observed 
after longer incubation times. 
2.3.9 In vitro Clonogenic assay of cells 
Murine PDAC cell lines were plated on 6-cm plates and transfected with 3 µg of 
turboRFP-containing scrambled or PDEδ shRNA plasmids, using Lipofectamine 2000 
according to manufacturer’s instructions. 24h after transfection, RFP-positive cells 
were sorted using a Beckman Coulter MoFlo cell sorter and subsequently re-plated in 
DMEM plus 20% fetal calf serum. To measure cell viability, 5000 RFP-positive cells 
were plated in 6-well dishes and then fixed in 4% formaldehyde 5 days later (6 days 
post-transfection). Following one wash in water, cells were stained with 0.1% crystal 
violet for 20 minutes and then washed with several volumes of water. Plates were 
photographed, then bound dye was extracted with 10% acetic acid and the absorbance 
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at 595 nm was determined. Each point was determined in triplicate. A fraction of 
sorted cells was also plated for western blot analysis, using goat anti-PDEδ antibody: 
(Santa Cruz Biotechnology, sc-50260) diluted 1:500 in TBS + 0.1% Tween-20 + 5% 
non-fat dry milk, and rat anti-tubulin antibody: (Abcam, YOL1/34) diluted 1:5,000 as 
a loading control. Following incubation with HRP-conjugated secondary antibodies 
(Jackson Immunoresearch) diluted 1:5000, blots were developed by 
chemiluminescence using ECL reagent (GE Healthcare). 
 
2.4 Microscopy and imaging techniques 
2.4.1 Microscopes 
Laser scanning confocal microscopy: 
FRAP and photoactivation experiments were performed on a Leica TCS SP5 AOBS 
equipped with HCX PL APO 60X/1.4 NA oil immersion lens and a temperature 
controlled incubation chamber maintained at 37°C and 5% CO2. CFP, mCitrine and 
paGFP were excited by 458 nm, 514 nm and 488 nm Ar laser lines, respectively. 
mCherry was excited by using the 561nm DSSP laser line. Photoactivation of paGFP 
was achieved by using a 405 nm diode laser. Fluorophore emission bands were 
detected in the following range- CFP: 469-505 nm, Citrine: 524-551 nm, Cherry: 571-
650 nm, paGFP (before excitation): 415-450 nm, paGFP (after excitation): 498-520 
nm.  
Time-domain FLIM: 
Fluorescence lifetime images were acquired using a confocal laser-scanning 
microscope (FV1000, Olympus, Germany) equipped with a time correlated single 
photon counting module (LSM Upgrade Kit, Picoquant, Germany). For detection of 
mCitrine, the sample was excited using a 470 nm diode laser (LDH 470, Picoquant) at 
40 MHz repetitions. Fluorescence was collected through an oil immersion objective 
(60X/1.35 UPlanSApo, Olympus) and spectrally filtered using a narrow band 
emission filter (HQ 525/15, Chroma, USA). Photons were detected using a single 
photon counting avalanche photodiode (PDM Series, MPD, Italy) and timed using a 
single photon counting module (PicoHarp 300, Picoquant). The instrument response 
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function of the system was measured to be below 200 ps (data not shown). 
2.4.2 FRAP and FLAP 
FRAP (Fluorescence recovery after photobleaching) is a useful method for 
measurement of the translational diffusion of fluorophores and fluorescently labeled 
macromolecules in cellular components. Fluorophores in a defined sample volume are 
irreversibly bleached using brief, intense laser pulse. The diffusion of unbleached 
molecules into bleached volume is then measured as a quantitative index of 
fluorophore translational diffusion. On the other hand FLAP (Fluorescence loss after 
photoactivation) allows fast switching of fluorescent protein properties with fewer 
photons by selective illumination with specific wavelength. The instrumentation for 
photobleaching/ photoactivation consists of a laser/light source to bleach, a 
fluorescence microscope, a defined sample volume and a detector. The beam intensity 
of an argon ion laser is modulated by an acousto-optic modulator and directed onto a 
fluorescent sample using an epifluorescence microscope with a dichroic mirror and 
objective lens. The emission path contains an interference filter, pinhole, and gated 
photomultiplier detector. For unrestricted diffusion of a single fluorescent species in a 
homogeneous environment, fluorescence recovers to the initial (prebleach) level and 
recovery curve contains a single component whose shape depends on geometry of 
bleached region. However, fluorescence recovery in cell systems is often incomplete 
(restricted diffusion) or multicomponent. Incomplete recovery often indicates that a 
fraction of the fluorescent molecules are immobile because of binding of slowly 
moving cellular components or trapping in noncontiguous compartments. 
2.4.3 FRET-FLIM 
FRET reduces the fluorescence lifetime of the donor fluorophore owing to the de-
population of its excited state; a phenomenon that fluorescence lifetime imaging 
microscopy (FLIM) makes use of. FRET can be detected purely via donor 
fluorescence because the fluorescence lifetime is an intrinsic fluorescence parameter, 
that is, only dependent on excited state processes. Specificity of the acceptor is not 
required because its fluorescence is not detected. Upon occurrence of FRET, the 
fluorescence lifetime is independent of the fluorophore concentrations as long as 
saturating amounts of acceptor are present. 
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The time domain FLIM- Here, a gated measurement of the fluorescence intensity is 
made following excitation of the sample with a short pulse of light (Sytsma et al., 
1998; Squire and Bastiaens, 1999). The fluorescence intensity is therefore sampled at 
sequential time points along the exponential fluorescence decay. In cases where a 
sample contains a single fluorescence species, the fluorescence lifetime is given as the 
time over which the fluorescence intensity falls to 1/e of its initial value. 
2.5 Data analysis 
2.5.1 Fluorescence loss after photoactivation (FLAP) 
In photoactivation experiments it was ensured that the duration of photoconversion 
did not exceed 5% of the fluorescent recovery half time. The radius of the illuminated 
area was kept small (< 25%) with respect to the radius of the diffusion area (Lopez et 
al., 1988). Images were background corrected, thresholded and the mean intensity in 
the ROI as well as in the whole cell was determined. To correct for bleaching the 
fluorescence intensity in the ROI was normalized by the whole cell fluorescence 
intensity at each time point. The initial peak intensities after photoconversion were 
normalized to one. The normalized data was fitted to the equation: f (t) =1− (1−η) exp 
(−2tD/t)[I0 (2tD/t) + I1 (2tD/t)] + η  where η  is the immobile fraction, I0 and I1 are 
modified Bessel functions as described in (Axelrod et al., 1976; Elson and Magde, 
1974). Effective diffusion was calculated using the expression Deff = r2/(4tD) where tD 
is the effective diffusion time (s), r is the radius of the photoconverted area (µm) and 
Deff is the effective diffusion constant (µm2/s). 
2.5.2  Fluorescence recovery after photobleaching (FRAP) 
Ratiometric analysis of Golgi FRAP data was performed as described in (Rocks et al., 
2010). GalT-CFP images were thresholded, median filtered and binarised to get a 
Golgi mask. The mask was used to calculate the ratio of the sum of mCit-Nras 
intensity over the sum of CFP-GalT intensity at each time point at the Golgi. The 
plateau values were normalized to one. 
2.5.3 FRET-FLIM 
Briefly, images were first intensity thresholded to segment the cell from the 
background. The photon-counting histograms of the regions of interest were then 
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Fourier transformed from the time domain to the frequency domain. Using the 
information contained in the high harmonics, the functional form of the IRF was 
derived. “Phase” and “modulation” values were calculated for each pixel and 
corrected using the derived IRF properties. All pixels measured with the same FRET 
pair were pooled together and analyzed using global analysis. From this process the 
fluorescence lifetime of the donor in presence or absence of the acceptor was 
calculated. Finally, the fraction of donor in complex with the acceptor was calculated 
in each pixel from which the image was reconstructed (Grecco et al., 2009). 
2.5.4 Western blots quantification 
Densitometric analysis of western blots was performed using Image J software 
(http://rsbweb.nih.gov/ij/index.html). The area under the curve (AUC) of specific 
signals was corrected for the AUC of the loading control. Mean and integrated density 
was determined and was used to calculate the relative amount of pErk1/2, pRaf and 
pAkt proteins by dividing by the mean value of total Erk1/2, Raf and Akt. 
To derive correlations between pErk1/2 and PDEδ levels for each concentration/ 
timepoint, pErk1/2 and PDEδ levels were first normalized using the formulas (1) & 
(2). The normalized levels of pErk1/2 were plotted against the normallized levels of 
PDEδ in a scatter plot and correlation coefficients were determined.  
pErk1/2 (siRNA/shRNA):tErk1/2 (siRNA/shRNA) / pErk1/2 (Scr):tErk1/2 (Scr)                      (1) 
PDEδ (siRNA/shRNA): cyclophilin-B (siRNA/shRNA) / PDEδ(Scr): cyclophilin-B(Scr)          (2) 
2.5.5 RT-PCR  
mRNA levels were estimated using a relative quantification method based on the 
cycle time (Ct) determination (Livak and Schmittgen, 2001) . First, the ΔCT value for 
each sample was determined by calculating the difference between the CT value of the 
target gene and an endogenous reference gene. This was determined for each siRNA 
treated sample and calibrator sample (control or untreated sample) using the formula:  
ΔCT (sample) = CT target gene – CT reference gene 
ΔCT (calibrator) = CT target gene – CT reference gene  
Next, the ΔΔCT value for each sample was determined by subtracting the ΔCT value 
of the sample from the ΔCT value of the calibrator: 
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ΔΔCT = ΔCT (sample) – ΔCT (calibrator)  
PCR efficiencies of the target and endogenous reference gene were found to be 
comparable; the normalized level of target gene expression is calculated using the 
formula 2-ΔΔCT. 
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III 
3 Investigating palmitoylation 
machinery specificity in DHHC 
motif containing Dictyostelium 
PATs 
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3.1 Abstract 
Palmitoylation machinery, which includes the palmitoyl-acyl transferases (PATs) and 
the deacylation enzymes, are responsible for maintaining proper spatial organization 
of several signaling proteins. Although various palmitoylatable substrates are known, 
a consensus motif or region where palmitoylation occurs cannot be identified (Linder 
and Deschenes, 2007). Therefore, it was hypothesized that the DHHC PATs activity 
does not recognize a specific sequence in the substrate proteins. Ras proteins are well-
characterized palmitoyl susbtrates, which were used in this study to delineate the 
specificity of DHHC PATs towards its substrates. Furthermore in an attempt to 
demonstrate the broad specificity of PATs, human Hras was ectopically expressed in 
Dictyostelium. The spatial organization and temporal kinetics of human Hras in 
Dictyostelium was reminiscent of mammalian cells, corroborating that there are no 
specific PATs for Ras proteins. From these studies it is clear that the DHHC PATs 
recognize and modify a broad spectrum of substrates, thereby regulating 
palmitoylated proteins at a global level.             
Rational and hypothesis 
 Anchal Chandra - Dissertation   61 
3.2 Rationale and hypothesis 
Acylation cycle controls the spatial organization of palmitoylated peripheral 
membrane proteins. Palmitoylation of farnesylated Ras proteins increases the affinity 
of these proteins towards specific membrane compartments and thus enhances kinetic 
trapping of Ras at the PM. Ras protein undergoes palmitoylation through a labile 
thioester linkage (S-palmitoylation) at the cysteine residues. This reaction is catalyzed 
by a set of enzymes called palmitoyl-acyl transferases (PATs), characteristic of 
DHHC family proteins (Roth et al., 2002). The main objective of this work is to 
investigate the following questions: 
Do the PATs specifically recognize certain motif in the Ras proteins, either 
the G-domains or the hypervariable C-terminal region (HVR) of Ras?  
Whether any specificity for the palmitoylation reaction resides in the DHHC 
domain containing PATs?  
Preliminary data  (from Rocks et al., 2010) using a genetically encoded YFP tagged 
tH (C-terminal fragment of Hras aa 175-190) as compared to that of mCherry tagged 
full length Hras (Figure 3.1) suggested that the palmitoylation machinery does not 
recognize structural motifs in the Ras G-domain. Involvement of Ras G-domains in 
imparting specificity to PATs is highly questionable since most of the Ras proteins 
share high sequence and structural homology in these regions (Dever et al., 1987; 
Bourne et al., 1991).  
 
Figure 3.1 Equivalent distribution of the tH versus full-length Hras protein
  (Reproduced from Rocks et al., 2010). 
 
Another finding highlighted the role of conserved acidic and basic residues in the 
HVR of Ras in stabilizing palmitoylation (Laude and Prior, 2008). Although it is not 
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clear whether the acidic patches in the HVR of these Ras isoforms serves as 
recognition site/motif for PATs and regulate the on/off rate of palmitoylation or they 
interfere with PAT binding at the cysteine residues hence modulating Ras 
palmitoylation. 
On the other hand, previous studies suggest that DHHC9/17/18/ yeast Erf2p-Erf4p 
complex exhibit substrate selectivity by specifically palmitoylating Ras proteins 
(Fukata et al., 2004; Lobo et al., 2002; Swarthout et al., 2005; Huang et al., 2004). 
However, in cells lacking Erf2 or Erf4, palmitate labeling of Ras2 is reduced, but did 
not eliminate palmitoylation of Ras2 (Bartels et al., 1999). Similarly, palmitoylation 
of Vac8 was uninhibited in S. cerevisiae on deletion of gene encoding the vacuolar 
PAT Pfa3 (Smotrys et al., 2005). This is further supported by shRNA-mediated 
knockdown of DHHC 9 [Figure 3.2 (Rocks et al., 2010)] where the loss of DHHC9 
neither affects the kinetics or spatial distribution of Hras. Hence the loss of function 
studies of DHHC family proteins in yeast and human cells suggested a discrete and 
partially overlapping PATs specificities for palmitoylated Ras proteins and argue 
against the specificity of palmitoylation reaction in DHHC motif containing PATs.  
 
 
Figure 3.2 shRNA mediated DHHC9 downregulation 
Left panel: Spatial distribution of mCitrine-Hras in Hela cells before/after 
DHHC9 downregulation. Middle panel: % mRNA expression in 
absence/presence of DHHC9 shRNA. Right panel: FRAP of Hras at Golgi in 
control shRNA (black) Vs DHHC9 shRNA (red) treated cells. (Reproduced 
from Rocks et al., 2010). 
 
The lack of any apparent recognition signature sequence for the de-/reacylation cycle 
as revealed argues against the involvement of mammalian palmitoyltransferases with 
specific substrates. Classification of 25 human DHHC proteins using a Hidden 
Markow Model (HMM) based on the bioinformatics approach (Smyth, 1997) revealed 
a conserved consensus sequence ‘W-X(4)-L-X(12)-TTNE’ adjacent to DHHC-CRD 
domain (Figure 3.3). Database search of different genomes with the same consensus 
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sequence also identified various known Ras specific PATs although Dictyostelium 
discoideum showed no homologues of human Ras specific DHHC PATs such as 
DHHC 9, 17, 18. Therefore in order to demonstrate the lack of substrate specificity 
for Ras PATs, we used Dictyostelium discoideum as a model organism and analyzed 
the spatial distribution and kinetics of human Hras in these cells.  
 
Figure 3.3 Consensus sequence alignment of mammalian and yeast genome 
Hits identified by the PROSITE scan of ‘W-X4-L-X12-TTNE’, showing high 
degree of conservation and fidelity. (Reproduced from Rocks et al., 2010). 
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3.3 Results 
3.3.1 Dictyostelium discoidens as a model organism  
Analysis of the completed Dictyostelium genome has revealed a total of 119 genes 
encoding small GTPases, encompassing all the five Ras subfamilies. The first 
Dictyostelium Ras protein to be characterized was RasD (Reymond et al., 1984). 
RasG, like RasD is highly homologous to the mammalian Hras, particularly in the 
effector loop. A third gene, rasB, is also closely related to the mammalian Hras, 
though with less similarity than rasD and rasG.  
Dictyostelium Hras homologues differ from farnesylated human Hras in a way that all 
of them are geranylgeranylated and lack any palmitoylatable cysteine (Figure 3.4). 
The C-terminus of Dictyostelium Ras proteins bear poly-cationic residues instead. 
Despite this, Dictyostelium genome consists of 8 DHHC PATs, None of these are 
homologous to known human Ras PATs such as DHHC9, 17, 18. Absence of any 
reported human Ras specific PATs in Dictyostelium thus makes it an ideal candidate 
to study broad specificity of PATs by observing palmitoylation of human Hras in 
Dictyostelium. 
 
Figure 3.4 Sequence alignment of Dictyostelium Ras proteins 
G box consensus sequences are shown in shaded yellow (G1 domain), light 
blue (G2 domain), green (G3 domain), purple (G4 domain), orange (G5 
domain). C terminal CaaX box is shown in shaded pink, polybasic residues 
are highlighted in blue, palmitoylatable cysteines in green and 
phosphorylatable serine in red. 
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3.3.2  Subcellular localization of human Hras in Dictyostelium 
discoidens 
In order to visualize the spatial distribution of Ras in Dictyostelium discoidens, cDNA 
encoding human Hras (Hras_Hs) was tagged into Dictyostelium expression vector 
bearing a genetically encoded green fluorescent protein – pDm317 GFP (Veltman et 
al., 2009). The plasmid DNA was then electroporated into vegetative Dictyostelium 
cells. Transformed cells were then observed on a confocal microscope for the plasmid 
expression. Upon excitation with 488nm laser, spatial distribution of exogenously 
expressed GFP tagged human Hras was visualized. Dictyostelium cells displayed an 
equal partioning of Hras_Hs at the plasma membrane (PM) and Golgi apparatus 
similar to that observed in mammalian cells Vegetative, nutrient starved as well as 
immobilized cells displayed similar localization (Figure 3.5A). 
Additionally, in case of vegetative cells we also observed some labeling of the 
endosomal compartments as well as some brightly illuminated structures in the 
cytoplasm of the cells. The endosomes that originates from the PM are abundantly 
present in Dictyostelium cells (Gerisch et al., 2004). However, on serum starvation 
the endosomal localization was lost but these cells retained the unspecific brightly 
stained structures. Since Dictyostelium display cellular autofluorescence at a 
wavelength range from 500 to 650 with maxima at 510nm (Engel et al., 2006), we 
compared the untransfected Dictyostelium cells (Figure 3.5C) excited with the same 
wavelength in order to differentiate between GFP tagged Human-Hs labeling and 
cellular autofluorescence. As evident from Figure 3.5C, the untransfected cells 
displayed similar bright staining in the cytoplasm, indistinguishable from polarized 
cells.  
The PM and Golgi enrichment of Hras_Hs indicated that human Hras was indeed 
palmitoylated in Dictyostelium cells since palmitoylation is an important requisite for 
the PM targeting of human Hras (Hancock et al., 1989; Cadwallader et al., 1994; 
Rocks et al., 2005). In contrast, expression of GFP tagged human Hras palmitoylation 
mutant (Hras C181S/C184S_Hs) did not show any specific preference to a specific 
membrane compartment and appeared on all endomembranes including Golgi (Figure 
3.5B). Mutating both the palmitoylatable cysteines C181 and C184 in Hras to serines 
render the Hras molecules unrecognized by PATs thus leading to an unspecific low 
affinity binding to the endomembranes (Rocks et al., 2005). This unpalmitoylated 
fraction was represented by the bright fluorescence in the cytoplasm (Figure 3.5B). 
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Figure 3.5 Human Hras spatial localization in Dictyostelium discoidens 
(A) GFP tagged human Hras expressed Dictyostelium AX2 strains in either 
vegetative (upper), polarized (middle) or immobilized stage showing 
enrichment at the PM and Golgi apparatus. (B) Dictyostelium AX2 strain 
expressing GFP-317 Hras C181S/C184S_Hs in vegetative stage. (C) Non-
electroporated Dictyostelium AX2 strain excited at 488nm wavelength. 
 
3.3.3  Effect of 2-Bromopalmitate on subcellular localization of human 
Ras in Dictyostelium  
Palmitoylation promotes stable attachment of otherwise cytosolic proteins to 
intracellular membranes such as PM and Golgi apparatus (Hancock et al., 1990); 
Cadwallader K.A et al., 1994; Rocks et al., 2005). In order to ensure that PM and 
Golgi enrichment of human Ras in Dictyostelium was due to the effective 
palmitoylation via PATs, human Hras transformed Dictyostelium cells were treated 
with palmitoylation inhibitor 2-Bromopalmitate (2-BP). 2-BP has been demonstrated 
as an inhibitor of fatty acid acylation (Webb et al., 2000). Treatment for 30 min in 
cells expressing GFP-317 Hras_Hs wt indeed caused redistribution of palmitoylated 
proteins to endomembranes and a decrease in PM localization (Figure 3.6) similar to 
that observed in case of depalmitoylated Hras C181S/C184S_Hs.  
 
Figure 3.6 2-Bromopalmitate inhibits human Hras palmitoylation 
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3.3.4 Depalmitoylated Hras displays faster diffusion kinetics over 
wildtype  
The rate of Ras trafficking is dictated by the stability of palmitate attachment (Rocks 
et al., 2005, Goodwin et al., 2005).  Therefore, we examined the diffusion kinetics of 
Hras wt in comparison to depalmitoylated Ras mutant. Ras recovery rates were 
determined after photobleaching either a part of cell or half the size of the cell. Hras 
wt showed slow recovery kinetics (t1/2=183.3+/- 3.8s). Hras wt diffusion mostly 
comprised of a slowly diffusing component mostly originating from PM and a faster 
diffusing component arising from the newly synthesized, solely farnesylated Hras as 
shown in Figure 3.7A. On the other hand, for depalmitoylated Hras mutant very fast 
uniform recovery was observed within few seconds (t1/2=5.6+/- 1.4s) (Figure 3.7B). 
Palmitoylation deficient mutant (Hras C181S/C184S) show weak binding affinity 
towards membranes henceforth contributes to the faster diffusing population whereas 
addition of palmitate moiety to Hras wt enhances its binding stability toward PM that 
accounts for slowly diffusing population. These results were in accordance with the 
Hras diffusion kinetics observed in mammalian cells. This experiment clearly 
demonstrates that PM and Golgi enrichment of human Ras in Dictyostelium cells is 
tightly regulated by activity of palmitoyl acyltransferases albeit lack of reported Ras 
specific PATs. In conclusion, no specific PAT activity exists for Ras. 
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Figure 3.7 FRAP kinetics of human Hras in Dictyostelium  
FRAP performed on Dictyostelium discoidens expressing GFP-317 Hras_Hs 
wt (A) and GFP-317 Hras C181S/C184S_Hs (B). Lower graph: FRAP curves 
(n=5 each) indicating diffusion kinetics of human Hras wt (black) and Hras 
C181S/C184S (red).  
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3.4 Discussion and future perspectives 
Substrate tolerance of palmitoylation machinery 
In this work using human Ras as a model the contribution of DHHC PATs to global 
palmitoylation has been evaluated. The ability of Dictyostelium PATs to palmitoylate 
human Ras in absence of Ras specific PATs was demonstrated. Ectopic expression of 
human Ras in Dictyostelium shows similar localization as observed in mammalian 
cells. The PM and golgi localization of human Ras in Dictyostelium was lost when 
the Hras C181S/C184S mutant was expressed indicating that the Dictyostelium 
DHHC PATs are indeed palmitoylating the human Ras protein. Pharmacological 
intervention using 2-Bromopalimate and FRAP experiments further corroborated the 
hypothesis that there are no specific PATs for Ras proteins. This was in agreement 
with the lack of a universal palmitoylation consensus motif that can be recognized by 
PATs (Bijlmakers and Marsh, 2003; Smotrys and Linder, 2004). The experiments 
performed with D amino acids and non-natural synthetic peptides demonstrate that the 
sequence flanking the target cysteine on the substrate does not contribute to PAT 
enzyme specificity (Rocks et al., 2010). A recent study in yeast further supports the 
assumption of overlapping specificities (Hou et al., 2009). In addition, deletion of the 
gene for Erf2 (yeast PAT) reduced the palmitoylation of broad spectrum of substrates 
(Bartels, D.J et al., 1999). These observations explain the compensation in 
palmitoylation upon loss of one or more DHHC proteins. Such a compensation 
mechanism can be beneficial for cellular systems in two ways:  
Firstly, the notion of` dedicated PATs for specific substrates creates the need for a 
large number of PATs, in order to meet the requirement of expanding family of 
palmitoylatable substrates. So far in humans, nearly 50 of substrates subjected to 
palmitoylation have been identified (Resh, 1999; Bijlmakers and Marsh, 2003; 
Smotrys and Linder, 2004). Additionally, more than 1100 confirmed eukaryotic 
myristoylated proteins bearing a palmitoylatable cysteine in the HVR adjacent to the 
myristoyl group have been reported (Maurer-Stroh et al., 2004). Moreover a large 
number of undefined C-terminal palmitoylatable substrates might be present. But an 
account of most of these palmitoylated substrates in human genome is difficult to 
acquire, due to the lack of palmitoylation specific consensus sequence. Therefore 
further amplifying the demand for substrate specific PATs. Although a eukaryotic cell 
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might have a large pool of putative palmitoylatable substrates, overlapping substrate 
specificity seems like a reasonable choice thus maintaining a constrained PAT 
repertoire in the genome. 
Secondly, redundant substrate recognition can serve in regulating proteins that have 
high turn over at the membranes at the level of DHHC activity, for example Ras. 
Since the palmitoylation and depalmitoylation reactions are uncoupled from specific 
sequence recognition motifs thus suggesting that a universal acylation/de-acylation 
mechanism is involved in regulating distribution of various palmitoylated membrane 
proteins. 
However, the presence of large number of DHHC PATs in yeast, Dictyostelium and 
mammals is still a mystery. One possibility could be that DHHC proteins might have 
other biological functions apart from PAT activity. Recently it has been shown that in 
yeast the DHHC protein Swf1p is involved in polarized secretion (Dighe and 
Kozminski, 2008). 
Based on the current knowledge, palmitoylation requires two-tier regulation:  
1) Thiolate formation on the substrate protein in close proximity to membrane. The 
presence of one or more lipid anchors further enhances the lipid-bilayer interaction. In 
certain Ras family proteins the prenyl group adjacent to the target cysteines ensures 
the transient interaction with lipid-bilayer and proximity of substrate protein with the 
membrane. The sulphydryl group of a substrate cysteine has an ionization constant 
pKA of 8.5. Since the cytosolic condition of the cell is maintained at neutral pH the 
formation of a thiolate group is unlikely. However, the presence of basic or charged 
residues in close proximity to the cysteine in the substrate protein might modulate the 
potential to form a thiolate (Mössner et al., 2000; Bizzozero et al., 2001). Similar to 
the modulation of cysteines by changes in redox environment, the presence of an 
additional protein in close proximity might also facilitate the thiolation. The 
deprotonation of cysteine can either achieved by enhancing the accessibility of the 
sulphydryl group, or by changing the local pKa of the target cysteine. The other 
noteworthy aspect of palmitoylation reaction is that palmitate (C16) is not the only 
substrate added to the cysteines. Studies have shown that apart from C-16 palmitate, 
other lipid moieties such as palmitoleate (C16:1), stearate (C18) and oleate (C18:1) 
have been found on the target cysteines (Hallak et al., 1994; Schroeder et al., 1996; 
Liang et al., 2002, 2004). These findings also indicate that the DHHC PAT enzymes 
must be less specific towards the substrate recognition in vivo. 
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2) Transfer of palmitate from palmitoyl Co-A to substrate’s thiolate 
The second important aspect of palmitoylation involves palmitate transfer from 
cellular palmitoyl Co-A to the substrate thiols by DHHC PATs. It has been 
demonstrated that the DHHC proteins can undergo spontaneous autoacylation (Lobo 
et al., 2002) in the presence of long-chain acyl Co-As. Therefore the PATs forms a 
thioester intermediate with palmitate group, thereby the DHHC PATs additionally is 
involved in storage, accumulation and presentation of palmitoyl Co-A. When these 
PAT thioester intermediates encounter a substrate with thiolated cysteine, they rapidly 
catalyze the transfer reaction. Thus the DHHC PATs maintain higher palmitoylation 
rates and ensuring more coordinated substrate encounter. The DHHC PAT thioester 
intermediates also transfers the palmitate group irrespective of recognizable specific 
structures on the palmitoylatable substrate other than the target cysteine.  In general 
the DHHC PAT thioester intermediate merely reduces the activation energy of the 
palmitoylation reaction due to thiolate stabilization. Thus, individual PAT/substrate 
pairs will not make any difference to the palmitate transfer reaction and in return will 
attenuate palmitoylation efficiency. 
A few mammalian DHHC PATs contain protein interaction domains such as ankyrin 
repeat in DHHC13, SH3 in DHHC6 and PDZ binding motifs in DHHC5/8/14 
(Tsutsumi et al., 2008; Huang et al., 2009). This suggests that these additional 
domains might be involved in enhancing interactions with specific substrates or sub-
cellular localization. But the influence of such interactions on global palmitoylation 
machinery still remains elusive and needs to be tested. 
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4.1 Abstract 
The distribution of Ras-family G-proteins in cellular membranes dictates their 
signaling capacity and potential to alter cell phenotype. The outcome of this study 
was that the GDI-like solubilizing factor (GSF), PDEδ determines Ras protein 
distribution by rapidly mobilizing depalmitoylated or plasma membrane (PM) 
desorbed polycationic forms of Ras. The GDI-like pocket of PDEδ binds and 
solubilizes farnesylated Ras proteins to allow more effective trapping of 
depalmitoylated Ras proteins at the Golgi and polycationic Ras proteins at the PM. 
Thereby, PDEδ plays a dual role in maintaining the equilibrium distribution of 
polybasic Kras at the PM and the non-equilibrium distribution of palmitoylated 
N/Hras at the Golgi and PM. Importantly, PDEδ activity augments K/Hras signaling 
by enriching Ras at the PM; conversely, PDEδ down-modulation not only suppresses 
regulated signaling and proliferation via wild-type Ras, but also constitutive 
oncogenic Ras signaling in cancer cells. Thus, the essential role of PDEδ in 
determining Ras topography has implications for cancer therapy. 
 
 
 
 
 
 
 
Rational and hypothesis 
 Anchal Chandra - Dissertation   74 
4.2 Rationale and Hypothesis 
Lipid modifications at the C-terminus of the Ras family of GTP-binding proteins are 
essential for their function in a wide range of signal transduction processes (Colicelli, 
2004). Hras and Nras proteins undergo two types of modifications: an irreversible 
farnesylation at the cysteine (Cys) residue of the CAAX box followed by a reversible 
palmitoylation at specific Cys residue(s) in the C-terminal hyper variable region 
(HVR). For the palmitoylated Ras proteins, three factors cooperate to confer a higher 
stability of accumulation in specific membranes - first, repeated cycles of Ras 
de/repalmitoylation, second, Golgi trapping by palmitoylation and third, the 
directionality of the secretory pathway. Together, these factors counter entropy-driven 
equilibration of palmitoylated Ras over all membranes (Goodwin et al., 2005; Rocks 
et al., 2010; Rocks et al., 2005). Thus, cleavage of the palmitoyl anchor by 
thioesterases (Camp and Hofmann, 1993; Dekker et al., 2010) reduces membrane 
affinity (Sang and Silvius, 2005) and enhances effective diffusion in the cytoplasm 
and redirection to the PM by the secretory pathway (Peyker et al., 2005; Rocks et al., 
2005, 2010). However, Ras family proteins such as Kras contain polybasic residues in 
their HVR, instead of reversibly palmitoylated Cysteine residues. For polybasic Ras 
proteins, the negatively charged PM serves as a thermodynamically favored trapping 
structure that causes their accumulation. The major conundrum in the field is how the 
slow diffusion of prenylated Ras on the membranes in the cytoplasm is affected to 
enhance the kinetics of Ras trapping at the PM and thereby counter the randomization 
of the Ras distribution on intracellular membranes by the inward flow of endocytic 
vesicles. The involvement of GDI-like protein has long been suggested and it has 
been even speculated that PDEδ might transport lipidated Ras proteins (Hanzal-Bayer 
et al., 2002a; Nancy et al., 2002; Zhang et al., 2004). But till date the mechanism of 
how or if not whether PDEδ mediates shuttling of Ras protein pools between PM, 
Golgi, ER and cytoplasm is not known. Therefore in this study, the hypothesis was 
put to test using cell biological, biochemical and imaging methods. 
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4.3 Results 
4.3.1 PDEδ affects spatial distribution of Ras family proteins 
Prenylated, peripheral Ras family proteins can be divided into two main subgroups 
based on the differences in their hypervariable (HVR) region. Ras proteins bearing 
palmitoylatable cysteines in their HVR region such as Hras, Nras etc. and the other 
subclass comprise of Ras proteins bearing polybasic residues in their HVR for 
example Kras, Rheb etc.  
Prenylated, palmitoylated Ras family proteins 
In order to determine whether binding of PDEδ regulates the spatial localization of 
palmitoylated Ras proteins, MDCK cells were transiently co-transfected with various 
Ras family proteins fused to the monomeric yellow fluorescent protein Citrine 
(Griesbeck et al., 2001) and PDEδ fused to the monomeric red fluorescent protein 
mCherry (Shaner et al., 2004). Palmitoylated Nras and Hras predominantly localize at 
the PM and Golgi as reported earlier (Choy et al., 1999; Rocks et al., 2005). PDEδ 
over-expression in these cells resulted in solubilization of membrane bound Nras 
while no clear effect was observed for Hras (Figure 4.1). This difference may arise 
because Hras is more stably associated with the PM than Nras, due to its stable 
palmitoylation on two cysteine residues in the C-terminus of the protein as compared 
to only one palmitoylatable cysteine in case of Nras (Figure 4.1). Supporting evidence 
for this hypothesis comes from the efficient solubilization of the more labile mono-
palmitoylated HrasC181S and Hras C184S mutant or depalmitoylated 
HrasC181S/C184S mutant upon co-expression of mCherry-PDEδ (Figure 4.1). This 
result suggests that the stability of palmitate attachment influences the effect of PDEδ 
on the localization of Ras.  
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Figure 4.1  PDEδ affects the spatial distribution of palmitoylated Ras proteins 
(A) Steady state localization of mCit fused Ras proteins (green) in MDCK 
cells alone (left panel) and co-transfected with mCh-PDEδ (red), right panel. 
On the right are the C-terminal sequences of the respective Ras proteins. The 
CaaX box is shown in red, C-terminal cysteines that are potential substrates 
for palmitoyl transfer are highlighted in green. Yellow boxes indicate 
replacement of these cysteines by serines. (B) Steady state localization of 
Rap proteins bearing two putative palmitoylation sites in the C-terminus in 
the presence (right panel) /absence (left panel) of mCh-PDEδ. (C) Bar graph: 
Mean Manders' coefficients (MC) for co-localization of different mCit-Ras 
proteins and mCh-PDEδ (n=10). High Manders’ coefficients indicate better 
co-localization of mCit-Ras proteins with PDEδ. Values less than 0.5 indicate 
no co-localization, denoted in dark grey stripes. (D) Palmitoylation levels 
determined by biotin acyl exchange assay: Upper panel: Western blot of 
immunoprecipitated Ras proteins on protein G-sepharose 4B showing 
biotinylated protein labeled with streptavidin IR 680 and total protein with 
anti-GFP (mouse). Lower panel: Quantification of the normalized 
palmitoylated fraction for each Ras and Rap isoform (n=4 blots). 
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Palmitoylated Rap2a and Rap2b were localized to the PM and Golgi apparatus, 
whereas Rap2c exhibited a Golgi and ER specific localization which may be 
conferred by its higher palmitate lability similar to the HrasC181S mutant (Rocks et 
al., 2005). Co-expression of PDEδ resulted in a shift in the distribution of the Rap2 
proteins to the cytoplasm indicating solubilization (Nancy et al., 2002) with the 
exception of Rap2b (Figure 4.1). These observations suggest that the loose association 
of Ras proteins with membranes is a key determinant for the interaction with PDEδ. 
Indeed, double lipid modified palmitoylated proteins seem to resist the solubilizing 
PDEδ effect (Figure 4.1), contrary to previous findings (Nancy et al., 2002). 
Unexpectedly, the farnesylated Rap2 proteins (Rap2a, -c) that also contain two 
potential palmitoylation sites in their HVR were also effectively solubilized by PDEδ. 
We therefore compared the steady state level of palmitoylation in these Ras family 
proteins by the biotin acyl exchange (BAE) assay (Drisdel and Green, 2004). 
Interestingly, the effective palmitoylation level of these proteins (Hras > Nras > 
HrasC181S) decreased in the order of their tendency to be solubilized by PDEδ with 
the Rap proteins showing the lowest levels of palmitoylation (Figure 4.1). These 
experiments confirm that PDEδ interacts preferentially with the farnesylated, 
depalmitoylated state of Ras proteins during the acylation cycle. 
PDEδ directly binds palmitoylatable Ras family proteins 
The influence of PDEδ on the steady-state localization of palmitoylatable Ras proteins 
can either result from indirect regulation by accessory proteins or through a direct 
interaction. To address this, Fluorescence Lifetime Imaging Microscopy (FLIM)-
based quantitative FRET measurements (Wouters et al., 2001) were performed using 
mCitrine on the N-terminus of Ras proteins as donor, and dCherry (mCherry-tandem 
spaced by a linker) fused to the C-terminus of PDEδ as acceptor. FLIM allows the 
quantification of the interacting fraction (α) of molecules that exhibit FRET as 
apparent from the lower fluorescence lifetime of the donor mCitrine (Wouters et al., 
2001). Co-expression of mCit-Nras and dCh-PDEδ showed a marked decrease in 
fluorescence lifetime in the cytoplasm of these cells indicating an interacting fraction 
(α) of mCit-Nras with PDEδ. In contrast, the higher lifetime of the PM-bound mCit-
Nras indicated a non-interacting population (Figure 4.2). Unlike mCit-Nras, doubly 
palmitoylated mCit-Hras (Figure 4.2) and its G12V mutant (not shown) didn’t show a 
clear interaction with dCh-PDEδ.  However, the mono-palmitoylated Hras mutants 
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(C181S or C184S) and the non-palmitoylated (C181S, 184S) mutant exhibited a clear 
interaction with dCh-PDEδ as measured by FLIM (Figure 4.2). We attribute this to 
the increased lability of palmitoylation on the mono-palmitoylated Hras mutants as 
compared to wt Hras, which increases the steady-state concentration of the 
depalmitoylated state capable of interacting with PDEδ. Other palmitoylated Ras 
family members like mCit-Rap2a and Rap2c (Figure 4.2) also showed a large fraction 
of molecules that interacted with dCh-PDEδ.  
 
Figure 4.2 FRET-FLIM based PDEδ-Ras interaction studies 
(A) Upper panel: MDCK cells co-expressing either mCit fused to Nras (first 
row), Hras (second row) or Hras palmitoylation mutants (lower two rows) 
and dCh-PDEδ. For each sample, the fluorescence intensity of mCit-Ras 
(donor), the fluorescence intensity of dCh-PDEδ (acceptor), the spatial 
distribution of the mean fluorescence lifetime (τav) and the molar fraction of 
interacting molecules (α) are shown according to the false color lookup 
tables. (B) Bar graph: Quantified average a values for different Ras proteins 
with dCh-PDEδ as acceptor.  
 
Prenylated, polycationic Ras family proteins 
To investigate whether the important classes of prenylated peripheral Ras family 
proteins that have a polybasic (HVR) instead of palmitoylatable cysteines next to the 
CaaX box also require PDEδ to sustain their spatial organization. A prototypical 
member of that G-protein family is Kras with 8 basic residues in its HVR. Stable 
anchorage of these proteins to the PM seems to require two components: an 
electrostatic interaction with negatively charged phospholipids and the partioning of 
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the hydrophobic prenyl group into the lipid bilayer. Co-expression of mCh-PDEδ with 
Ras proteins that have five or more basic residues in the HVR (Kras, Diras) did not 
lead to a significant change in their spatial localization (Figure 4.3). However, Ras 
proteins with fewer basic residues in the HVR were more effectively solubilized by 
PDEδ as is clearly evident from the cytoplasmic distribution of farnesylated Rheb and 
Rheb-L1 that contain either two or one basic residue (Figure 4.3). A correlation was 
thus apparent between the extent of solubilization of Ras proteins by PDEδ and the 
amount of basic residues that they contain in the HVR. We then investigated with 
FRET-FLIM whether the solubilization of Ras proteins containing polybasic stretches 
requires direct interaction with PDEδ. mCit-Kras/ mCit-KrasG12V that are mostly 
associated with the PM showed no change in fluorescence lifetime upon co-
expression of mCh-PDEδ; in contrast, a homogeneously distributed population of 
mCit-Rheb molecules exhibited an interaction with PDEδ (Figure 4.3). We then 
generated mutants of Kras that have a gradual replacement of the basic lysines by 
acidic glutamates in the HVR (Kras Δ2E, Δ4E, Δ6E) and measured the extent of their 
solubilization by PDEδ. This replacement resulted in a gradual destabilization of Kras 
from the PM in increasing order of acidity. The redistribution to endomembranes was 
matched by an increased solubilization by PDEδ (Figure 4.3) and increased 
interaction with dCh-PDEδ  (Figure 4.3). This implies that high affinity binding of 
polycationic Ras proteins to the negatively charged PM (Heo et al., 2006; Yeung et 
al., 2006, 2008, 2009) hinders their association with PDEδ. On the other hand, weaker 
PM association of less positively charged proteins leads to a higher dissociation rate 
that allows solubilization by PDEδ. This is indicative of the fact that PDEδ might 
sequester Kras mostly from endomembranes, thereby delineating its function in the 
spatial organization of polybasic stretch containing Ras molecules. Thus, membrane-
bound Kras must be desorbed before it can interact with PDEδ. 
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Figure 4.3    PDEδ solubilizes polybasic stretch containing Ras proteins 
(A) Left panel: Steady state localization of mCit fused to polybasic stretch containing Ras proteins in MDCK cells. Right panel: MDCK cells co-
transfected with plasmids encoding for mCit tagged polybasic Ras proteins (green) and mCh-PDEδ (red). Right: C-terminal sequences of the 
respective Ras proteins showing basic residues in pink and the CaaX-box in red. Lower bar graph: Manders’ coefficients (MC, n=10 each) 
displaying co-localization of different Ras polycationic proteins with PDEδ. The number of basic residues at the C-terminus is given in brackets. 
Manders’ coefficient less than 0.5 denote no co-localization (dark grey). (B) FLIM-FRET measurements in MDCK cells co-expressing either 
mCitrine fused to Kras (8 basic residues, upper row) or Rheb (one basic residue, lower row) with dCh-PDEδ. Lower bar graph: Quantified average 
a values (fraction of interacting molecules) for different Ras proteins with dCh-PDEδ. (C) The number of cationic residues in the HVR affects Kras 
distribution and solubilization by PDEδ. The four panels show the fluorescence distribution of mCit tagged Kras where 0, 2, 4 or 6 lysines in the 
polybasic stretch have been replaced by glutamic acid. The upper row in each panel shows the fluorescence distribution of mCit-Kras wild type and 
mutants (mCitrine) as well as the distribution of the ER-marker mTFP-Calreticulin. (D) Fluorescence distribution of mCit-Kras wild type and 
mutants in cells co-expressing mCh-PDEδ (mCherry) as well as the merge of both channels. Lower bar graph: Quantification of co-localization of 
mCit-Kras mutants with the ER marker (mTFP-Calreticulin) or mCh-PDEδ using Manders’ coefficients (n=10 each). (E) Quantified average molar 
fraction of interacting Kras mutants with dCh-PDEδ  (n=5 each). 
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4.3.2 Prenylation/farnesylation is essential for PDEδ-Ras interaction 
Rap2b bears similar modifications at the C-terminus as Rap2a and Rap2c except for 
the CVIL CaaX box which is a substrate for geranylgeranyl transferase (Farrell et al., 
1993; Winegar et al., 1991). This indicates a specificity of PDEδ for farnesylated Ras 
over geranylgeranylated Ras proteins. Indeed, when the C-terminus of the non-
palmitoylated HrasC181S/C184S mutant was replaced with a CaaX box for 
geranylgeranylation (CLLL) its solubilization was abolished (Figure 4.4). FLIM 
experiments also showed that a geranylgeranylated Nras mutant (mCit-Nras CLLL) 
did not interact with PDEδ in stark contrast to farnesylated Nras wt (CVVM) (Figure 
4.4).  
 
Figure 4.4 PDEδ does not interact with geranylgeranylated Ras proteins 
FLIM-FRET measurements in MDCK cells co-expressing either Hras mutant 
bearing a geranylgeranylated C-terminal (CLLL CaaX box) fused to mCitrine 
HrasC181S/C184S CLLL or Nras geranylgeranylated mutant (mCit-
NrasCLLL) and dCh-PDEδ shows no interaction as well as no change in 
spatial localization. The upper row show example of farnesylated mCit-
HrasC181S/C184S interacting fraction with dCh-PDEδ. For each sample, the 
fluorescence intensity of mCit-Ras (donor), the fluorescence intensity of 
dCh-PDEδ (acceptor), the spatial distribution of the mean fluorescence 
lifetime (τav) and the fraction of interacting molecules (α) are shown 
according to the false color lookup tables. 
 
This was consistent with the fact that the localization of the Nras CLLL mutant was 
not affected by PDEδ and that farnesylated but not geranylgeranylated Nras protein 
Results 
 Anchal Chandra - Dissertation   82 
could be pulled down with recombinant human PDEδ (Figure 4.5). An increased 
affinity of PDEδ for farnesylated over geranylgeranylated moieties was also 
demonstrated in previous in vitro experiments by (Zhang et al., 2004). 
 
Figure 4.5 GST pulldown assay 
MDCK whole cell lysates transiently transfected with Hras, Nras wt and 
various other mutants were subjected to GST pulldown assays by either 
recombinantly purified GST-RafRBD (positive control) or GST-PDEδ. 
Samples were treated with beads containing either no GST or only GST to 
serve as negative control (left side panel). Pulled down proteins were 
detected by immunoblotting against mouse anti-GFP (49KDa) and the total 
amount of loaded protein in each lane was verified by probing blots with 
rabbit anti cyclophilin-B. 
 
4.3.3  PDEδ-Ras interaction is independent of Ras nucleotide bound 
state 
From the similarity in the structures of PDEδ and Rho-GDI, it was suggested that 
PDEδ has a GDI-like function (Alexander et al., 2009; Hanzal-Bayer et al., 2002). 
However, structural alignment of PDEδ with Rho-GDI bound to Rho shows that 
PDEδ has a shorter N-terminus (Figure 4.6) that cannot block the switch regions of 
the bound G-protein to stabilize the inactive, GDP bound conformation as is the case 
for Rho-GDI (Gosser et al., 1997). 
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Figure 4.6 Structural overlay of PDEδ with Rho-RhoGDI complex  
Ribbon representations of PDEδ (in orange) and Rho (Gray)- RhoGDI 
(Brown). The switch region of Rho is indicated in yellow where blockage of 
effector binding occurs by the extended N-terminus of RhoGDI. In case of 
PDEδ the N terminus (as marked by black arrow) lacks a helical extension 
compared to RhoGDI and is unable to interact with the switch regions in the 
G-domain. 
 
Indeed, as shown above, PDEδ showed equivalent binding affinity to wt Nras, 
dominant negative Nras (S17N) and constitutively active Nras (G12D) mutants. Also, 
no interactions of Nras ΔCaaX mutants with PDEδ could be detected even though 
these mutants retain intact effector binding switch regions (Figure 4.7). Thus, one can 
conclude from here that PDEδ-mediated solubilization of farnesylated Ras proteins 
occurred to the same extent regardless of whether they were bound to GDP or GTP 
and thus occurs independently of the nucleotide state of the protein (Nancy et al., 
2002). This differs from the role of RhoGDI proteins in solubilizing prenylated G-
proteins, which preferentially affects the GDP-bound forms (Gosser et al., 1997; 
Longenecker et al., 1999). Hence, the term GDI-like solubilizing factor (GSF) reflects 
the function of PDEδ as an efficient solubilizer of Ras proteins irrespective of the 
bound nucleotide state. 
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Figure 4.7 PDEδ shows no preference to GDP or GTP bound Ras 
FLIM-FRET measurements in MDCK cells co-expressing either 
constitutively active NrasG12D mutant (upper panel) or dominant negative 
NrasS17N mutant (middle panel), NrasG12D without C-terminal CaaX box 
mutant (NrasG12D ΔCaaX, lower panel) and dCh-PDEδ. For each sample, 
the fluorescence intensity of mCit-Ras (donor), the fluorescence intensity of 
dCh-PDEδ (acceptor), the spatial distribution of the mean fluorescence 
lifetime (τav) and the fraction of interacting molecules (α) are shown 
according to the false color lookup tables. 
 
4.3.4 PDEδ downregulation alters Ras spatial localization 
As evident from above results, spatial localization of polycationic Kras as well as 
doubly palmitoylated Hras was not affected on expression of PDEδ. A feasible 
explanation of this comes from the fact that the cells still have enough endogeneous 
PDEδ that interact with stably associated Ras isoforms with higher affinity in order to 
maintain their spatial localization. A parallel in vitro study done with full-length semi-
synthetic proteins revealed that affinity of PDEδ toward polycationic Kras was much 
higher as compared to other Ras isoforms (Chen et al., 2010). Although the in vitro 
studies were done in absence of any charged membranes, which points out that the 
strong electrostatic affinity of Kras towards PM might have a role in regulating 
interaction with PDEδ. In order to determine the relative stoichiometry of 
endogeneous Ras isoforms compared to endogeneous PDEδ, concentrations of 
recombinant H/N/Rheb and PDEδ proteins were determined by densitometric analysis 
of coomassie blue-stained gels using BSA as a standard. Various amounts of lysates 
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(10-80µg) were analyzed alongside titrated recombinant protein standards by SDS-
PAGE and immunoblotted using antisera against N/K/H/Rheb and PDEδ. 
Immunodetected proteins were quantified densitometrically and cellular 
concentrations were calculated (Figure 4.8). The endogeneous levels of PDEδ were 
approximately four times those of Ras in both the cell lines (Table 4.1) although 
molar sum of all the Ras proteins together was approximately equal to the molar 
amount of PDEδ. This correlates well with high endogeneous levels, high affinity of 
PDEδ for polycationic Kras and presence of very low amounts of unphosphorylated 
and endomembrane bound Kras in the cytoplasm. 
 
 
Figure 4.8 Endogeneous PDEδ , Ras protein concentration determination 
(A) Upper panel: Whole cell lysate of MDCK probed with Anti PDEδ, 
Anti-Rheb and GAPDH (loading control) analyzed alongside titrated 
protein standard. Middle panel: Recombinantly purified PDEδ protein 
standard and recombinantly purified Rheb (Lower panel) for 
concentration determination using silver staining. (B) Densitometric 
analysis of silver stained protein standards to calculate subcellular 
concentrations of proteins. 
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Table 4.1 Relative Content of Ras-GTPase and PDEδ  in two cell 
lines 
  MDCK  HEK293T 
PDEδ 230ng/106 cells 320ng/106 cells 
Rheb/Ras  56ng/106 cells 88ng/106 cells 
Molar Ratio  1:4  1:4 
 
To test if this hypothesis, PDEδ was downregulated in MDCK cells using dog specific 
PDEδ siRNA (Table 2.1, experimental procedures, 2.1.7). Cells were treated with 
four different dog-PDEδ siRNAs for 48-72h and were assessed for downregulation in 
these cells. Three out of four siRNA sequences showed effective PDEδ 
downregulation after 48h (Figure 4.9) on analysis via western blotting. Same siRNA 
sequences were also analyzed for PDEδ downregulation after incubation for 72h by 
quantifying mRNA levels using RT-PCR.  
Further, to investigate the whether the role of PDEδ is to constitutively regulate Ras 
spatial localization the spatial partioning of mCitrine fused palmitoylated Ras proteins 
(H/N/Kras) in MDCK cells either untreated or treated with PDEδ-specific siRNA 
(Table 2.1) was analyzed. The down-regulation of PDEδ protein expression (Figure 
4.10) resulted in loss of PM and Golgi specific H/Nras localization, shifting the 
distribution to non-specific labeling of endomembranes (Figure 4.10). This was 
distinct from Ras distribution in cells over-expressing PDEδ that show a more 
homogeneous, cytoplasmic distribution. The randomized endomembrane distribution 
of mCit-Kras (Figure 4.10) in cells treated with PDEδ-specific siRNA indeed 
indicates that PDEδ plays a constitutive role in the maintenance of Ras at the PM. The 
affect of spatial distribution of Ras on PDEδ downregulation was quantified using 
Manders co-localization coefficient (MC). MC serves as an index of the fraction of 
Ras protein that co-localized with the ER marker (mTFP-Calreticulin) in untreated as 
well as PDEδ siRNA treated cells. As evident from the Figure 4.10 cells treated with 
PDEδ siRNA showed increased overlap with the ER marker indicated by higher 
overlap coefficient as compared to untreated cells. This indicates that on depleting 
PDEδ endogeneous pool, most of the Ras proteins fail to escape endomembrane after 
post-translational modifications at the ER and hence are not able to reach PM. This 
result in drastically altering PM bound Kras and Golgi/PM steady state localization in 
case of H/Nras. From this one can also decipher that PDEδ plays an important role on 
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transport of polycationic proteins from ER to PM presumably via solubilization. 
 
Figure 4.9 Validation of siRNA specificity towards canine PDEδ 
(A) siRNA mediated PDEδ downregulation in MDCK cells analyzed by 
western blot (left) and relative PDEδ protein levels quantified (right) in 
knockdown cells using unspecific scrambled siRNA as negative, and 
GAPDH as loading controls. (B) Validation of PDEδ knockdown in MDCK 
cells by real-time PCR: Amplification curves were generated using a SYBR 
green detection kit. The real-time PCR curves show a ~2 fold delay in 
amplification in cells treated with PDEδ siRNA as compared to unspecific 
scrambled and GAPDH siRNA (left). Bar graph: mRNA levels in PDEδ-
specific siRNA treated MDCK cells as quantified by real time PCR (right). 
 
Another interesting aspect of this PDEδ mediated regulation of polycationic Ras 
proteins is their electrostatic interaction with the PM. The electrostatic interaction 
which targets signaling Ras molecules to the phosphatidylserine (PS)-enriched 
endomembranes can be modulated by varying surface charge of the membrane or by 
altering the net charge on the protein. Alteration in surface charge results in 
externalization of plasmalemma PS and PI(4,5)P2 hydrolysis. As a result, the 
plasmalemma surface charge decreases and becomes comparable to that of 
endomembranes, which can now compete effectively for binding with Kras. Kras, 
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which carries +8 charge at its C-terminus and localizes primarily at the PM in resting 
cell showed dramatic redistribution to the endomembranes on PDEδ downregulation 
(Figure 4.10). In order to ensure that this relocalization is not an effect of 
redistribution of surface charges on the PM and endomembranes, the endogeneous 
distribution of Phosphatidylserine (PS) was analyzed. Using a PS specific probe, 
Lact-C2 was probed (Yeung et al., 2008) on these charged membranes in untreated as 
well as PDEδ siRNA treated cells. To verify the specificity of Lact-C2 probe towards 
PS, the GFP-Lact-C2 probe was co-expressed in MDCK cells along with 
endomembrane marker (mTFP-Calreticulin) and its intracellular distribution was 
observed by fluorescence confocal microscopy. GFP-Lact-C2 localized prominently 
at the PM, confirming the presence of PS on its inner leaflet. Interestingly, in some of 
the cells intracellular vesicles were also labeled with GFP-Lact-C2 but mostly all the 
cells demonstrated PM specific labeling. Cells treated with PDEδ specific siRNA also 
exhibited similar distribution reflecting that PDEδ downregulation does not alter the 
surface charge distribution of the membranes (Figure 4.11). 
 
Figure 4.10 siRNA mediated downregulation of PDEδ causes redistribution of 
Ras 
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Hras (upper two rows), Nras (middle two rows) and Kras (lower two rows) 
redistributes to endomembranes/ endoplasmic reticulum (ER). The ER 
marker mTFP-Calreticulin (second column) and the Golgi marker TagRFP-
T-GalT (third column) were co-expressed in all cells. The fourth column 
shows a merge of the three fluorescence channels with DAPI. Micrographs 
are representative of at least 10 individual measurements. Bar graph: 
Manders’ coefficients (MC) for colocalization of Ras isoforms with the ER 
marker (mTFP-Calreticulin) in cells with (gray)/without (black) PDEδ 
downregulation (n=10). 
 
In another experiment, subjecting cells expressing R-pre-mRFP (Figure 4.12) (a Kras 
analogue with a polyarginated/ unphosphorylatable {HVR} as described in (Yeung et 
al., 2008) to PDEδ siRNA exhibited a similar endomembrane distribution to that of 
Kras upon PDEδ downregulation (Figure 4.10). This delineates the role of the 
polycationic tail in the specific high affinity interaction with the PM and minimal 
requirement of the farnesyl moiety for the interaction with PDEδ, regardless of the 
HVR sequence. 
 
 
 
Figure 4.11 PDEδ downregulation does not alter surface charge distribution 
on the PM 
MDCK cells co-transfected with Lact-C2-GFP (green) and mCh-Kras wt 
(red) in the absence (upper row) or presence (lower row) of PDEδ siRNA. 
Right bar graph: Mean Manders’ coefficient (n=8 cells) indicating extent of 
overlap between Lact-C2 -GFP and mCh-Kras wt in cells with (gray) or 
without (black) siRNA downregulation. 
 
 
Figure 4.12 Farnesylation is the only pre-requisite for PDEδ-Ras interaction 
Distribution of R-pre (a Kras analogue with a polyarginated/ 
unphosphorylatable HVR, green) in MDCK cells (upper row) and cells 
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treated with PDEδ specific siRNA (lower row). mTFP-Calreticulin is used as 
ER/endomembrane (red) and ECFP-GalT (white) as Golgi marker. Overlay 
of R-pre RFP and mTFP-Calreticulin is shown in fourth column. Right bar 
graph: Mean Manders’ coefficient (n=10 cells) indicating extent of overlap 
between R-pre-RFP and mTFP-Calreticulin in cells with (gray) or without 
(black) siRNA downregulation. 
 
4.3.5 PM desorbed Kras interacts with PDEδ 
Phosphorylation of amino acids in a positively charged protein domain decreases its 
net charge thereby dissociating it from the PM (Kim et al., 1994). Such a 
phosphorylation event has been reported for polycationic Kras (Bivona et al., 2006) 
mediated by PKC activation and translocation. As demonstrated above that affinity of 
PDEδ towards Ras isoforms increases with decrease in PM interaction (Figure 4.2A, 
Figure 4.3A). In such a scenario, desorbing polycationic Kras by reducing net 
effective charge on the protein will help us visualize the dynamics of Kras-PDEδ 
interaction, which is otherwise not possible in presence of high affinity interaction 
between the two. To monitor the dynamics of Kras interaction with PDEδ, a PKC 
agonist Bryostatin-1 was used. Bryostatin-1, along with the phorbol esters and the 
endogeneous ligand diacyl glycerol (DAG), modulate PKC activity by binding to the 
C1 domain of the protein and thus initiating PKC translocation from the cytosol to the 
cellular membranes (Szallasi et al., 1994; Bivona et al., 2006). This activated PKC 
then induces phosphorylation of Kras at S181 next to the polybasic stretch and 
thereby causes its redistribution to endomembranes (Bivona et al., 2006). MDCK 
cells co-expressing mCit-Kras and mCh-PDEδ were treated with Bryostatin-1. Over a 
period of 50 minutes a marked redistribution of Kras from the PM to the cytoplasm 
was observed (Figure 4.13). Concomitant with this cytoplasmic redistribution an 
increased fraction (α) of interacting mCit-Kras and mCh-PDEδ was observed. In this 
case, Bryostatin-1 treatment increases the pool of less cationic Kras that desorbs more 
readily from PM and thereby can be sequestered by PDEδ. This phosphorylated Kras 
likely has a more comparable affinity for the PM and endomembranes due to the 
partial alleviation of the electrostatic interaction at the PM. On the other hand, 
unphosphorylated Kras that is (mis)-localized on endomembranes gets more readily 
solubilized by PDEδ and can thereby quickly diffuse in the cytoplasm to be (re)-
captured at the negatively charged PM. The interaction of Kras with endomembranes 
is independent of the polybasic stretch and therefore much weaker. This results in a 
higher endomembrane-off-rate and interaction with PDEδ in the cytoplasm. Instead, 
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Kras at the PM is tightly bound via electrostatic interactions and therefore has a low 
membrane off-rate that precludes its interaction with PDEδ in the cytoplasm. PDEδ 
thereby increases the kinetics of electrostatic trapping at the PM and in doing so 
maintains a non-homogeneous equilibrium distribution.  
 
Figure 4.13 PDEδ solubilizes Kras mostly from endomembranes 
FLIM time series on cells expressing mCit-KrasG12V and mCh-PDEδ 
indicate increasing interaction between KrasG12V and PDEδ in the 
cytoplasm after 100 nM of the protein kinase C agonist Bryostatin-1 
treatment. Upper two rows: fluorescence intensity distribution of the 
indicated fluorescent fusion proteins.  Lower two rows: average fluorescence 
lifetime τav and molar fraction (α) of interacting mCit-KrasG12V with mCh-
PDEδ. Bar Graph: Quantification of co-localization of mCit-KrasG12V with 
mCh-PDEδ after 100 nM Bryostatin-1 treatment at different time-points 
using Manders’ coefficients (n=6 each). 
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4.3.6 Pharmacological intervention of Ras acylation cycle 
Unlike Nras, doubly palmitoylated Hras wt and its G12V mutant did not show a clear 
interaction with PDEδ (Figure 4.2 A,B). However, partially mutating palmitoylation 
sites as in case of HrasC181S, HrasC184S and non-palmitoylated mutant 
(C181S/C184S) resulted in a clear interaction with PDEδ as measured by FLIM 
(Figure 4.2 A,B and Figure 4.4). This indicates that only depalmitoylated, prenylated 
Hras is solubilized by interaction with PDEδ. In case of the mono-palmitoylated Hras 
mutants the increased lability of palmitoylation as compared to wt Hras causes an 
increase in the steady state concentration of depalmitoylated state that can interact 
with PDEδ (Figure 4.2 A,B). Therefore in order to corroborate the importance of 
reversible palmitoylation on Ras-PDEδ interaction we investigated if increased Ras 
palmitoylation/depalmitoylation by selective inhibition of Ras de-acylation/acylation 
cycle influence the interaction with PDEδ. Localized palmitoylation activity of the 
PATs at the Golgi apparatus and thioesterase activity all over the cells (Rocks et al., 
2010) contributes to the partioning of palmitoylatable Ras. Blocking either of the 
reactions will influence the distribution of palmitoylated over depalmitoylated Ras. If 
this is true, then pharmacological inhibition of Hras palmitoylation should increase 
PDEδ-Ras interaction, whilst the suppression of depalmitoylation should have the 
opposite effect. Indeed, treatment of mCit-HrasG12V transfected MDCK cells with 
50 µM of the palmitoylation inhibitor 2-Bromopalmitate (2-BP) (Webb et al., 2000) 
resulted in a significant increase in the interacting fraction (α) of mCit-HrasG12V 
(Figure 4.14). Blocking palmitoylation with inhibitor of palmitate synthesis increased 
the net unpalmitoylated form of Ras. This unpalmitoylated Ras form confers low 
membrane affinity and hence was easily solubilized by PDEδ as observed (Figure 
4.14). Conversely, selective inhibition of Ras de-acylation by the thioesterase 
inhibitor Palmostatin-B gave rise to a fully palmitoylated but randomized 
endomembrane Ras distribution (Dekker et al., 2010) that did not interact with PDEδ 
(Figure 4.14). Equilibrium distribution of this palmitoylated endomembrane localized 
Ras was similar to depalmitoylated Ras form obtained on treatment with 2-BP.  
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Figure 4.14 Pharmacological intervention with the Ras acylation cycle affects 
   PDEδ activity  
Left panel: Inhibition of palmitoyl transferase activity by 50 mM 2-
Bromopalmitate. FLIM time series on cells expressing mCit-HrasG12V and 
mCh-PDEδ indicate increasing interaction between HrasG12V and PDEδ in 
the cytoplasm after 2-Bromopalmitate treatments. Upper two rows: 
fluorescence intensity distribution of the indicated fluorescent fusion 
proteins. Lower two rows: average fluorescence lifetime (τav) of mCit-
HrasG12V and molar fraction (α) of interacting mCit-HrasG12V with mCh-
PDEδ. Right panel: Time lapse FLIM of mCit-NrasG12D and mCh-PDEδ 
transfected MDCK cells show the loss of PDEδ-NrasG12D interaction after 
thioesterase inhibition by Palmostatin-B treatment. Quantified change in 
average HrasG12V/ NrasG12D populations interacting with PDEδ <α>, 
calculated from cells incubated with 2-Bromopalmitate (red) or Palmostatin-
B (black) (n=4 per data point). 
 
This shows that the depalmitoylated fraction and not simply the cellular localization 
of Ras proteins is the major factor that determines the interaction with PDEδ. This 
also explains why the more labile palmitoylation of Nras facilitates a much more 
efficient solubilization by PDEδ than for Hras at steady state in cells. Comparison of 
the palmitoylation level of Ras using the Biotin Acyl Exchange (BAE) assay in cells 
treated with and without Palmostatin-B indeed showed that about half of the Nras 
molecules are depalmitoylated versus a quarter of the Hras molecules at steady state 
(Figure 4.15). This also shows that at least 50% of Nras is already depalmitoylated 
Results 
 Anchal Chandra - Dissertation   94 
when it reaches the PM via the secretory pathway, accentuating the role of acylation 
cycle dynamics in the maintenance of palmitoylatable Ras protein localization.  
 
Figure 4.15 Palmitoylated Ras levels after thioesterase inhibition (BAE assay) 
Comparative increase in the fraction of palmitoylated Hras versus Nras 
protein in live cells upon treatment with Palmostatin-B as measured by the 
BAE method (Dekker et al., 2010; Drisdel and Green, 2004). Arbitrary 
fluorescence units (A.F.U.) determined using IR dyes were quantified from 
western blots representing 3 independent experiments. Samples left to right: 
DMSO vehicle treated Hras expressing MDCK cells; Palmostatin-B treated 
Hras expressing MDCK cells; Palmostatin-B treated Nras expressing MDCK 
cells; DMSO vehicle treated Nras control cells. Palmostatin-B treatment 
caused a remarkable 2-fold difference in palmitoylated Nras levels relative to 
control cells, compared to only a 1.3-fold increase in palmitoylated Hras 
levels under the same experimental conditions. 
 
 
4.3.7 PDEδ acts as a shuttling factor for palmitoylatable Ras  
To clarify the role of PDEδ as a shuttling factor for depalmitoylated Ras proteins and 
to ascertain that the mobility of palmitoylated and non-palmitoylated Ras proteins is 
affected by PDEδ expression. The diffusional properties of the non-palmitoylated 
HrasC181S/C184S mutant fused to a photoactivatable variant of GFP (paGFP) were 
measured by FLAP (Fluorescence Loss After Photoactivation) (Figure 4.16). paGFP 
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displays little fluorescence initially on excitation with 488nm wavelength. However, 
exposure to short irradiation with near-UV light lead to hundred times increase in 
fluorescence that allows imaging of selected protein pools within a single cell 
(Patterson and Lippincott-Schwartz, 2002). A small circular region in the cytoplasm 
of the cell was shortly illuminated by 405 nm laser light. This selectively 
photoconverted fraction of cytoplasmic depalmitoylated Ras pool but not the protein 
on endomembranes. Diffusion of photoconverted molecules within this small region 
was then observed to deduce the diffusion rate of these molecules. Ectopic expression 
of PDEδ led to an increase in the effective diffusion of paGFP-HrasC181S/C184S as 
compared to cells lacking ectopic PDEδ expression, whereas downregulation of PDEδ 
by siRNA led to a much slower effective diffusion (Figure 4.16). In agreement with 
results that PDEδ cannot solubilize geranylgeranylated Ras, the effective diffusion of 
geranylgeranylated paGFP-HRasC181/C184S CLLL mutant was not affected by the 
expression of PDEδ (Figure 4.16) and was comparable to that of paGFP-
HrasC181S/C184S in PDEδ-specific siRNA treated cells (Figure 4.16). Similarly, the 
effective diffusion of ∆CaaX box mutant of Nras was not affected by PDEδ 
expression (Figure 4.16, Table 4.2).  
FRAP experiments were performed to ascertain role of PDEδ in affecting kinetics of 
Ras diffusion from Golgi to PM. MDCK cells transiently transfected with the Golgi 
marker GalT-CFP and mCit-Nras in the presence /absence of mCh-PDEδ were treated 
with cycloheximide for 2-3 h prior experiment and maintained at 37°C (Figure 4.17). 
mCitrine fluorescence was bleached at the Golgi and the time course of fluorescence 
recovery was obtained. mCh-PDEδ expression substantially increased the 
fluorescence recovery at the Golgi (Figure 4.17, lower panel), showing that PDEδ 
enhances the effective diffusion of the depalmitoylated Nras thereby increasing the 
probability of encounter with the Golgi and thus the rate at which Ras gets re-
palmitoylated.  
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Figure 4.16 PDEδ enhances the effective diffusion of farnesylated Ras proteins 
(A) Fluorescence loss after photoactivation (FLAP) in a defined region in the cytoplasm of solely farnesylated paGFP-HrasC181S/C184S fusion 
proteins in the presence (lower panel) or absence (upper panel) of dCh-PDEδ ectopic expression. A white circle in the image time series outlines 
the photoactivated region. (B) Left panels: Overlay of FLAP curves: paGFP-HrasC181S/C184S (upper, n=10), paGFP-HrasC181S/C184S CLLL 
(middle, n=7) and Nras ΔCaaX (lower, n=8). Red curves indicate fluorescence loss after photoactivation in cells co-expressing dCh-PDEδ, grey 
curves indicate cells without dCh-PDEδ expression and blue curves represents cells after siRNA mediated PDEδ knockdown (n=8). All curves 
are normalized to one. Right panels: Mean diffusion constant Deff was determined from Deff = r 2/(4τD) where tD was obtained from fitting the 
fluorescence loss in the ROI with f (t) = 1− (1− η) exp(−2τD / t )[I0 (2τD/ t ) + I1 (2τD/ t )] + η in different measurements. siRNA1/2 represent two 
different siRNA sequences used to downregulate PDEδ. Calculated mean Deff and relation time (τD) are also shown in table 4.1.  
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Table 4.2 Calculated τD and Deff from FLAP performed on different Ras 
mutants 
 
a) Relaxation time (τD) 
 Untreated PDEδ expression 
Hras C181S/C184S 2.80 ±  0.3 sec 1.82 ± 0.14 sec 
Hras C181S/C184S CLLL 3.53 ± 0.18 sec 3.45  ±  0.17 sec 
NrasG12D ΔCaaX 1.19 ± 0.15 sec 1.21 ± 0.11 sec 
Nras ΔCaaX 1.25 ± 0.10 sec 1.23 ± 0.21 sec 
Hras C181S/C184S_siRNA-1 4.75 ± 0.62 sec n.a 
Hras C181S/C184S_siRNA-2 4.20 ± 0.78 sec n.a 
n.a = not applicable 
 
b) Effective Diffusion (Deff) 
 Untreated PDEδ expression 
Hras C181S/C184S 1.32 ± 0.14 mm2/sec 1.94 ± 0.14 mm2/sec 
Hras C181S/C184S CLLL 1.14 ± 0.03 mm2/sec 1.12 ± 0.04 mm2/sec 
NrasG12D ΔCaaX 2.80 ± 0.33 mm2/sec 2.77 ± 0.3 mm2/sec 
Nras ΔCaaX 2.38 ± 0.15 mm2/sec 2.25 ± 0.14 mm2/sec 
Hras C181S/C184S_siRNA-1  0.70 ± 0.29 mm2/sec     n.a 
Hras C181S/C184S_siRNA-2  0.82 ± 0.11 mm2/sec     n.a 
n.a = not applicable 
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Figure 4.17 PDEδ enhances the effective diffusion of Ras 
Fluorescence recovery after selective photobleaching at the Golgi of mCit-
Nras in the absence (upper panel, n=6) or presence of ectopic mCh-PDEδ 
expression (lower panel, n=10) was ratiometrically quantified using local 
GalT-CFP fluorescence intensity as a reference (see methods). MDCK cells 
were treated with cycloheximide to block protein synthesis. An overlay of all 
the curves is shown on the right side of both panels. 
 
4.3.8 PDEδ rescues Ras localization in HepG2 cells 
To substantiate the role of PDEδ as a regulator of Ras localization, spatial distribution 
of Ras proteins in cells where endogenous PDEδ expression is low or absent was 
assessed. Human liver carcinoma cells (HepG2) lack PDEδ (Wilson and Smyth, 
2006) and have been reported to undergo TPA-induced PKCα-mediated MEK 
activation, independent of Ras and Raf, to trigger sustained ERK (MAPK) signaling 
and cell cycle arrest (Wen-Sheng, 2006). Indeed, the steady state localization of 
H/N/K-Ras proteins in these cells was remarkably disorganized as compared to other 
cell lines that express PDEδ, such as MDCK cells (Figure 4.18, odd columns). Ras 
proteins mostly exhibited non-specific endomembrane distribution marked by overlap 
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with ER marker mTFP-Calreticulin. Strikingly, by expressing PDEδ in these HepG2 
cells, the PM enrichment of the three Ras isoforms could be reinstated as shown in 
(Figure 4.18, even columns). This was apparent from the sharp ring of green 
fluorescence at the periphery of cells that over-express PDEδ. PDEδ expression 
induced dramatic redistribution of mCit-H/Nras to the PM and the Golgi apparatus 
while mCit-Kras was highly enriched at the PM. Similar effect was observed for 
constitutively active Ras isoforms (Figure 4.19). 
In the case of Hras and Nras, the Golgi localized Ras fraction was not prominent 
presumably because of slower palmitate turnover kinetics in these cells. This was 
confirmed by inhibiting vesicular transport by temperature block (16°C). At 
temperatures below 17°C, endocytosis and other known forms of vesicular transport 
are blocked (Punnonen et al., 1998). As expected shift in the steady state distribution 
of wild type and constitutively active (G12V) mCit-H/Nras towards the Golgi 
apparatus was observed in HepG2 cells (Figure 4.19, lower panel).  
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Figure 4.18 PDEδ expression reinstates PM Ras localization in HepG2 cells 
Confocal images of HepG2 cells expressing mCitrine labeled Hras (left 2 
columns), Nras (middle two columns) and Kras (right two columns) in the 
presence (even columns) and absence (uneven columns) of mCh-PDEδ 
expression. The ER was marked by expression of mTFP-Calreticulin (second 
row). Bar graph: Mean Manders’ coefficient (MC) calculated for each Ras 
isoform indicating extent of overlap with ER marker (mTFP-Calreticulin) in 
untreated and cells expressing ectopic mCh-PDEδ. In the latter case values of 
Manders’ coefficient are less than 0.5 (dark grey) indicating no co-
localization. 
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Figure 4.19 Confocal imaging of HepG2 cells 
Upper panel: Confocal images of HepG2 cells expressing mCitrine tagged 
constitutively active Ras proteins alone or co-expressing dCh-PDEδ and the 
Golgi marker ECFP-GalT indicating unspecific membrane distribution and 
their dramatic PM redistribution after dCh-PDEδ expression. Lower panel: 
Temperature block of secretory pathway performed at 16°C for 4-8 hr on 
HepG2 cells co-expressing mCit-Ras, dCh-PDEδ and ECFP-GalT (Golgi 
marker). 
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4.3.9 PDEδ modulates Ras signaling response in normal and 
transformed cells 
The dynamic regulation of Ras localization is tightly coupled to its signaling output 
(Dekker et al., 2010; Lorentzen et al., 2010). For example, long-term inhibition of 
thioesterase activity by Palmostatin-B down-modulates oncogenic HrasG12V 
signaling through loss of PM localization (Dekker et al., 2010). Since PDEδ restores 
PM localization of Ras in HepG2 cells, it might also be relevant in altering growth 
factor signaling output in these cells. HepG2 cells that ectopically expressed PDEδ, 
indeed showed a several fold increase in phosphorylated extracellular regulated 
kinase (pErk)1/2 levels upon EGF stimulation (Figure 4.20). MDCK cells that express 
endogenous PDEδ showed further enhancement of pErk1/2 levels after stimulation 
with EGF upon ectopic expression of mCh-PDEδ. Conversely, downregulation of 
PDEδ by RNA interference in these cells reduced phosphorylated Erk1/2 levels 
(Figure 4.20). These results show that Ras induced downstream Erk activity is tightly 
coupled to the PDEδ-mediated enrichment of Ras at the PM. 
Signaling downstream of oncogenic Ras is a potent driver of cancerous growth in a 
variety of different tissues. It is considered pivotal for both the initiation and the 
maintenance of the malignant phenotype, while more recently it has further emerged 
as a predictor of response to targeted therapies. Somatic Hras, Nras and Kras-4B 
mutations encode mutant proteins with reduced intrinsic GTPase activity and 
resistance to GAP (GTPase activating protein) activity that therefore accumulate in 
the GTP-bound, active conformation. Therefore, tuning of PDEδ levels could also 
affect constitutive signaling via oncogenic Ras. To test this hypothesis that PDEδ 
down-regulation could suppress constitutive Ras signaling in cells expressing 
oncogenic Ras, BJ-hTERT/SV40 cells ectopically expressing Hras G12V were treated 
with PDEδ specific siRNA for 48-72 hrs. Downregulation of PDEδ in these cells 
indeed resulted in significantly reduced pErk1/2 levels (Figure 4.21). 
However, mutant oncogenic Ras in human cancer is frequently expressed from its 
endogenous locus under normal regulatory control; indeed, several studies show that 
the native expression of a constitutively active Ras mutant has distinct phenotypic 
outcomes when compared to the exogenous over-expression of a Ras transgene 
(Sarkisian et al., 2007; Tuveson et al., 2004). Therefore similar studies were extended 
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to murine pancreatic ductal adenocarcinoma cells (mPDAC) from a genetically 
engineered mouse model that faithfully recapitulates the key clinical, histological and 
molecular features of the human disease (Tuveson et al., 2004; Hingorani et al., 
2005). In this model, a tissue-specific conditional KrasG12D allele (Hingorani et al., 
2005, 2003; Skoulidis et al., 2010) has been ‘knocked in’ to a single endogenous 
locus, and is expressed under native regulatory control just as in the corresponding 
human cancers. KrasG12D activation is triggered via tissue-specific expression of Cre 
recombinase, driven by the regulatory elements of the pancreatic and duodenal 
homeobox 1 (Pdx1) promoter, with or without concurrent expression of the 
Trp53R270H trans-dominant mutant. Thus, KrasG12D (and Trp53R270H, where 
present) are expressed in Pdx1-positive pancreatic progenitors, which are a cell of 
origin of pancreatic cancer (Gidekel Friedlander et al., 2009). Primary cultures of 
early passage mPDAC cells were subjected to PDEδ downregulation via siRNA 
treatment (Figure 4.21). Notably, variable knockdown of PDEδ resulted in 
significantly reduced levels of phosphorylated Erk1/2 without affecting total Ras 
levels and regardless of the Trp53 status of the primary tumor analyzed 48-72 hrs 
after PDEδ depletion (Figure 4.21). Here, a clear correlation between the residual 
expression of PDEδ and phosphorylated Erk1/2 levels became apparent from a 2D- 
histogram of PDEδ levels versus pErk1/2 levels as obtained from the western blot 
analysis of the three cell lines (Figure 4.21). 
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Figure 4.20 PDEδ modulates wild type Ras signaling 
(A) Western blot analysis of Erk1/2 phosphorylation levels in response to 
EGF stimulation (100 ng/ml) in MDCK and HepG2 cells, in the absence and 
presence of PDEδ ectopic expression at indicated time points. (B) 
Densitometric quantification of Erk1/2 phosphorylation levels from western 
blots in response to EGF stimulation in MDCK (n=4) and HepG2 cells (n=4), 
in the absence (red lines) and presence (blue lines) of mCh-PDEδ ectopic 
expression. Green lines show the Erk1/2 phosphorylation response to EGF in 
MDCK cells with siRNA-mediated downregulation of PDEδ (n=4). The 
signal for pErk1/2 was normalized to total Erk levels. 
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Figure 4.21 Effect of siRNA mediated PDEδ down-regulation on pErk1/phosphorylation  levels in oncogenic Ras transformed cells 
(A) Upper panel: Western blot analysis of siRNA mediated PDEδ downregulation in Human foreskin fibroblast BJ-hTERT/SV40/HrasG12V 
(left), mouse pancreatic ductal adenocarcinoma cells (mPDAC) engineered to stably express KrasG12D on one allele (clone 79990, middle) or, 
with additional knock-in of p53 (R270H) (clone 79751, right). Immunoblotting was performed with pErk1/2, tErk1/2, PDEδ, cyclophilin-B and 
H/Kras antibodies to determine endogenous protein levels following treatment with different concentrations of PDEδ specific siRNA. Lower 
panel: Relative Erk1/2 phosphorylation levels were measured by densitometric analysis of western blots  (n=3) in mock (black), scrambled 
siRNA (gray) and PDEδ specific siRNA (200nM, red) transfected cells. (B) Upper panel: siRNA mediated PDEδ knockdown correlates with 
pErk downregulation at different time points (24h, 48h, 72h) in various mPDAC cell lines as indicated. Lower scatter plots: Western blot 
analysis shows the correlation between phosphorylated Erk1/2 and PDEδ levels for all siRNA treated cells. pErk and PDEδ levels are relative to 
those in cells treated with scrambled siRNA. 
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In order to verify that PDEδ knockdown also affects the distribution of endogenous 
Ras in these cancer cell lines, we compared the distribution of active, GTP-loaded Ras 
in fixed, permeabilized mPDAC cells with/without PDEδ knockdown by incubation 
with recombinantly purified, Cy3.5 labeled triple (3X)-RBD (Ras binding domain of 
Raf). mPDAC cells treated with PDEδ siRNA showed an endomembrane distribution 
of (3X)-RBD in contrast to the clear PM localization in untreated cells (Figure 4.22), 
confirming the role of PDEδ in maintaining Ras at the PM. 
 
Figure 4.22 PDEδ downregulation disturbs oncogenic KasG12D spatial 
partioning 
mPDAC cells (clone 79751) engineered to express oncogenic KrasG12D and 
Trp53R270H were stained with Cy3.5 labeled triple RBD ((3X)-RBD) to 
detect GTP-loaded endogenous Ras localization in cells treated with 
(right)/without (left) PDEδ specific siRNA. 
 
4.3.10 PDEδ ablation inhibits cell proliferation and viability in 
oncogenic Ras transformed cells 
To examine the inhibitory effect of PDEδ knockdown on cell proliferation and 
viability, clonogenic assays were performed. Both BJ hTERT-SV40/HrasG12V and 
mPDAC/KrasG12D cell lines in which stable, long-term PDEδ downregulation was 
achieved by shRNA. PDEδ down-regulation in these cancer lines resulted in reduced 
colony formation that correlated with PDEδ expression levels (Figure 4.23). By 
quantifying PDEδ and pErk1/2 levels by Western blot analysis under different 
shRNA-mediated downregulation conditions, there was a clear correlation between 
residual PDEδ and pErk1 or pErk2 levels at 72 hours after onset of PDEδ 
downregulation (Figure 4.23).  
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Figure 4.23 Effect of PDEδ ablation on Ras induced proliferative growth and viability 
(A) Upper panel: Clonogenic assay performed on BJ-hTERT/SV40/HrasG12V (left), mPDAC KrasG12D/+ (clone 79990, middle) and 
mPDAC KrasG12D/+/Trp53R270H/wt (clone 79751, right) cells treated with scrambled or two different PDEδ specific shRNAs and stained 
with crystal violet 6 days post transfection. Middle panel: Quantified absorbance measured at 595nm after dye extraction with 10% acetic acid. 
Values were normalized to the absorbance of scrambled shRNA samples. Lower panels: western blot analysis of PDEδ levels in shRNA 
transfected cells by probing with anti-tubulin (loading control) and PDEδ antibody. (B) mPDAC cell lines treated with different shRNA specific 
to PDEδ for 72h showing correlation between residual PDEδ and pErk levels. Different mPDAC cell lines responded to different shRNA as 
shown. Lower scatter plots as obtained from western blot analysis showing the correlation between pErk1 (red) / pErk2 (blue) and PDEδ levels 
in shRNA treated BJ-hTERT/SV40/HrasG12V (left), mPDAC-79990 (middle) and mPDAC-79751 (right) cells after 72 h. pErk and PDEδ levels 
are relative to those in cells treated with scrambled shRNA. 
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Strikingly, the phosphorylated Erk1/2 levels in one of the tested mPDAC cell lines 
increased after 13 days of shRNA incubation and exhibited no correlation with 
residual PDEδ levels (Figure 4.24). This increase in pErk levels with time after PDEδ 
down-regulation may represent a selection process of cells that overcome the lack of 
PDEδ mediated Ras signaling from the PM by switching to a Ras-independent 
signaling pathway or alternatively strongly overexpress oncogenic Ras to survive. 
Thus collectively, these observations suggest that oncogenic Hras and Kras-induced 
Erk signaling in a number of different settings can be controlled by modulating PDEδ 
expression or by affecting the interaction between PDEδ and Ras. 
 
Figure 4.24 Long-term PDEδ shRNA treatment 
Blots showing increased pErk1/2 levels in mPDAC clone 79751 and clone 
80000 cells after 13 days of PDEδ downregulation by shRNA transfection. 
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4.4 Discussion and future perspectives 
PDEδ is a GDI-like solubilizing factor (GSF) that is essential for the spatial 
organization of Ras family proteins. The GSF acts by facilitating diffusion and 
thereby enhancing the kinetics of trapping at a specific membrane compartment. In 
the case of palmitoylatable Ras proteins, PDEδ solubilizes Ras proteins that have 
been depalmitoylated by thioesterase activity such that they can rapidly diffuse and 
get trapped and concentrated at the Golgi by (re)-palmitoylation. In this case, PDEδ 
helps maintain a non-equilibrium distribution of Ras on the Golgi and the PM. This is 
facilitated by intermembrane diffusion of Ras and thereby enhancing the encounter 
probability with the Golgi. From there, the Ras proteins are redirected to PM by the 
secretory pathway. PDEδ thus effectively enhances the speed of redirection of Ras to 
the PM, to continuously counter the entropic tendency of lipidated Ras molecules to 
occupy all membranes in the cell (Silvius and l’ Heureux, 1994; Shahinian and 
Silvius, 1995). 
4.4.1 Polycationic Ras protein trafficking and membrane targeting 
Contrary to the vesicular transport mechanism of H/Nras, no clear mechanism has 
been demonstrated for the transport and trapping of Kras at the PM. The polybasic 
stretch containing Ras proteins such as Kras, is solubilized by PDEδ is therefore play 
essential role in maintaining proper localization. Newly synthesized Kras will acquire 
a membrane affinity after being farnesylated, and will thus predominantly interact 
with the most abundant endomembrane system (endoplasmic reticulum). Binding to 
endomembranes is highly dynamic and does not require secondary targeting signals 
(Choy et al., 1999). Endomembrane-bound polybasic Ras undergoes slow 
spontaneous transmembrane transfer and is finally trapped at the PM because this 
association is favored by the overall higher negative electrostatic profile of the PM. 
As compared to other intracellular membranes the PM is mainly contributed by the 
monovalent phospholipids such as phosphatidylserine and phosphatidylinositol (Heo 
et al., 2006; van Meer et al., 2008; Yeung et al., 2006, 2008, 2009). This spontaneous 
transmembrane exchange of farnesylated Ras is consistent with the previous 
observation that Kras reaches the PM via a nonvesicular, diffusional mechanism 
(Apolloni et al., 2000; Choy et al., 1999). However, this intermembrane exchange of 
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farnesylated Ras enroute to the PM trap is a relatively slow process (Daleke, 2003; 
Williamson and Schlegel, 1994) that is actively countered by the inward membrane 
flow of endocytic vesicles, which tend to randomize the Ras distribution over all 
membranes. As evident from the earlier reports (Yokoe and Meyer, 1996) (Leventis 
and Silvius, 1998b), rate of exchange between PM and cytoplasm (Koff) for 
polycationic proteins particularly those bearing hydrophobic anchorage site is much 
faster, involves secretory pathway (active process) and highly dynamic. Solubilization 
by PDEδ thus increases the speed at which Kras can get (re)-trapped at the PM by 
electrostatic interactions, and thereby counters the entropic tendency of the dynamic 
PM to redistribute Ras over endomembranes. In contrast to the role of PDEδ in the 
acylation cycle where it helps maintain an asymmetric out of equilibrium Ras 
distribution, in case of polybasic stretch containing Ras proteins it helps re-instate an 
asymmetric equilibrium distribution. In both cases, the diffusional exploration of the 
system is increased by PDEδ to enhance trapping at the right membrane compartment.  
4.4.2 Inter-compartmental exchange of palmitoylated and polycationic 
Ras 
Supporting evidence suggests that inter-lipid-bilayer transfer and recruitment of Kras 
to other compartments like mitochondria (Bivona et al., 2006) and Golgi (Fivaz and 
Meyer, 2005) or rapamycin-induced recruitment to mitochondrial membranes (Silvius 
et al., 2006) also occur by diffusion through endomembranes rather than vesicular 
membrane trafficking. Intervesicular membrane trafficking occur at much slower rate 
at lower temperatures as compared to rapamycin induced redistribution to various 
intracellular sites at the same temperature observed in case of FRB-Ras system 
(Silvius et al., 2006). Additionally simultaneous depletion from different membranous 
compartments occur at much faster rate at 22°C which might not true if vesicular 
membrane trafficking is involved (Silvius et al., 2006). This affirms the role of a 
generic solubilization based diffusion system for protein exchange between diverse 
cellular membranes, which is unaccountable by specific membrane trafficking 
pathway. 
4.4.3 Prenylation specificity of PDEδ  and its homologues 
Characterizing the binding constants of PDEδ towards semi-synthetic Ras proteins 
showed its preference towards farnesylated, carboxymethylated Ras proteins (Chen et 
al., 2010). Confirming our findings, this in vitro study also revealed that PDEδ does 
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not binds geranylgeranylated Ras proteins with similar affinity. Although it is clear 
that PDEδ is not a GSF for geranylgeranylated Ras proteins, details regarding the 
involvement of any other GDI-like protein in their active transport are still elusive. 
One such candidate is the Human retinal gene 4 (HRG4) or UNC119, a photoreceptor 
synaptic protein homologous to PDEδ. HRG4 also interacts with Arl2 in a nucleotide 
dependent manner (Veltel et al., 2008). Since HRG4 has similar residues as in the 
binding pocket of PDEδ and interacts with Arl2, it is tempting to suggest that HRG4 
might have a chaperone activity for the transport of lipidated proteins. 
UNC119, a C. elegans ortholog of HRG4 is predominantly present in retinal cells and 
is involved in transducin trafficking. Although UNC119 main function has been 
described in photoreceptors, it is also expressed in leukocytes, T cells, fibroblasts etc. 
Also UNC119 has been found in flagellar prosites, indicating that UNC119 could 
function in transport of wide range of proteins apart from GPCRs. Recently a crystal 
structure of UNC119 in complex with transducin-alpha (Tα) was solved (Zhang et al., 
2011). The structure shows UNC119 adopts an immunoglobulin like fold and has a 
hydrophobic pocket similar to PDEδ and RhoGDI. The complex structure also shows, 
how a lipid moiety, in this case a myristoyl group could bind to the UNC119 lipid 
binding pocket. Unlike the structures RhoGDI and PDEδ with a lipid moiety in the 
hydrophobic pocket (see chapter 5), the UNC119 complex structure reveals the 
entrance of beta-sandwich fold pried open. The opening of the UNC119 pocket is 
occupied by the first six amino acids of Tα with the myristoyl chain deeply inserted 
into the cavity. Therefore from the structure and biochemical studies it was suggested 
that in UNC119 the amino acids adjacent to the lipidation site could play a role in 
specificity (Zhang H et al., 2011). 
In another dimension, the structure also shed light in to the specificity of 
HRG4/UNC119 towards different lipid moieties. Since the UNC119- Tα – myristoyl 
group shows that the myristoyl group is inserted deep in the pocket and the entrance is 
occupied by six amino acids from the Tα (14 carbon + 6 amino acids). This suggests 
that the UNC119/HRG4 could potentially accommodate a geranylgeranyl group (20 
carbon) in the pocket. Moreover, the first few amino acids adjacent to the acyl group 
are GAGASA, which has no or small side chains in a way similar to the carbon chain 
in long chain fatty acids further supporting the notion of a geranylgeranyl group and 
HRG4 interaction, which still needs to be tested. 
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In a recent complementary study in collaboration with Ismail et al., 2011 
(unpublished) it was demonstrated that the delivery of farnesylated Ras to the right 
(trapping) membrane compartment is an active, regulated process, where unloading 
from PDEδ is facilitated by the interaction with the local active state of another G-
protein (see chapter 5). Such a mechanism not only emphasizes a crucial role of PDEδ 
in spatially and temporally regulating farnesylated Ras proteins. But also projects it’s 
potential as an indispensible mediator of synergy between Arl and Ras signaling 
pathways. An interesting preposition regarding such a crosstalk is regulation of PDEδ 
by Arl2/3 in release and /or uptake of these prenylated Ras proteins, which has been 
tested and discussed in chapter 5 of this thesis. Interaction of Arl2 with PDEδ 
involves β-sheet/β-sheet interface (Hanzal-Bayer et al., 2002) and not the 
hydrophobic pocket hence raising prospect for formation of a transient ternary 
complex. Hence, Ras:PDEδ complex can be regulated by local concentration of 
activated Arl2/3. Such an event will lead to displacement of Ras and subsequent 
termination of Ras signaling. Further investigation will decipher other important 
aspect of PDEδ synchronization with Arl family proteins and their effect on Ras 
signaling, most essentially implications of regulatory microtubular/cytoskeletol 
machinery by Arl-PDEδ complex (Zhou et al., 2006a). Such findings can emphasis on 
the role played by cytoskeletal machinery in impeding long-range lateral diffusion 
within PM of Kras like proteins. 
Whether PDEδ is involved in active extraction of prenylated, lipidated Ras 
proteins from the PM? 
Considering the fact that not all interaction partners of PDEδ process palmitoyl 
modifications that can be cleaved by depalmitoylating enzymes, it remains an open 
issue how an active solubilization event occurs that mediate extraction of different 
proteins and how is it triggered, if solely the C-termini of the proteins are the binding 
determinants. Although involvement of PDEδ in mediating active protein extraction 
from PM as described in case of RhoGDIs is still unknown. As in such a scenario the 
overexpression of PDEδ will result in rapid solubilization of polycationic Ras protein, 
which is indeed not the case (Figure 4.3A). PKC mediated phosphorylating events at 
S181 of Kras-4B (Bivona et al., 2006) triggers the dissociation of the Kras protein 
from the PM and its reassociation with low affinity endomembranes thus suggesting a 
model in which PDEδ is not actively involved in extracting Ras proteins. Instead 
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PDEδ functions as diffusion facilitator and aids in mixing by solubilization to rapidly 
relocate mistargeted, depalmitoylated dephosphorylated Ras in order to restore 
equilibrium. 
4.4.4 Modulating Ras signaling at the PM 
Dynamic regulation of compartmentalized and segregated Ras proteins is essential for 
maintaining their signaling specificity (Rotblat et al., 2004; Dekker et al., 2010; 
Rocks et al., 2005). Proteins attain various reversible and irreversible modifications in 
order to gain access to specific signaling compartments and thus sustain their 
signaling capacity. The steady state distribution of Ras proteins maintained by 
acylation cycle, as well as their inter compartmental exchange-rate maintained by 
specific GEFs and GAPs thereby regulating their signaling potential. Affecting the 
spatial organization of Ras thus provides a new means of modulating Ras signaling. 
PDEδ levels in cells serve as an important determinant of the signaling outcome of 
Ras activity by growth factor receptor stimulation or due to oncogenic mutation. In 
human hepatocarcinomas (HepG2) cells, the Erk (MAPK) signaling is triggered by 
PKCα mediated MEK activation, independent of Ras and Raf (Wen-Sheng W, 2006). 
By re-introducing PDEδ in HepG2 cells, Ras localization (Figure 4.18, Figure 4.19) 
and thereby EGF-induced Ras-mediated signaling (Figure 4.20) could be re-instated.  
This indicates that the restoration of Ras spatial localization by PDEδ gears up Ras-
Raf mediated Erk stimulation from the PM. This partnership determines the strength, 
duration, and selectivity of the Ras signal. Ability of PDEδ to redeem Ras-Raf 
dependent Erk signaling might also rescue HepG2 cells from growth inhibition 
observed due to TPA induced PKCa hyperactivity (Wen-Sheng W., 2006).  
Similarly, down-regulation of PDEδ levels in both human transformed cell lines 
engineered to stably express oncogenic HrasG12V and mPDAC lines expressing 
endogenous oncogenic KrasG12D caused decreased phosphorylated Erk levels 
(Figure 4.21) as well as reduced cell proliferation (Figure 4.23), indicated that PDEδ 
also modulates the signaling from oncogenic Ras by affecting its localization. 
Selection processes in the clonogenic assay, that became apparent after several days, 
can lead to the restoration of phosphorylated Erk levels without increase in 
downregulated PDEδ levels. This suggests that these tumorigenic cells either switch 
to a Ras-independent Erk signaling pathway or, alternatively, strongly overexpress 
oncogenic Ras. In the latter case, the high level of spatially randomized oncogenic 
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Ras generates a sufficiently high residual population at the PM, which efficiently 
couples to the Raf/Mek/Erk pathway. 
4.4.5 PDEδ gene targeting studies 
PDEδ specific gene targeting studies performed on mice showed anomalous 
photoreceptor physiology attributed to defective transport of membrane associated 
proteins and progressive rod/cone dystrophy (Zhang et al., 2004). Although, PDEδ 
knockout mice exhibit a notable reduction in body weight (20-30%) as compared to 
wild-type controls, lack of embryonic lethality argues against its functional relevance. 
These findings are logical with regard to reduced cell proliferation observed in case of 
oncogenic Kras transformed mPDAC cell-lines as demonstrated in this work (Figure 
4.23). The biological significance of PDEδ mediated Ras signaling has also been 
challenged by the broad spectrum of PDEδ interacting farnesylated proteins. In 
argument to this, while Hras/Nras double knockout mice are viable (Esteban et al., 
2001; Umanoff et al., 1995), Kras gene disruption results in embryonic lethality 
(Koera et al., 1997; Plowman et al., 2003) exhibiting its’ indispensible nature. Hence 
even though PDEδ  has a broad range of effects on different Ras family protein, there 
remains a good possibility that the weight reduction phenotype observed in 
PDEδ knockout mice indeed stems from Kras mislocalization and reduced Kras 
signaling during development. 
By knocking down PDEδ in “normal” cells, Ras is diluted over all membranes in the 
cell, yet the remaining Ras at the PM can still signal – although with lower strength 
and thereby can maintain a basal functionality as in the developmental processes in 
mice. However, in oncogenic Ras transformed cells, down-regulation of PDEδ lowers 
the dose of (strong) oncogenic Ras signaling from the PM. In this case, the residual 
wild type Ras (encoded by the other of the two alleles) can signal in a low-dose 
regime from the PM that now allows cells to respond to extracellular cues again and 
thereby reinstate their normal function. Therefore interrupting the PDEδ-Ras 
interaction can be therapeutically very valuable since it would still allow "normal" 
cells" to exhibit sufficient external-cue-guided Ras signaling to function, whereas 
persistent oncogenic signaling would be strongly decreased. Thus the regulation of 
Ras localization and signaling by the solubilizing factor PDEδ (GSF) implicates this 
mechanism as an attractive target for cancer therapeutics. The spatial and temporal 
regulation of the PDEδ-Ras complex is crucial for Ras enrichment at the PM and thus 
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has a profound effect on oncogenic Ras signaling by coupling to downstream 
effectors. Pharmacological targeting of this interaction might also provide a means to 
lower the oncogenic Ras dose at the PM below a threshold that fully activates the 
wild-type Ras expressed from the non-mutated allele. Here, the allosteric RasGTP 
binding site on SOS (Margarit et al., 2003) might provide the feedback that activates 
wild-type Ras by binding oncogenic Ras in a dose dependent manner. By lowering 
the dose of Ras at the PM this local feedback is weakened to a point that again allows 
growth factor induced switching of the wild type Ras, and thereby cellular decisions 
to be taken. However, if the dose of oncogenic RAS at the plasma membrane is high 
enough to overcome a threshold, all Ras in the cell is activated and can no longer 
switch in response to extracellular stimulation as observed mostly in case of 
transformed, tumor cells. This situation is analogous to PDEδ downregulation 
obtained on treatment with siRNA/shRNA, which can reduce effective dose of 
oncogenic Ras in proximity to the plasma membrane below a threshold needed to 
activate SOS feedback.  
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5.1 Abstract 
GDI like solubilizing factor (GSF)- PDEδ binds, solubilizes prenylated Ras proteins 
and aids in delivering Ras proteins to their specific, cognate membrane compartments. 
Here a novel, GDI displacement factor (GDF) that can release GSF PDEδ from 
prenylated Ras proteins has been described. Crystal structure of fully modified 
farnesylated Rheb in complex with PDEδ [Ismail S.A et al., 2011, Nature Chem. 
Biol., 2011(In press)] deciphered in collaboration with this study contributes to our 
knowledge of how farnesylated group interacts with residues in the hydrophobic 
pocket.  Live cells experiments performed concomitantly along with structural, 
biochemical evidence provides a mechanistic overview of how G-proteins Arl2/Arl3 
act in a GTP-dependent manner as allosteric release factors for farnesylated cargo. 
Thus a novel transport mechanism specific for PDEδ binding farnesylated G-proteins 
and regulation by its decisive GDF has been described in this work. 
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5.2 Rationale and hypothesis 
GDI like solubilizing factor (GSF)- PDEδ binds, solubilizes prenylated Ras proteins 
(GNBPs) and aids in delivering Ras proteins to their specific membrane 
compartments {Chandra et al (unpublished)}. However, the mechanism involving the 
release of prenylated Ras from PDEδ  is  still elusive. Various factors (GDI 
dissociation factors- GDFs) has been described previously that mediate release of 
prenylated GNBPs from their corresponding GDIs (Dirac-Svejstrup et al., 1997; 
Takahashi et al., 1997). GNBPs complexed to their GDI in the GDP-bound form are 
not substrates for their cognate GEFs (Takai et al., 1995). Rather, GDFs are needed to 
dissociate the GNBP from its GDI before activation can take place.  
Arl2 forms complex with PDEδ in a nucleotide dependent manner (Hanzal-Bayer et 
al., 2002) and based on similarity to Arf family proteins and their important 
contribution in intracellular vesicular transport, it has been hypothesized that Arl 
proteins might mediate transport of prenylated proteins in conjugation with PDEδ in 
photoreceptor cells (Figure 5.1) (Zhang & Baehr., 2006).  
 
 
Figure 5.1 Proposed role of Arl in photoreceptor physiology  
 (From Zhang & Baehr et al., 2005). 
 
According to the proposition, in the photoreceptor cells prenyl-binding protein 
(PDEδ) solubilizes C-terminal prenylated GRK1 from the endoplasmic reticulum 
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(ER) for post-translational modifications. The resulting soluble protein complex 
interacts with a trafficking protein such as Arl2/3‐ GDP. An unidentified guanine 
nucleotide exchange factor (GEF) exchanges GDP with GTP to activate Arl2/3, and 
the complex is then transported through the connecting cilium. When a GTPase 
activating protein (GAP) accelerates GTP hydrolysis on Arl2/3, the complex falls 
apart and GRK1 associates with the disk membrane in the outer segment. 
Concurrently, Arl2/3‐GDP and PDEδ return to the inner segment to participate in 
another round of protein transport.  
The hypothetical model raises several concerns including proposed role of Arl. 
Contrary to previous belief, it has been reported that intraflagellar transport (IFT) that 
is required for the assembly and maintenance of cilia (ciliogenesis), is negatively 
regulated by Arl3 (Li et al., 2010). Which contradicts the proposed function of Arl in 
facilitating diffusion of prenylated proteins and rather presents Arl2/3 as a potential 
candidate for GDI displacement factor (GDF) for PDEδ. This further adds an 
additional level of complexity to the spatial activity of Ras family proteins. Moreover, 
as proposed in the aforementioned model where PDEδ prematurely binds Arl2-GDP 
and later is activated by a specific GEF. This seems highly implausible as interaction 
with PDEδ is dependent on GTP and the binding substantially stabilizes GTP binding, 
increasing affinity and decreasing dissociation rates by a similar factor (Hanzal-Bayer 
et al., 2005; Hanzal-Bayer et al., 2002). Thirdly, unlike most other Ras proteins, Arl2 
has micromolar affinity for nucleotides that allows rapid exchange and precludes the 
requirement of a GEF (Hanzal-Bayer et al., 2005). 
Considering the cellular environment where three times lower affinity for nucleotides 
and the estimated 50-fold higher concentration of GTP would result in most of the 
Arl2 in GTP bound form. Hence Arl2 would be able to interact with effectors where 
reduced GTP dissociation will assist in increased stability and lifetime of the 
complex. In such a scenario Arl2-specific GAP would not be able to form complex 
with Arl2. Since PDEδ seems to be involved in binding farnesylated CaaX box 
GNBPs, the regulation of the Arl2-GTP binding cycle might thus not be due to the 
action of GEF and GAP, but rather due to the transport and release of prenylated 
proteins. 
Thus in order to delineate role of Arl2/3 in regulating PDEδ binding to prenylated 
GNBPs, in this work the following aspects has been investigated: 
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Whether PDEδ*Arl & PDEδ*Ras complex are mutually exclusive or involves 
either a stable or transient tertiary complex formation? 
 
Whether Arl2/3 contributes to diffusion/transport of PDEδ  bound prenylated Ras 
or it mediates release of Ras from PDEδ  complex? 
 
What is the mechanism that accounts for release of Ras from PDEδ  in presence of 
Arl2/3? 
 
Visualizing spatial activity of PDEδ-Arl2/3 complex and its role in regulating 
PDEδ-Ras activity in mammalian cells. 
 
Characterizing PDEδ  mutants, defective for Arl2/3 binding and their effect in vivo. 
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5.3 Results 
5.3.1 Conformational differences between far-Rheb•PDEδ  and 
Arl2•GTP•PDEδ  complexes  
In a collaborative study with Shehab Ismail [Ismail S.A et al., 2011 (unpublished)], 
structure of PDEδ in complex with C-terminally modified (S-farnesylated, 
carboxymethylated) full length Rheb (Chen et al., 2010) was determined (Figure 5.2). 
The structure clearly revealed the binding pocket of PDEδ with Rheb farnesyl group 
embedded into the hydrophobic pocket. Additional electron density for C-terminal 
177-181 residues, contacting the PDEδ with main chain atoms that involves a PDEδ  
flexible loop (residues 111 to 117) was observed.  
       
 
Figure 5.2 Structural analysis of farnesylated Rheb*PDEδ  complex 
(A) Ribbon representation of F-Rheb in green, with the farnesyl group in red 
and switches in yellow, in complex with PDEδ in grey and the flexible loop 
in light brown. GDP bound to Rheb is shown as ball-and-stick (B) Surface 
presentation of PDEδ, with transparency set at 40%, showing the farnesyl 
deeply penetrating PDEδ. Farnesylated Rheb*PDEδ complex was solved by 
Shehab Ismail (Post-doctoral fellow in laboratory of Prof. Alfred 
Wittinghofer). Figure reproduced from Ismail S.A et al., 2011 (unpublished). 
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Analogous to Rac*RhoGDI complex (PDB: 1HH4) (Figure 5.3), the structure, also displayed negative charge on the surface close to C-terminus of 
Rheb [Ismail S.A et al., 2011(unpublished)] (Figure 5.3). This would explain the binding of polycationic C-terminus containing Ras proteins for 
instance Kras-4B as reported in chapter 4.  In contrast to RhoGDI, the PDEδ binds prenylated Ras only at the C-terminus, not involving the switch 
regions as indicated in Figure 4.6 (Chapter 4). In addition to this, the binding does not involve contributions from prenylated Ras unlike CDC42-
RhoGDI binding.  
 
Figure 5.3 Electrostatic surface charge distribution 
(A) RhoGDI (gray) bound to Rac (orange) (B) PDEδ (gray) in complex with Rheb (green) showing the negative charges surrounding the 
opening of the farnesyl binding pocket (marked by yellow circle). The polycationic C-terminus of Rac and Rheb is indicated in blue and the C-
terminus geranylgeranylated lipid moiety (A) and farnesylated peptide (B) is shown in yellow.  
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5.3.2 Rationale design of PDEδ  mutants: Structural insights  
(A) Mutants influencing prenylated Ras*PDEδ interaction:  
Mutations were designed to interrupt the binding of farnesylated group into the PDEδ 
binding pocket. Based on the structural similarity to RhoGDI, the lipid-binding pocket 
in the PDEδ structure could be deduced. From the Arl-PDEδ complex structure, two 
residues were chosen which are present at the entrance of PDEδ pocket (Figure 5.4). 
V80 and V127 were mutated to tyrosine (Y). Tyrosine has a bulky side chain and the 
presence of a bulky residue might sterically hinder the prenyl group from entering in 
to the PDEδ pocket. Although V127 is not visible in the structure, based on sequence 
similarity and UV cross-linking studies (Alexander et al., 2009) V127 residue was 
also mutated (Figure 5.4).  
 
Figure 5.4 Diagrammatic representation of hydrophobic pocket of PDEδ  
(yellow) in complex with Arl2 (not shown) 
  (A) Top view (B) Front view indicating mutation at residue V80 (red) (left side 
pane) present at the entry of the prenyl-binding pocket. Right side panel: The 
V80 position when mutated to tyrosine (Y) The V80Y mutation was modelled 
in 1KSG pdb coordinates.  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 (B) Mutants influencing Arl2*PDEδ interaction: 
Arl2*PDEδ interface: 
The complex structure of Arl2*PDEδ (Figure 5.5) was used to introduce mutations in 
PDEδ to disrupt Arl2 binding (Hanzal-Bayer et al., 2002). Out of 8 main chain - main 
chain interactions, two residues in PDEδ, Q106 and T104 were mutated to lysine in 
the interface of Arl2-β2*PDEd-β7 complex.  Since the Arl2-β2*PDEd-β7 sandwich 
is dominated by main chain interaction Q106K and T104K did not affect the interface 
(data not shown). 
PDEδ F94A/I98A mutation: 
 
On the other hand a large number of hydrophobic residues from PDEδ are involved in 
the interface with Arl2 (Figure 5.5). Therefore, Phe 94 and Ile 98 were mutated to Ala 
(A) to disrupt Arl2 binding. In the meantime the farnesylated Rheb*PDEδ complex 
structure was solved and showed that the Phe94 undergoes a conformational change 
between open and closed states [Ismail S.A et al., 2011(unpublished)]. Therefore, 
these two residues might be good candidates for testing the effect on the allosteric 
regulation by Arl2.  
 
Figure 5.5 The interface of Arl2 and PDEδ-Schematic representation 
Interactions as dotted lines. Residues are boxed; circles represent water 
molecules. Figure reproduced from Hanzal-Bayer et al., 2002. 
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PDEδ G28V mutation: 
 
Due to cloning artifact, PDEδ featured an additional mutation at Gly 28 to Val 
(G28V). As shown in (Figure 5.5), substitution of Val in place of Gly at position 28 
could affect the Arl2-PDEd interface. Although the G28V on itself did not show any 
observable effect in vitro and in vivo (see section 5.3.5). The V80Y mutation in the 
G28V background showed dramatic effects. This could be due to the presence a bulky 
residue at the entrance of PDEδ lipid binding pocket. This bulky residue could lead to 
a distortion in the binding pocket, which is transmitted to the Arl2 interface. 
Therefore, the G28V mutation was further analyzed using cell biological and 
biochemical methods (see section 5.3.5). 
 
Figure 5.6 Mutations influencing Arl2*PDEδ  interaction 
PDEδ (yellow) in complex with Arl2-GTP (gray). Mutations are shown is red 
were modeled in to the 1KSG pdb coordinates. Enlarged pictogram is 
depicted on right side. 
 
5.3.2.1 Spatial distribution of Ras*PDEδ  in presence of constitutive 
active Arl2  
Based on these structural predictions, the regulation of PDEδ*Ras complex by Arl2 in 
living cells was investigated. The effect of PDEδ on the spatial localization of Rheb 
was observed in presence or absence of Arl2. Since the binding of Arl2 to PDEδ is 
dependent on nucleotide state (Hanzal-Bayer et al., 2002), a constitutively active Arl2 
mutant (Arl2Q70L) was thus expressed to visualize the effect. MDCK cells were 
transiently transfected with either wild-type Rheb labeled with monomeric Cherry 
fluorescent protein (mCherry-Rheb) or co-expressed with monomeric citrine 
(mCitrine) fused to PDEδ. As expected the cells expressing mCherry-Rheb showed a 
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clear endomembrane localization mostly labeling Golgi apparatus and ER (Figure 5.7; 
first row). Co-expression of mCherry-Rheb and mCitrine-PDEδ resulted in an 
apparent homogenous cytoplasmic distribution of Rheb supporting the idea that PDEδ 
is a solubilizing factor for farnesylated Rheb (Figure 5.7; second row) (chapter 4 of 
this thesis). Interestingly, in cells co-expressing mCherry-Rheb, mCitrine-PDEδ and 
mTFP-Arl2Q70L no Rheb solubilization was observed. Instead, mCherry-Rheb 
localized at the endomembranes analogous to the steady state distribution of 
mCherry-Rheb observed when Rheb was expressed alone (Figure 5.7; third row). 
Similarly, the partially solubilized mCherry-Nras coexpressed with PDEδ (Figure 5.7; 
third row), relocalized to its specific plasma membrane (PM) and Golgi compartment 
in the presence of mTFP-Arl2Q70L. This suggests that Arl2 and farnesyl-Rheb/Nras 
binding to PDEδ is mutually exclusive. In the presence of Arl2, PDEδ and Rheb/Nras 
binding is abrogated thus resulting in restoration of Rheb/Ras spatial distribution. 
To test this, PDEδ mutants defective in responding to Arl2 were designed as 
explained in section 5.3.2. Expression of mCitrine-PDEδ F94A/I98A mutant in 
MDCK cells resulted in complete solubilization of Rheb/Nras (Figure 5.7; fourth row) 
similar to that observed for PDEδ wild-type (Figure 5.7; second row). However, 
MDCK cells expressing all the three plasmids DNA encoding mCitrine-PDEδ 
F94A/I98A, mCherry-Rheb/Nras wt and mTFP-Arl2Q70L displayed partial 
solubilization with reduced soluble fraction in the nucleus (Figure 5.7; fifth row). This 
was indicative of impaired function of PDEδ mutant in presence of ArlQ70L, 
probably due to its weakened binding to Arl2. 
In order to quantify the effective solubilization of mCherry-Rheb/Nras in MDCK cells 
co-expressing either mCitrine-PDEδ wt or F94A/I98A mutant in presence and 
absence of mTFP-Arl2Q70L, spectral overlap coefficients (Manders coefficients) 
were determined. Manders coefficient were generated by applying Intensity 
Correlation Analysis (ICA) (Li.Q et al., 1004) representing co-localization of 
mCherry-Rheb/mCherry-NRas with either mCitrine-PDEδ wt or PDEδF94A/I98A 
(Figure 5.7; lower right bar graphs). Even though marked change in solubilization of 
Rheb/Nras in case of PDEδ wt and PDEδ F94A/I98A mutant was observed, on 
quantification using Manders coefficient, no significant difference was determined. 
Thus, fluorescence intensity in the nucleus of these cells was determined and 
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compared in each case. The integrated nuclear intensity obtained after background 
subtraction was normalized to total cell intensity and a comparison was made for each 
situation. As expected very less nuclear intensity values were obtained in case of 
triple expression with PDEδ wt comparable to expression of Rheb/Nras alone 
indicating so solubilization. In contrast, values obtained in case of triple expression 
with PDEδ F94A/I98A mutant were more as compared to the previous case but were 
significantly low as compared to situation that represented complete solubilization. 
These observations were consistent with the biochemical experiments performed 
using C-terminally modified lipidated farnesylated-Rheb peptide in collaboration with 
A.Wittinghofer group [Ismail A. S et al., 2011 (unpublished)]. While visual 
examination of individual cells indicated a difference between co-expressing 
Rheb/NRas and PDEδ and coexpressing Rheb/NRas, PDEδ(F94A/I98A) and 
Arl2Q70Lin localizing Rheb/NRas, in particular the nucleus, the Manders coefficient, 
which summarizes the fluorescence intensity difference between the two channels 
pixel by pixel over a number of cells, clearly showed that the PDEδ mutant does not 
release Rheb or NRas 
. 
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Figure 5.7 Restoration of Rheb and NRas cellular steady state localization upon Arl2Q70L expression 
(A) The first panel, MDCK cells expressing Rheb labeled with monomeric Cherry fluorescent protein (mCherry-Rheb) (green) the second panel, 
MDCK cells expressing mCherry-Rheb (green) and PDEδ labeled with monomeric Citrine fluorescent protein (mCitrine-PDEδ) (red) the third 
panel, cells expressing mCherry-Rheb (green), mCitrine-PDEδ (red) and Arl2Q70L labeled with monomeric teal fluorescent protein (mTFP-
Arl2Q70L) (gray), the fourth panel is the same as third panel with the double mutant (94/98) PDEδ instead of the wild type  (B) Same 
experiment as in (A), with mCherry-NRas instead of mCherry-Rheb. Bar graph on extreme right of each panel: Manders' coefficient (n= 8-10 
cells each) representing co-localization of mCherry-Rheb/mCherry-NRas with mCitrine-PDEδ wt (bar 1) or with mCitrine-PDEδ wt in the 
presence of Arl2Q70L (bar 2) or with mCitrine-PDEδ F94A/I98A in the presence of Arl2Q70L (bar3).…                                                  …    
………………..llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll
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5.3.3 Disruption of Rheb*PDEδ  complex by Arl2Q70L 
The above data and findings from biochemical, FCCS experiments done in 
collaboration (Yong Xiang Chen and Alexandra Rusinova) suggested that Arl2 and 
farnesyl-peptide binding is mutually exclusive. Since for both Arl2 and Rheb/Ras 
PDEδ binding sites are non-overlapping (farnesylated moiety of Rheb binds in the 
hydrophobic pocket whereas Arl2 share a βsheet-βsheet interaction), one would 
deduce an allosteric mode of regulation. In vitro fluorescence polarization 
experiments also indicated a reduced polarization signal on addition of Arl2GppNHp 
to the F-Rheb*PDEδ complex formed initially (indicated by high polarization signal) 
in a nucleotide and concentration dependent manner [Ismail S. A et al., 
2011(unpublished)]. In a different experiment with labeled F-Rheb peptide indicated 
that the release of Rheb from PDEδ by Arl2 is also concentration dependent [Ismail S. 
A et al., 2011(unpublished)]. Hence, in order to validate the mechanism for release of 
farnesylated Rheb/Ras from PDEδ by Arl2 in cellular environment, we performed 
FRET based FLIM (Fluorescence Lifetime Imaging Microscopy) in MDCK cells. 
Fluorescence lifetimes of FRET pair donor mTFP fused to Arl2 Q70L were measured 
in presence and absence of PDEδ and Rheb/Nras Fluorescence lifetime of mTFP-
Arl2Q70L alone was detected around 2.7ns similar to the reported lifetime of mTFP 
fluorophore at 37°C (Walther et al., 2011) ensuring that the mutation does not 
influence the lifetime decay of mTFP. Next, cells co-expressing mTFP-Arl2Q70L and 
mCitrine-PDEδ wt were measured. A significant reduction in donor fluorescence 
lifetime was recorded (τAv= 2.4±0.1ns) indicating efficient FRET between donor 
mTFP-Arl2Q70L and acceptor mCitrine-PDEδ (Figure 5.8, left bar graph). FRET 
efficiency was also determined indicated by alpha (α) values (Figure 5.8, right bar 
graph). Then, the lifetime decay curves of donor mTFP-Arl2Q70L were obtained in 
cells co-expressing either mCitrine-PDEδ wt (Figure 5.8, second row in each panel) 
or mCitrine-PDEδ F94A/I98A (Figure 5.8, third row in each panel) along with 
mCherry-Rheb (Figure 5.8A)/mCherry-Nras (Figure 5.8) to determine if the binary 
complex of Arl2 and PDEδ sustains in presence of Rheb/Ras. As indicated in Figure 
5.8, reduction in fluorescence lifetime of mTFP fused to ArlQ70L in this case (binary 
complex) was comparable to that of cells in absence of Rheb/Nras (τAv= 2.3±0.10ns). 
The Rheb/Nras localization in these cells was similar to their steady state distribution. 
The PDEδ F94A/I98A mutant also demonstrated similar binding affinity with 
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comparable α with exception to solubilization effect on Rheb/Nras as described 
previously (Figure 5.7). This affirms the previous findings from biochemical data that 
the interaction of Rheb/Nras*PDEδ and Arl2*PDEδ is mutually exclusive and Arl2 
acts as a displacement factor for farnesylated proteins bound to PDEδ. 
 
Figure 5.8 PDEδ double mutant and wild type interaction with Arl2 Q70L  
FLIM-FRET measurements in MDCK cell co-expressing mTFP-Arl2Q70L 
and mCitrine-PDEδ in the presence of mCherry-Rheb (A) or mCherry-Nras 
(B). For each sample, the fluorescence intensity of mTFP–Arl2Q70L (donor), 
the fluorescence intensity of mCitrine-PDEδ (acceptor), the spatial 
distribution of the mean fluorescence lifetime (τav) and the fraction of 
interacting molecules (α) are shown according to the false color lookup 
tables. τav values are distributed between 2 - 2.8ns where the higher lifetimes 
are indicated by red and the lower lifetimes are indicated by blue color. 
Fluorescent lifetime of the donor mTFP-Arl2Q70L is close to 2.7ns. On the 
extreme right hand side, enlarged micrograph exhibiting distribution of Ras 
proteins such as Rheb (A) and Nras (B) is shown. Lower row in each panel 
(A & B) represents FLIM measurements performed with mCitrine-PDE 
F94A/I98A double mutant. Enlarged micrograph of mCherry-Rheb 
distribution (extreme right) in these cells shows partial solubilization. 
Presented micrographs are representative of at least 8-12 independent 
measurements. (C) Quantified average lifetimes (left graph) and mean a 
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(right graph) for donor mTFP-ArlQ70L with mCitrine-PDEδ wt (black) or 
mCitrine-PDEδ F94A/I98A (gray) as acceptor in cells coexpressing 
mCherry-Rheb/Nras. Values for average lifetime and α  in cells  expressing 
donor mTFP-Arl2Q70L with mCitrine-PDEδ wt or mCitrine-PDEδ 
F94A/I98A as acceptor in absence of mCherry-Rheb/Nras are represented in 
white and red bars respectively (n=8-12).  
5.3.4 Influence of PDEδ  mutants on Golgi apparatus 
To characterize the PDEδ mutants designed to block interaction with Ras (described 
in section 5.3.2), MDCK cells were transfected with mCitrine-Ras and mCherry fused 
PDEδ mutants co-expressed with either GalT (Golgi specific marker) or Calreticulin 
(ER specific marker). Cells were then visualized on a confocal microscope to specify 
the spatial distribution of Ras in presence of these mutants. All of the PDEδ mutants 
also featured an additional mutation Gly 28 to Valine (G28V) (Section 5.3.2). As 
shown in Figure 5.9 cells expressing PDEδ constructs with only G28V mutation 
displayed similar Ras distribution, as in case of PDEδ wt expression. In contrast, the 
ectopic expression of PDEδ G28V/V80Y in MDCK cells affected Hras spatial 
distribution to some extent and exhibited dispersed Golgi apparatus with considerable 
size (Figure 5.9, left side panels). Golgi resident enzymes marked by GalT 
fluorescence (Golgi resident human galactosyltransferase enzyme) showed a 
remarkable distributed appearance (white arrows) and labeled the neighboring 
membranes. Introduction of an additional V127Y mutation (Section 5.3.2) further 
aggravated the leakage of Golgi resident enzymes across all membranes in the cell. 
Ras seemed to be trapped in membrane compartments. These PDEδ mutants showed 
no effect on ER indicated by Calreticulin staining (Figure 5.9). Similar observations 
were made for other Ras isoforms for instance Nras (Figure 5.9, middle panel) and 
Kras (Figure 5.9, right panel). To reevaluate the contribution of G28V mutation 
towards observed Golgi and Ras distribution, mutated Val was substituted back to 
Gly. Cells expressing PDEδ V80Y/V127Y without G28V mutation showed no 
redistribution of either Ras or Golgi resident enzymes (marked by GalT) (Figure 
5.10). 
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Also expression of only PDEδ G28V mutant with GalT resulted in a similar dispersed Golgi organization indicating that this effect is independent 
of Ras* PDEδ interaction and probably interferes with Arl2/3*PDEδ interaction. This also confirmed that G28V mutation alone has no impact on 
Golgi structure and organization but together with other mutations of residues lining the entrance of the PDEδ hydrophobic pocket may have a 
regulatory role in maintaining Golgi structure and function. 
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Figure 5.9 Effect of PDEδ  mutants on Golgi apparatus 
(A) MDCK cells expressing ECFP-GalT (Golgi specific marker) and 
mCitrine-Hras (left panel), mCitrine-Nras (middle panel), mCitrine-Kras 
(right panel) in presence of either PDEδ wt (First row of each panel), PDEδ 
G28V (second row of each panel), PDEδ G28V/V80Y (third row of each 
panel) or PDEδ G28V/V80Y/V127Y (fourth row of each panel). (B) Same as 
(A) with exception of second column indicating mTFP-Calreticulin (ER 
marker) co-expression in MDCK cells. Representative micrograph of 10-15 
cells each. Dispersed Golgi apparatus is indicated with white arrows in each 
panel. 
 
 
 
 
Figure 5.10 Substitution of mutated valine to glycine 
Ras steady state localization on remutating Val at position 28 back to Gly in 
PDEδ. Ras is indicated in red, GalT (Golgi specific marker) in green and 
PDEδ mutant expression in blue. DIC image is also shown (fourth column). 
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In order to further investigate the dramatic impact of PDEδ G28V/V80Y and 
G28V/V80Y/V127Y mutants on Golgi structure and organization, PDEδ sequences 
obtained from various species were aligned. The alignment showed that the Gly28 
residue is highly conserved across kingdoms (Figure 5.11). This observation raises a 
possibility for structural and functional conservation of Gly28 across the various 
species, thus implicating a pivotal role of Gly28 in maintaining Golgi structure by 
regulating Arl. 
 
Figure 5.11 PDEδ  sequence alignment in different species 
Sequence alignment of PDEδ shows conserved Gly28 in different species. 
Gly28 is highlighted in yellow. 
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5.4 Discussion and future perspectives 
5.4.1 Arl2 acts as a displacement factor for PDEδ  in cells 
Understanding the mechanisms by which signaling events are localized and the 
physiological consequences of spatial restriction is an important subject of 
investigation. This study was performed in collaboration with Ismail et al., 
2011(unpublished) where, a novel regulator [GDI displacement factor (GDF)] of 
GSF-PDEδ in complex with Rheb/Ras has been described. Insights from structural 
information derived from PDEδ*Rheb complex [Ismail et al., 2011(unpublished)] 
together with previously determined PDEδ*Arl2 complex (Hanzal-Bayer et al., 2002) 
provides a mechanistic overview of Arl2 function in teasing apart GSF/GTPase 
interaction. GDF Arl2 promote displacement and help recruit GTPase Rheb/Ras onto 
the membranes thus modulating G-proteins activation spatially and temporally. Since 
PDEδ is a pleiotropic factor capable of interacting with many different members of 
the same family, this suggests a generic role of Arl2 in modulating several of Ras 
family GTPases. 
G-protein bound RabGDI and RhoGDI structures revealed a fully open hydrophobic 
pocket. In analogy to the system described here, a GDF Arl2/3 would thus be 
expected to allosterically stabilize a closed conformation of the GDI. The different 
conformation of PDEδ in the two complexes together with mutual exclusion of the 
two interactions make the possibility of forming a ternary complex highly unlikely, 
although a short-lived transient complex is formed. Inability of allosterically defective 
Arl2 mutant F94A/I98A to displace Rheb from lipid-binding site of PDEδ in living 
cells further substantiated this claim. Such a mechanism would also seem logical for 
cells to temporally and developmentally regulate the process of membrane attachment 
via GDFs. 
In chapter 4 of this thesis, it has been demonstrated how signaling via wild-type as 
well as oncogenic Ras is affected by its subcellular distribution which in turn is 
modulated by Ras*PDEδ interaction [Chandra et al., 2011(unpublished)]. The 
establishment of Arl2/3 in allosterically regulating PDEδ-Ras/Rheb interaction opens 
up new prospects for targeting mutated Ras in tumorigenic models.  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5.4.2 Functional significance of regulated Ras release mechanism 
Much is known about the spatial regulation of Ras proteins, which are dominated by 
the lipid modifications (Rocks et al., 2005; Goodwin et al., 2005; Hancock et al., 
1989, 1990) and/or regulation by GEFs and GAPs. Although this modulates the 
biological activity of the protein, very little information about dynamic interaction of 
Ras with membrane microenviroments is available. Lipid microenvironments on the 
cell surface known as lipid rafts or caveolae also take part in the signal transduction 
process (Simons and Toomre, 2000); (Foster et al., 2003). In response to intra- or 
extracellular stimuli, signaling proteins enriched in these lipid rafts and caveolae 
undergo changes in either size or composition in order to activate signaling cascades. 
This has been demonstrated in a variety of membrane-anchored proteins such as Hras 
(Roy et al., 1999)(Prior et al., 2001). Hras association with lipid rafts allows it to exist 
in a dynamic equilibrium between the liquid-ordered and disordered plasma 
membrane. It has been demonstrated that GTP-loading redistributes Hras from rafts 
into bulk plasma membrane by a mechanism involving adjacent hypervariable region 
of Hras. GTP bound Hras moves in and out of these liquid-ordered and disordered 
membranes in a regulated manner thereby efficiently activating the Raf kinase. For 
such a regulated event, the proposed function of Arl in mediating Ras release as 
described in the work will help us understand the mechanics behind this event. 
PDEδ have been implicated in trafficking of agonist-induced internalization and 
recycling of IP receptors (Wilson and Smyth, 2006). IP receptors are mostly 
expressed partly in the lipid rafts (Liu et al., 2008) (Ostrom and Insel, 2004). 
Stimulation of the cell with a hormone or growth factor would lead to the transient 
fusion of lipid rafts. Alternatively, rafts could contain a nearly complete signaling 
pathway that would be activated when a receptor or other required molecule that is 
normally localized in the non-raft portion of the membrane is recruited into the raft. 
Thus, regulation either on account of Arl2/3 cycle or similar molecules could in 
principle be a way of enhancing the signaling specificity by receptor localization to a 
particular class of rafts that contain a specific subset of signaling components. Such a 
restriction would limit access of the receptor to the components of other signaling 
pathways and prevent crosstalk thus altering the spatial and temporal pattern of 
agonist-induced internalization and trafficking of these receptors. 
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Furthermore, the spatial localization of various Ras family proteins in the lipid rafts 
would suggest a similar regulatory mechanism where Arl2/3 mediated regulation 
could support focal activation of various pathways, introducing additional specificity 
into the response. 
Another interesting candidate - Rho6 [Rnd1; (Nobes et al., 1998)] is a binding partner 
of PDEδ (Hanzal-Bayer et al., 2002a). At the subcellular level, Rnd1 controls 
rearrangements of the actin cytoskeleton and changes in cell adhesion considering its 
high concentration at adherens junctions both in confluent fibroblasts and in epithelial 
cells. This Rho homologue has no GTPase activity as a result of low affinity for GDP 
and spontaneously exchanges nucleotide rapidly in physiological buffer. Furthermore, 
Rnd1 lacks intrinsic GTPase activity suggesting that in vivo, it might be constitutively 
in a GTP-bound form. Expression of Rnd1 or Rnd3/RhoE in fibroblasts inhibits the 
formation of actin stress fibers, membrane ruffles, and integrin-based focal adhesions 
and induces loss of cell–substrate adhesion leading to cell rounding. The transient 
interaction with PDEδ, regulated by the Arl2/3 cycle, could thus in a way regulate its 
spatial localization and biological activity at the focal adhesions, axon guidance and 
cell migration. 
5.4.3 GDI (-like) regulation via GNBP cross-talk 
Signal transduction pathways involving GNBPs are often regulated by other sub-
family GNBPs. For example, several Ras effectors in turn regulate the GEF and GAP 
activities of Rho and Arf family proteins. Although this type of regulation across 
GNBP sub families is a common theme in cell signaling, regulation via transport 
factors is often overlooked. In the case of Rho-GDI, so far few regulatory protein has 
been identified which aids or enhance the release of geranylgeranylated Rho family 
proteins. However, the Rho-GDIs have a role in stabilizing nucleotide and interacts 
with the switch regions of Rho proteins. It is widely accepted that the Rho-GDI 
binding interferes with GEF and GAP activity and also vice versa.  Thereby 
facilitating the release of geranylgeranylated Rho family proteins at the right place 
and time (Gregory R. Hoffman, 2000).  
Unlike the Rho-GDIs, the recently identified transport factor for Ras proteins, PDEδ 
is a GSF for Ras and an effector of Arl2/3 proteins [Chandra et al., 2011 
(unpublished); (Hanzal-Bayer et al., 2002)]. From the crystal structure of Far-Rheb-
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PDEδ, cell biological and biochemical experiments it is clear that the PDEδ does not 
bind to the Ras proteins except for the C-terminus. Therefore, it is thermodynamically 
unfavorable to release the farnesylated Ras protein, once the farnesyl group binds in 
to the PDEδ pocket. This creates a need for an external factor (GDF) such as Arl2/3, 
where the PDE interacts with ARL2/3-GTP, thereby inducing the conformational 
changes to release the farnesylated Ras. The allosteric regulation of PDEδ (a transport 
factor for Ras family) by Arf family (Arl2/3) represents a novel example of GNBP 
cross talking involving an additional tier of spatial and temporal regulation. 
5.4.4 Arl2*PDEδ  mediated Golgi structure and function maintenance 
The Arl proteins exhibit a great diversity of functions as they have been implicated as 
regulators of microtubule-dependent processes [Arl2 and Arl3 (Bhamidipati et al., 
2000; Zhou et al., 2006b; Sharer et al., 2002; Hoyt et al., 1990)], lysosome mobility, 
and microtubule binding [Arl8 (Hofmann and Munro, 2006; Okai et al., 2004)], 
ciliogenesis [Arl3 and Arl6 (Avidor-Reiss et al., 2004; Chiang et al., 2004; Fan et al., 
2004; Li et al., 2004; Pazour et al., 2005)], and tumorigenesis [Arl11 (Calin et al., 
2005; Petrocca et al., 2006)]. Evidence for a role for Arl2 in microtubule growth in 
cells and more recently in maintenance of energy (ATP) levels by newly identified 
Arl2 GAPs/effectors in the ELMO (Engulfment and cell motility) family indicates its 
involvement in regulation of mitochondria and golgi morphology. As described in this 
study, the effect of PDEδ mutants on Golgi morphology hence adds another key 
player in understanding Arl2 mediated complex signaling pathways. However, 
additional experiments need to be done in order to gain insight regarding involvement 
of PDEδ in regulating Arl2/3 and to determine the extent of overlap in their actions 
and protein partners thus affecting its biological functions. Several interesting 
propositions in this regard can be made for instance it can be postulated that 
ELMOD1 act in cells as an ArfGAP (Bowzard et al., 2007) in order to attenuate Arf 
signaling at the Golgi and impact membrane traffic also at the TGN, where it has 
effector properties.  
Apart from this the idea of Golgi-derived microtubules and their importance in 
organizing the Golgi itself also seems very tempting (Miller et al., 2009). Previous 
studies emphasizing on the role of microtubules in the organization and localization 
of Golgi apparatus (Miller et al., 2009; Sandoval et al., 1984; Wehland et al., 1983) 
Discussion and future perspectives 
 Anchal Chandra - Dissertation   139 
also provide scope for further investigation of these PDEδ mutants and to decipher the 
mode of regulation of Arl2/3 proteins via PDEδ.  
5.4.4 Significance of Arl mediated regulation in ciliary dysfunction 
The association of renal and retinal diseases with ciliary dysfunction is becoming 
increasingly appreciated. The functions of primary cilia in some organs are now being 
elucidated but in many other organs it has not been studied at all, and much remains 
to be done. Retinal photoreceptor physiology has been extensively studied in light of 
the visual transduction cascade--a prototypical G-protein coupled receptor 
transduction pathway. 
The human Arf subfamily of Ras superfamily contains 16 Arl proteins (Gillingham 
and Munro, 2007), most of which are uncharacterized with unidentified regulatory 
factors such as GEFs and GAPs. Both Arl2/3 and PDEδ has been implicated in 
photoreceptor physiology where PDEδ has been shown to be involved in trafficking 
of prenylated proteins such as catalytic subunit of PDE6 and GRK1 to the outer 
segment of photoreceptors via connecting cilium (Norton et al., 2005). Knocking out 
PDEδ resulted in reduced in 20-30% reduction in mice body weight thus implicating 
its role in mice development, mistargeting of prenylated proteins in the photoreceptor 
outer and inner segments as well as retinal degeneration (Zhang et al., 2007). On the 
other hand, Arl3 has been implicated in ciliary disease affecting the kidney, ciliary 
tract, pancreas, and retina. Mice with Arl3 (-/-) knockout exhibited abnormal 
development of renal, hepatic and pancreatic tubule structures indicative of autosomal 
recessive polycystic kidney disease. Excessive photoreceptor degeneration and 
abnormal epithelial cell proliferation and cyst formation were also characteristic of 
these Arl3 mutant mice. Inability of these mutants to thrive after 3 weeks suggests 
that it is an important regulator of intracellular signaling, vesicular trafficking 
pathways, and/or movement of cellular components within or along cilia.  
The mechanistic control of PDEδ activity by Arl as described in this work thus 
explains role of Arl3 to polarize the ciliated epithelial cells and prevent 
mislocalization of critical proteins via IFT. This is firmly supported by 
mislocalization of rhodopsin in Arl3 (−/−) rod cell bodies. With expression of PDEδ 
in renal tissues, one can speculate that dysfunctioning of renal primary cilia that 
modulate renal tubular epithelial cell proliferation and differentiation as reported in 
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Arl2(-/+) mice might involve spatial control of PDEδ mediated trafficking of ciliary 
proteins by Arl3 similar to what is described in this work.  
Several point mutations in Arl3 specific GAP – ‘RP2’ have been reported in case of 
retinal degenerative diseases such as X-linked retinitis pigmentosa. Additionally, 
PDEδ in also reported to interact and regulate another X-linked RP gene (RPGR) 
hence highlighting the specific functional role of different Arl proteins (Arl2/Arl3) in 
mediating ciliary transport. Based on the therapeutic significance of these mutations 
in regulating retinal signal transduction pathways, an intensive study involving ciliary 
protein transport will prove to be very promising in finding drug targets to treat 
retinitis pigmentosa.  
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